Victor J. Dzau
James B. Duke Distinguished Professor of Medicine
Current Appointments & Affiliations
- James B. Duke Distinguished Professor of Medicine, Medicine, Cardiology, Medicine 2005
- Professor of Medicine, Medicine, Cardiology, Medicine 2004
- Professor of Pathology, Pathology, Clinical Science Departments 2004
Contact Information
- Victor J. Dzau Laboratory GSRBII # Room 4015, Duke University, Durham, NC 27710
- Victor J. Dzau Laboratory, GSRBII # Room 4015, Durham, NC 27710
-
victor.dzau@duke.edu
(919) 668-5448
- Background
-
Education, Training, & Certifications
- Fellow in Cardiology, Medicine, Massachusetts General Hospital 1979 - 1980
- Chief Resident Physician, Children's Hospital Boston 1978 - 1979
- Postdoctoral Research Fellow, Physiology, Harvard University 1976 - 1978
- Fellow in Cardiology, Medicine, Massachusetts General Hospital 1976 - 1978
- Senior Assistant Resident, Children's Hospital Boston 1975 - 1976
- Clincal Fellow, Medicine, Harvard University 1974 - 1976
- Assistant Resident, Children's Hospital Boston 1974 - 1975
- Resident in Pathology, Pathology, Children's Hospital Boston 1973 - 1974
- Intern in Medicine, Medicine, Cornell University 1972 - 1973
- M.D., McGill University (Canada) 1972
-
Previous Appointments & Affiliations
- Research Professor of Global Health, Duke Global Health Institute, University Institutes and Centers 2011 - 2015
- Chancellor of Health Affairs, School of Medicine, Duke University 2004 - 2014
- Consulting Professor of Medicine, Medicine, Cardiology, Medicine 2004
- Recognition
-
In the News
-
JUN 11, 2014 Durham Herald-Sun -
JUN 10, 2014 Durham Herald-Sun -
APR 11, 2014 U.S. News & World Report -
MAR 28, 2014 Durham Herald-Sun -
FEB 26, 2014 WRAL -
FEB 21, 2014 Durham Herald-Sun -
FEB 21, 2014 News & Observer -
FEB 20, 2014 WRAL -
FEB 19, 2014 -
FEB 17, 2014 the News & Observer
-
-
Awards & Honors
- NAI Fellow. National Academy of Inventors. 2014
- Fellows. American Academy of Arts and Sciences. 2012
- Excellence Award for Hypertension Research. American Heart Association. 2001
- Member. Institute of Medicine of The National Academies. 1998
- Distinguished Investigator Award. American College of Clinical Pharmacology. 1992
- Research
-
Selected Grants
- Mandel 2021-2024 awarded by Edna and Fred L. Mandel, Jr. Foundation 2018 - 2023
- Integrated Cellular and Tissue Engineering for Ischemic Heart Disease awarded by University of Alabama at Birmingham 2016 - 2023
- Multidisciplinary Heart and Vascular Diseases awarded by National Institutes of Health 1975 - 2023
- Sfrp2 promotes cardiac regeneration via c-Kit(+) cell differentiation awarded by National Institutes of Health 2018 - 2022
- Novel strategy for Enhancing miRNA as a Therapeutic for Cardiac Regeneration awarded by National Institutes of Health 2016 - 2020
- Sfrp2 and Cardiac Progenitor Cells in Regenerative Response to Ischemic Injury awarded by National Institutes of Health 2005 - 2016
- Multidisciplinary Neonatal Training Grant awarded by National Institutes of Health 2010 - 2015
- Institutional Training Grant in Pediatric Cardiology awarded by National Institutes of Health 2009 - 2015
- Gene Therapy for Long-Term Myocardial Protection awarded by National Institutes of Health 2003 - 2014
- Genetically Altered Mesenchymal Stem Cell; Paracrine Effect on Neovascularization awarded by National Institutes of Health 2003 - 2014
- Agilent Direct Drive 9.4T MRS/MRI Console awarded by National Institutes of Health 2012 - 2013
- Renin Gene Expression in Cardiovascular Regulation: Mechanisms of JG Hyperplasia awarded by National Institutes of Health 1985 - 2013
- Role of Sfrp2 in Cardiac Regeneration awarded by National Institutes of Health 2006 - 2007
- AT2 Receptor-Mediated Gene Programming of Smooth Muscle awarded by Department of Health and Human Services 1997 - 2007
-
External Relationships
- Duke NUS Graduate Medical School
- Gairdner Foundation
- Global Preparedness Monitoring Board
- Healthy Brain Global Initiative
- Imperial College Health Partners
- Made In Durham
- Qatar Precision Medicine Institute
- Recardia Therapeutics
- Research!America
- Publications & Artistic Works
-
Selected Publications
-
Books
-
Creager, M. A., V. J. Dzau, and J. Loscalzo. Vascular medicine: A companion to Braunwald's heart disease, 2006. https://doi.org/10.1016/B978-0-7216-0284-4.X5001-5.Full Text
-
-
Academic Articles
-
Dzau, Victor J. “Anticipating the Future of Health and Medicine-The National Academy of Medicine Prepares for Its Next 50 Years.” Jama 329, no. 17 (May 2, 2023): 1445–46. https://doi.org/10.1001/jama.2023.4081.Full Text Link to Item
-
Sun, Hualing, Richard E. Pratt, Victor J. Dzau, and Conrad P. Hodgkinson. “Neonatal and adult cardiac fibroblasts exhibit inherent differences in cardiac regenerative capacity.” J Biol Chem 299, no. 5 (May 2023): 104694. https://doi.org/10.1016/j.jbc.2023.104694.Full Text Link to Item
-
Baksh, Syeda S., Jiabiao Hu, Richard E. Pratt, Victor J. Dzau, and Conrad P. Hodgkinson. “Rig1 receptor plays a critical role in cardiac reprogramming via YY1 signaling.” Am J Physiol Cell Physiol 324, no. 4 (April 1, 2023): C843–55. https://doi.org/10.1152/ajpcell.00402.2022.Full Text Link to Item
-
Dzau, V., and P. Yadav. “The influenza imperative: we must prepare now for seasonal and pandemic influenza.” The Lancet Microbe 4, no. 4 (April 1, 2023): e203–5. https://doi.org/10.1016/S2666-5247(23)00013-7.Full Text
-
Hsueh, Ying-Chang, Richard E. Pratt, Victor J. Dzau, and Conrad P. Hodgkinson. “Novel method of differentiating human induced pluripotent stem cells to mature cardiomyocytes via Sfrp2.” Sci Rep 13, no. 1 (March 9, 2023): 3920. https://doi.org/10.1038/s41598-023-31144-3.Full Text Link to Item
-
Dzau, Victor J., Melissa H. Laitner, and Celynne A. Balatbat. “Has traditional medicine had its day? The need to redefine academic medicine.” Lancet 400, no. 10361 (October 22, 2022): 1481–86. https://doi.org/10.1016/S0140-6736(22)01603-8.Full Text Link to Item
-
Baksh, Syeda Samara, Richard E. Pratt, José Gomez, Victor J. Dzau, and Conrad P. Hodgkinson. “A novel Cbx1, PurB, and Sp3 complex mediates long-term silencing of tissue- and lineage-specific genes.” J Biol Chem 298, no. 6 (June 2022): 102053. https://doi.org/10.1016/j.jbc.2022.102053.Full Text Link to Item
-
Dzau, Victor J., Celynne A. Balatbat, and Anaeze C. Offodile. “Closing the global vaccine equity gap: equitably distributed manufacturing.” Lancet 399, no. 10339 (May 21, 2022): 1924–26. https://doi.org/10.1016/S0140-6736(22)00793-0.Full Text Link to Item
-
Dzau, Victor J., William F. Ellaissi, K Ranga Rama Krishnan, and Celynne A. Balatbat. “How Academic Health Systems Can Be Ready for the Next Pandemic.” Acad Med 97, no. 4 (April 1, 2022): 479–83. https://doi.org/10.1097/ACM.0000000000004572.Full Text Link to Item
-
Utz, Paul J., Mukesh K. Jain, Vivian G. Cheung, Brian K. Kobilka, Robert Lefkowitz, Tadataka Yamada, and Victor J. Dzau. “Translating science to medicine: The case for physician-scientists.” Sci Transl Med 14, no. 632 (February 16, 2022): eabg7852. https://doi.org/10.1126/scitranslmed.abg7852.Full Text Link to Item
-
Dzau, Victor J., Kedar Mate, and Margaret O’Kane. “Equity and Quality-Improving Health Care Delivery Requires Both.” Jama 327, no. 6 (February 8, 2022): 519–20. https://doi.org/10.1001/jama.2022.0283.Full Text Link to Item
-
Dzau, Victor J., Celynne A. Balatbat, and William F. Ellaissi. “Revisiting academic health sciences systems a decade later: discovery to health to population to society.” Lancet 398, no. 10318 (December 18, 2021): 2300–2304. https://doi.org/10.1016/S0140-6736(21)01752-9.Full Text Link to Item
-
Zhang, Jianyi, Roberto Bolli, Daniel J. Garry, Eduardo Marbán, Philippe Menasché, Wolfram-Hubertus Zimmermann, Timothy J. Kamp, Joseph C. Wu, and Victor J. Dzau. “Basic and Translational Research in Cardiac Repair and Regeneration: JACC State-of-the-Art Review.” J Am Coll Cardiol 78, no. 21 (November 23, 2021): 2092–2105. https://doi.org/10.1016/j.jacc.2021.09.019.Full Text Link to Item
-
Gomez, José A., Alan Payne, Richard E. Pratt, Conrad P. Hodgkinson, and Victor J. Dzau. “A role for Sfrp2 in cardiomyogenesis in vivo.” Proc Natl Acad Sci U S A 118, no. 33 (August 17, 2021). https://doi.org/10.1073/pnas.2103676118.Full Text Link to Item
-
Sun, Hualing, Conrad P. Hodgkinson, Richard E. Pratt, and Victor J. Dzau. “CRISPR/Cas9 Mediated Deletion of the Angiotensinogen Gene Reduces Hypertension: A Potential for Cure?” Hypertension 77, no. 6 (June 2021): 1990–2000. https://doi.org/10.1161/HYPERTENSIONAHA.120.16870.Full Text Link to Item
-
Lurie, Nicole, Gerald T. Keusch, and Victor J. Dzau. “Urgent lessons from COVID 19: why the world needs a standing, coordinated system and sustainable financing for global research and development.” Lancet 397, no. 10280 (March 27, 2021): 1229–36. https://doi.org/10.1016/S0140-6736(21)00503-1.Full Text Link to Item
-
Dzau, Victor J. “Bench to Bedside Discovery, Innovation, Global Health Equity, and Security: A Conversation With Victor J. Dzau, MD.” Circulation 143, no. 11 (March 16, 2021): 1076–80. https://doi.org/10.1161/CIRCULATIONAHA.121.054151.Full Text Link to Item
-
Hu, Jiabiao, Conrad P. Hodgkinson, Richard E. Pratt, JaeWoo Lee, Bruce A. Sullenger, and Victor J. Dzau. “Enhancing cardiac reprogramming via synthetic RNA oligonucleotides.” Mol Ther Nucleic Acids 23 (March 5, 2021): 55–62. https://doi.org/10.1016/j.omtn.2020.10.034.Full Text Link to Item
-
Dzau, Victor J., Mark B. McClellan, J Michael McGinnis, Jessica C. Marx, Rebecca D. Sullenger, and William ElLaissi. “Vital Directions For Health And Health Care: Priorities For 2021.” Health Aff (Millwood) 40, no. 2 (February 2021): 197–203. https://doi.org/10.1377/hlthaff.2020.02204.Full Text Open Access Copy Link to Item
-
Wang, Xiaowen, Conrad P. Hodgkinson, and Victor J. Dzau. “Production of Cardiomyocytes by microRNA-Mediated Reprogramming in Optimized Reprogramming Media.” Methods Mol Biol 2239 (2021): 47–59. https://doi.org/10.1007/978-1-0716-1084-8_4.Full Text Link to Item
-
Dzau, Victor J., and Kenneth I. Shine. “Two Decades Since To Err Is Human: Progress, but Still a "Chasm".” Jama 324, no. 24 (December 22, 2020): 2489–90. https://doi.org/10.1001/jama.2020.23151.Full Text Link to Item
-
Sun, Hualing, Richard E. Pratt, Conrad P. Hodgkinson, and Victor J. Dzau. “Sequential paracrine mechanisms are necessary for the therapeutic benefits of stem cell therapy.” Am J Physiol Cell Physiol 319, no. 6 (December 1, 2020): C1141–50. https://doi.org/10.1152/ajpcell.00516.2019.Full Text Link to Item
-
Kang, Martin H., Jiabiao Hu, Richard E. Pratt, Conrad P. Hodgkinson, Aravind Asokan, and Victor J. Dzau. “Optimizing delivery for efficient cardiac reprogramming.” Biochem Biophys Res Commun 533, no. 1 (November 26, 2020): 9–16. https://doi.org/10.1016/j.bbrc.2020.08.104.Full Text Link to Item
-
Dzau, Victor J., and Celynne Balatbat. “Strategy, coordinated implementation, and sustainable financing needed for COVID-19 innovations.” Lancet 396, no. 10261 (November 7, 2020): 1469–71. https://doi.org/10.1016/S0140-6736(20)32289-3.Full Text Link to Item
-
Dzau, Victor J., Elizabeth M. Finkelman, Celynne A. Balatbat, Eric M. Verdin, and Roderic I. Pettigrew. “Achieving healthy human longevity: A global grand challenge.” Sci Transl Med 12, no. 566 (October 21, 2020). https://doi.org/10.1126/scitranslmed.abd3816.Full Text Link to Item
-
Dzau, Victor J., Darrell Kirch, and Thomas Nasca. “Preventing a Parallel Pandemic - A National Strategy to Protect Clinicians' Well-Being.” N Engl J Med 383, no. 6 (August 6, 2020): 513–15. https://doi.org/10.1056/NEJMp2011027.Full Text Link to Item
-
Dzau, Victor J., Harvey V. Fineberg, Kenneth I. Shine, Samuel O. Thier, Debra Malina, and Stephen Morrissey. “A Half-Century of Progress in Health - A Perspective Series in Honor of the 50th Anniversary of the National Academy of Medicine.” N Engl J Med 383, no. 1 (July 2, 2020): 76–77. https://doi.org/10.1056/NEJMe2020118.Full Text Link to Item
-
Kavanagh, Matthew M., Ngozi A. Erondu, Oyewale Tomori, Victor J. Dzau, Emelda A. Okiro, Allan Maleche, Ifeyinwa C. Aniebo, Umunya Rugege, Charles B. Holmes, and Lawrence O. Gostin. “Access to lifesaving medical resources for African countries: COVID-19 testing and response, ethics, and politics.” Lancet 395, no. 10238 (May 30, 2020): 1735–38. https://doi.org/10.1016/S0140-6736(20)31093-X.Full Text Link to Item
-
Carayon, Pascale, Christine Cassel, and Victor J. Dzau. “Clinician Burnout and Professional Well-being-Reply.” Jama 323, no. 13 (April 7, 2020): 1318. https://doi.org/10.1001/jama.2020.1455.Full Text Link to Item
-
Saleem, Mohammad, Conrad P. Hodgkinson, Liang Xiao, Juan A. Gimenez-Bastida, Megan L. Rasmussen, Jason Foss, Alan J. Payne, et al. “Sox6 as a new modulator of renin expression in the kidney.” Am J Physiol Renal Physiol 318, no. 2 (February 1, 2020): F285–97. https://doi.org/10.1152/ajprenal.00095.2019.Full Text Link to Item
-
Wu, Albert W., and Victor J. Dzau. “What Can Patient Safety Teach Us About Clinician Burnout?” Ann Intern Med 171, no. 12 (December 17, 2019): 933–34. https://doi.org/10.7326/M19-2397.Full Text Link to Item
-
Carayon, Pascale, Christine Cassel, and Victor J. Dzau. “Improving the System to Support Clinician Well-being and Provide Better Patient Care.” Jama 322, no. 22 (December 10, 2019): 2165–66. https://doi.org/10.1001/jama.2019.17406.Full Text Link to Item
-
Dzau, Victor J., and Jo Ann C. Jenkins. “Creating a Global Roadmap for Healthy Longevity.” J Gerontol a Biol Sci Med Sci 74, no. Suppl_1 (November 13, 2019): S4–6. https://doi.org/10.1093/gerona/glz226.Full Text Link to Item
-
Dzau, Victor J., Sharon K. Inouye, John W. Rowe, Elizabeth Finkelman, and Tadataka Yamada. “Enabling Healthful Aging for All - The National Academy of Medicine Grand Challenge in Healthy Longevity.” N Engl J Med 381, no. 18 (October 31, 2019): 1699–1701. https://doi.org/10.1056/NEJMp1912298.Full Text Link to Item
-
Dzau, Victor J., and Celynne A. Balatbat. “Future of Hypertension.” Hypertension 74, no. 3 (September 2019): 450–57. https://doi.org/10.1161/HYPERTENSIONAHA.119.13437.Full Text Link to Item
-
Dzau, Victor J. “Clarification of Reporting of Potential Conflicts of Interest in JAMA Articles.” Jama 322, no. 7 (August 20, 2019): 696. https://doi.org/10.1001/jama.2019.11051.Full Text Link to Item
-
Leshner, Alan I., and Victor J. Dzau. “Medication-Based Treatment to Address Opioid Use Disorder.” Jama 321, no. 21 (June 4, 2019): 2071–72. https://doi.org/10.1001/jama.2019.5523.Full Text Link to Item
-
Dzau, Victor J., Marcia McNutt, and Venki Ramakrishnan. “Academies' action plan for germline editing.” Nature 567, no. 7747 (March 2019): 175. https://doi.org/10.1038/d41586-019-00813-7.Full Text Link to Item
-
Dal-Pra, Sophie, Conrad P. Hodgkinson, and Victor J. Dzau. “Induced cardiomyocyte maturation: Cardiac transcription factors are necessary but not sufficient.” Plos One 14, no. 10 (2019): e0223842. https://doi.org/10.1371/journal.pone.0223842.Full Text Link to Item
-
Dzau, Victor J., Marcia McNutt, and Chunli Bai. “Wake-up call from Hong Kong.” Science 362, no. 6420 (December 14, 2018): 1215. https://doi.org/10.1126/science.aaw3127.Full Text Link to Item
-
Affronti, Mary Lou. “Introduction.” Semin Oncol Nurs 34, no. 5 (December 2018): 417–19. https://doi.org/10.1016/j.soncn.2018.10.003.Full Text Link to Item
-
Dzau, Victor J., and Paula A. Johnson. “Ending Sexual Harassment in Academic Medicine.” N Engl J Med 379, no. 17 (October 25, 2018): 1589–91. https://doi.org/10.1056/NEJMp1809846.Full Text Link to Item
-
Dzau, Victor J., and Celynne A. Balatbat. “Health and societal implications of medical and technological advances.” Sci Transl Med 10, no. 463 (October 17, 2018). https://doi.org/10.1126/scitranslmed.aau4778.Full Text Link to Item
-
Hodgkinson, Conrad P., José A. Gomez, Syeda Samara Baksh, Alan Payne, Jeffrey Schmeckpeper, Richard E. Pratt, and Victor J. Dzau. “Insights from molecular signature of in vivo cardiac c-Kit(+) cells following cardiac injury and β-catenin inhibition.” J Mol Cell Cardiol 123 (October 2018): 64–74. https://doi.org/10.1016/j.yjmcc.2018.08.024.Full Text Link to Item
-
Dzau, Victor J., and Celynne A. Balatbat. “Reimagining population health as convergence science.” Lancet 392, no. 10145 (August 4, 2018): 367–68. https://doi.org/10.1016/S0140-6736(18)31372-2.Full Text Link to Item
-
Hodgkinson, Conrad P., Richard E. Pratt, Imke Kirste, Sophie Dal-Pra, John P. Cooke, and Victor J. Dzau. “Cardiomyocyte Maturation Requires TLR3 Activated Nuclear Factor Kappa B.” Stem Cells 36, no. 8 (August 2018): 1198–1209. https://doi.org/10.1002/stem.2833.Full Text Link to Item
-
Daniels, Ron, and Victor Dzau. “Supporting the Next Generation of Biomedical Researchers.” Jama 320, no. 1 (July 3, 2018): 29–30. https://doi.org/10.1001/jama.2018.7902.Full Text Link to Item
-
Dzau, Victor J., and Alan I. Leshner. “Public Health Research on Gun Violence: Long Overdue.” Ann Intern Med 168, no. 12 (June 19, 2018): 876–77. https://doi.org/10.7326/M18-0579.Full Text Link to Item
-
Bareja, Akshay, Shubham Patel, Conrad P. Hodgkinson, Alan Payne, and Victor J. Dzau. “Understanding the mechanism of bias signaling of the insulin-like growth factor 1 receptor: Effects of LL37 and HASF.” Cell Signal 46 (June 2018): 113–19. https://doi.org/10.1016/j.cellsig.2018.02.013.Full Text Link to Item
-
Bareja, Akshay, Conrad P. Hodgkinson, Erik Soderblom, Greg Waitt, and Victor J. Dzau. “The proximity-labeling technique BioID identifies sorting nexin 6 as a member of the insulin-like growth factor 1 (IGF1)-IGF1 receptor pathway.” J Biol Chem 293, no. 17 (April 27, 2018): 6449–59. https://doi.org/10.1074/jbc.RA118.002406.Full Text Link to Item
-
Leshner, Alan I., and Victor J. Dzau. “Good gun policy needs research.” Science 359, no. 6381 (March 16, 2018): 1195. https://doi.org/10.1126/science.aat5127.Full Text Link to Item
-
Dzau, Victor J., Darrell G. Kirch, and Thomas J. Nasca. “To Care Is Human - Collectively Confronting the Clinician-Burnout Crisis.” N Engl J Med 378, no. 4 (January 25, 2018): 312–14. https://doi.org/10.1056/NEJMp1715127.Full Text Link to Item
-
Dzau, Victor J., Nicole Lurie, and Reed V. Tuckson. “After Harvey, Irma, and Maria, an Opportunity for Better Health-Rebuilding Our Communities as We Want Them.” Am J Public Health 108, no. 1 (January 2018): 32–33. https://doi.org/10.2105/AJPH.2017.304194.Full Text Link to Item
-
Fuster, Valentin, Jendayi Frazer, Megan Snair, Rajesh Vedanthan, Victor Dzau, and Victor Committee on Global Health and the Future of the United States: A Report of the National Academies of Sciences, Engineering and Medicine. “The Future Role of the United States in Global Health: Emphasis on Cardiovascular Disease.” J Am Coll Cardiol 70, no. 25 (December 26, 2017): 3140–56. https://doi.org/10.1016/j.jacc.2017.11.009.Full Text Link to Item
-
Dzau, Victor J. “Commentary: Vaccines-Protecting Health and Saving Lives.” Psychol Sci Public Interest 18, no. 3 (December 2017): 147–48. https://doi.org/10.1177/1529100618760522.Full Text Link to Item
-
Tuckson, Reed V., Victor J. Dzau, and Nicole Lurie. “Creating Healthy Communities after Disasters.” N Engl J Med 377, no. 19 (November 9, 2017): 1806–8. https://doi.org/10.1056/NEJMp1711834.Full Text Link to Item
-
Batson, Amie, Michael Merson, and Victor Dzau. “Innovating through "interesting times" in global health.” Lancet 390, no. 10106 (October 28, 2017): e33–34. https://doi.org/10.1016/S0140-6736(17)32522-9.Full Text Link to Item
-
Matsushita, Kenichi, and Victor J. Dzau. “Mesenchymal stem cells in obesity: insights for translational applications.” Lab Invest 97, no. 10 (October 2017): 1158–66. https://doi.org/10.1038/labinvest.2017.42.Full Text Link to Item
-
Dzau, Victor, Valentin Fuster, Jendayi Frazer, and Megan Snair. “Investing in Global Health for Our Future.” N Engl J Med 377, no. 13 (September 28, 2017): 1292–96. https://doi.org/10.1056/NEJMsr1707974.Full Text Link to Item
-
Yamey, Gavin, Marco Schäferhoff, Ole Kristian Aars, Barry Bloom, Dennis Carroll, Mukesh Chawla, Victor Dzau, et al. “Financing of international collective action for epidemic and pandemic preparedness.” Lancet Glob Health 5, no. 8 (August 2017): e742–44. https://doi.org/10.1016/S2214-109X(17)30203-6.Full Text Link to Item
-
Dal-Pra, Sophie, Conrad P. Hodgkinson, Maria Mirotsou, Imke Kirste, and Victor J. Dzau. “Demethylation of H3K27 Is Essential for the Induction of Direct Cardiac Reprogramming by miR Combo.” Circ Res 120, no. 9 (April 28, 2017): 1403–13. https://doi.org/10.1161/CIRCRESAHA.116.308741.Full Text Link to Item
-
Dzau, Victor J., Mark B. McClellan, J Michael McGinnis, Sheila P. Burke, Molly J. Coye, Angela Diaz, Thomas A. Daschle, et al. “Vital Directions for Health and Health Care: Priorities From a National Academy of Medicine Initiative.” Jama 317, no. 14 (April 11, 2017): 1461–70. https://doi.org/10.1001/jama.2017.1964.Full Text Link to Item
-
Dzau, V. J., D. A. Asch, B. Hannaford, R. Aggarwal, and C. M. Pugh. “Debate on the cost of innovation in healthcare: Is it too costly?” Bmj Simulation and Technology Enhanced Learning 3 (March 1, 2017): S33–36. https://doi.org/10.1136/bmjstel-2016-000174.Full Text
-
Bareja, Akshay, Conrad P. Hodgkinson, Alan J. Payne, Richard E. Pratt, and Victor J. Dzau. “HASF (C3orf58) is a novel ligand of the insulin-like growth factor 1 receptor.” Biochem J 474, no. 5 (February 20, 2017): 771–80. https://doi.org/10.1042/BCJ20160976.Full Text Link to Item
-
Moon, Suerie, Jennifer Leigh, Liana Woskie, Francesco Checchi, Victor Dzau, Mosoka Fallah, Gabrielle Fitzgerald, et al. “Post-Ebola reforms: ample analysis, inadequate action.” Bmj 356 (January 23, 2017): j280. https://doi.org/10.1136/bmj.j280.Full Text Link to Item
-
Dzau, Victor J., and Celynne A. Balatbat. “Cardiovascular Research and the National Academy of Medicine: Advancing Progress in Science and Medicine: Part 1: Who We Are.” Circ Res 120, no. 1 (January 6, 2017): 20–22. https://doi.org/10.1161/CIRCRESAHA.116.309992.Full Text Link to Item
-
Dzau, Victor J., and Celynne A. Balatbat. “Cardiovascular Research and the National Academy of Medicine: Advancing Progress in Science and Medicine: Part 2: What We Do.” Circ Res 120, no. 1 (January 6, 2017): 23–26. https://doi.org/10.1161/CIRCRESAHA.116.310358.Full Text Link to Item
-
Califf, Robert M., Melissa A. Robb, Andrew B. Bindman, Josephine P. Briggs, Francis S. Collins, Patrick H. Conway, Trinka S. Coster, et al. “Transforming Evidence Generation to Support Health and Health Care Decisions.” N Engl J Med 375, no. 24 (December 15, 2016): 2395–2400. https://doi.org/10.1056/NEJMsb1610128.Full Text Link to Item
-
Li, Yanzhen, Sophie Dal-Pra, Maria Mirotsou, Tilanthi M. Jayawardena, Conrad P. Hodgkinson, Nenad Bursac, and Victor J. Dzau. “Tissue-engineered 3-dimensional (3D) microenvironment enhances the direct reprogramming of fibroblasts into cardiomyocytes by microRNAs.” Sci Rep 6 (December 12, 2016): 38815. https://doi.org/10.1038/srep38815.Full Text Link to Item
-
Sands, Peter, Anas El Turabi, Philip A. Saynisch, and Victor J. Dzau. “Assessment of economic vulnerability to infectious disease crises.” Lancet 388, no. 10058 (November 12, 2016): 2443–48. https://doi.org/10.1016/S0140-6736(16)30594-3.Full Text Link to Item
-
Dzau, Victor J., and Geoffrey S. Ginsburg. “Realizing the Full Potential of Precision Medicine in Health and Health Care.” Jama 316, no. 16 (October 25, 2016): 1659–60. https://doi.org/10.1001/jama.2016.14117.Full Text Link to Item
-
Dzau, Victor J., Mark McClellan, and J Michael McGinnis. “Vital Directions for Health and Health Care: An Initiative of the National Academy of Medicine.” Jama 316, no. 7 (August 16, 2016): 711–12. https://doi.org/10.1001/jama.2016.10692.Full Text Link to Item
-
Matsushita, Kenichi, Yaojiong Wu, Richard E. Pratt, and Victor J. Dzau. “Deletion of angiotensin II type 2 receptor accelerates adipogenesis in murine mesenchymal stem cells via Wnt10b/beta-catenin signaling.” Lab Invest 96, no. 8 (August 2016): 909–17. https://doi.org/10.1038/labinvest.2016.66.Full Text Link to Item
-
Dzau, Victor J., and Peter Sands. “Beyond the Ebola Battle--Winning the War against Future Epidemics.” N Engl J Med 375, no. 3 (July 21, 2016): 203–4. https://doi.org/10.1056/NEJMp1605847.Full Text Link to Item
-
Dzau, Victor J. “The National Academy of Medicine and the Cardiovascular Community: Partnering for a Healthier Future.” Circulation 134, no. 3 (July 19, 2016): 183–85. https://doi.org/10.1161/CIRCULATIONAHA.116.022139.Full Text Link to Item
-
Sridhar, Devi, Ilona Kickbusch, Suerie Moon, Victor Dzau, David Heymann, Ashish K. Jha, Jorge Saavendra, Barbara Stocking, Liana Woskie, and Peter Piot. “Facing forward after Ebola: questions for the next director general of the World Health Organization.” Bmj 353 (May 18, 2016): i2666. https://doi.org/10.1136/bmj.i2666.Full Text Link to Item
-
Gostin, Lawrence O., Oyewale Tomori, Suwit Wibulpolprasert, Ashish K. Jha, Julio Frenk, Suerie Moon, Joy Phumaphi, et al. “Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola.” Plos Med 13, no. 5 (May 2016): e1002042. https://doi.org/10.1371/journal.pmed.1002042.Full Text Link to Item
-
Dzau, Victor J. “The Institute of Medicine: ensuring integrity and independence in scientific advice on health.” Lancet 387, no. 10028 (April 16, 2016): 1686–92. https://doi.org/10.1016/S0140-6736(15)00468-7.Full Text Link to Item
-
Yuan, Hsiangkuo, Jose A. Gomez, Jennifer S. Chien, Lunan Zhang, Christy M. Wilson, Shuqin Li, Andrew M. Fales, et al. “Tracking mesenchymal stromal cells using an ultra-bright TAT-functionalized plasmonic-active nanoplatform.” J Biophotonics 9, no. 4 (April 2016): 406–13. https://doi.org/10.1002/jbio.201500173.Full Text Link to Item
-
Sands, Peter, Carmen Mundaca-Shah, and Victor J. Dzau. “The Neglected Dimension of Global Security--A Framework for Countering Infectious-Disease Crises.” N Engl J Med 374, no. 13 (March 31, 2016): 1281–87. https://doi.org/10.1056/NEJMsr1600236.Full Text Link to Item
-
Wang, Xiaowen, Conrad P. Hodgkinson, Kefeng Lu, Alan J. Payne, Richard E. Pratt, and Victor J. Dzau. “Selenium Augments microRNA Directed Reprogramming of Fibroblasts to Cardiomyocytes via Nanog.” Sci Rep 6 (March 15, 2016): 23017. https://doi.org/10.1038/srep23017.Full Text Link to Item
-
Matsushita, Kenichi, Fulvio Morello, Zhiping Zhang, Tomoko Masuda, Shiro Iwanaga, Knut R. Steffensen, Jan-Åke Gustafsson, Richard E. Pratt, and Victor J. Dzau. “Nuclear hormone receptor LXRα inhibits adipocyte differentiation of mesenchymal stem cells with Wnt/beta-catenin signaling.” Lab Invest 96, no. 2 (February 2016): 230–38. https://doi.org/10.1038/labinvest.2015.141.Full Text Link to Item
-
Hodgkinson, Conrad P., Akshay Bareja, José A. Gomez, and Victor J. Dzau. “Emerging Concepts in Paracrine Mechanisms in Regenerative Cardiovascular Medicine and Biology.” Circ Res 118, no. 1 (January 8, 2016): 95–107. https://doi.org/10.1161/CIRCRESAHA.115.305373.Full Text Link to Item
-
Dzau, Victor J. “The National Academy of Medicine's Vision: Leadership, Innovation, and Impact for a Healthier Future.” Jama 314, no. 20 (November 24, 2015): 2127–28. https://doi.org/10.1001/jama.2015.15820.Full Text Link to Item
-
Dzau, Victor J., and Judith Rodin. “Creating a Global Health Risk Framework.” N Engl J Med 373, no. 11 (September 10, 2015): 991–93. https://doi.org/10.1056/NEJMp1509136.Full Text Link to Item
-
Schmeckpeper, Jeffrey, Amanda Verma, Lucy Yin, Farideh Beigi, Lunan Zhang, Alan Payne, Zhiping Zhang, Richard E. Pratt, Victor J. Dzau, and Maria Mirotsou. “Inhibition of Wnt6 by Sfrp2 regulates adult cardiac progenitor cell differentiation by differential modulation of Wnt pathways.” J Mol Cell Cardiol 85 (August 2015): 215–25. https://doi.org/10.1016/j.yjmcc.2015.06.003.Full Text Link to Item
-
Dzau, Victor J., and Kee Chee Soo. “Mentorship in Academic Medicine: A Catalyst of Talents.” Ann Acad Med Singap 44, no. 7 (July 2015): 232–34.Link to Item
-
Dzau, Victor J., and Ralph J. Cicerone. “Responsible Use of Human Gene-Editing Technologies.” Hum Gene Ther 26, no. 7 (July 2015): 411–12. https://doi.org/10.1089/hum.2015.29004.vjd.Full Text Link to Item
-
Matsushita, Kenichi, Yaojiong Wu, Richard E. Pratt, and Victor J. Dzau. “Blockade of angiotensin II type 2 receptor by PD123319 inhibits osteogenic differentiation of human mesenchymal stem cells via inhibition of extracellular signal-regulated kinase signaling.” J Am Soc Hypertens 9, no. 7 (July 2015): 517–25. https://doi.org/10.1016/j.jash.2015.06.006.Full Text Link to Item
-
Dzau, V. J., G. S. Ginsburg, K. Van Nuys, D. Agus, and D. Goldman. “Erratum: Aligning incentives to fulfil the promise of personalised medicine Lancet (2015) 385 (2118-19)).” The Lancet 385, no. 9987 (June 27, 2015): 2576. https://doi.org/10.1016/S0140-6736(15)61160-6.Full Text
-
Manolio, Teri A., Marc Abramowicz, Fahd Al-Mulla, Warwick Anderson, Rudi Balling, Adam C. Berger, Steven Bleyl, et al. “Global implementation of genomic medicine: We are not alone.” Sci Transl Med 7, no. 290 (June 3, 2015): 290ps13. https://doi.org/10.1126/scitranslmed.aab0194.Full Text Link to Item
-
Dzau, Victor J., Geoffrey S. Ginsburg, Karen Van Nuys, David Agus, and Dana Goldman. “Aligning incentives to fulfil the promise of personalised medicine.” Lancet 385, no. 9982 (May 23, 2015): 2118–19. https://doi.org/10.1016/S0140-6736(15)60722-X.Full Text Link to Item
-
Hodgkinson, Conrad P., Martin H. Kang, Sophie Dal-Pra, Maria Mirotsou, and Victor J. Dzau. “MicroRNAs and Cardiac Regeneration.” Circ Res 116, no. 10 (May 8, 2015): 1700–1711. https://doi.org/10.1161/CIRCRESAHA.116.304377.Full Text Link to Item
-
Yang, Yanqiang, Jose A. Gomez, Marcela Herrera, Romelia Perez-Marco, Peter Repenning, Zhiping Zhang, Alan Payne, et al. “Salt restriction leads to activation of adult renal mesenchymal stromal cell-like cells via prostaglandin E2 and E-prostanoid receptor 4.” Hypertension 65, no. 5 (May 2015): 1047–54. https://doi.org/10.1161/HYPERTENSIONAHA.114.04611.Full Text Link to Item
-
Unger, T., U. M. Steckelings, and V. J. Dzau. “The Angiotensin AT2 Receptor: From Enigma to Therapeutic Target,” April 22, 2015, 1–9. https://doi.org/10.1016/B978-0-12-801364-9.00001-8.Full Text
-
Unger, T., U. M. Steckelings, and V. J. Dzau. “The Protective Arm of the Renin Angiotensin System (RAS): Functional Aspects and Therapeutic Implications.” The Protective Arm of the Renin Angiotensin System (Ras): Functional Aspects and Therapeutic Implications, April 22, 2015, 1–297. https://doi.org/10.1016/C2013-0-23135-4.Full Text
-
Hodgkinson, Conrad P., and Victor J. Dzau. “Conserved microRNA program as key to mammalian cardiac regeneration: insights from zebrafish.” Circ Res 116, no. 7 (March 27, 2015): 1109–11. https://doi.org/10.1161/CIRCRESAHA.115.305852.Full Text Link to Item
-
Jayawardena, Tilanthi M., Elizabeth A. Finch, Lunan Zhang, Hengtao Zhang, Conrad P. Hodgkinson, Richard E. Pratt, Paul B. Rosenberg, Maria Mirotsou, and Victor J. Dzau. “MicroRNA induced cardiac reprogramming in vivo: evidence for mature cardiac myocytes and improved cardiac function.” Circ Res 116, no. 3 (January 30, 2015): 418–24. https://doi.org/10.1161/CIRCRESAHA.116.304510.Full Text Link to Item
-
Dzau, Victor J., and Harvey V. Fineberg. “Restore the US lead in biomedical research.” Jama 313, no. 2 (January 13, 2015): 143–44. https://doi.org/10.1001/jama.2014.17660.Full Text Link to Item
-
Dzau, V., and S. Ince. “Victor Dzau: cardiovascular physician scientist takes helm at IOM.” Circulation Research 117, no. 1 (2015): 13–16. https://doi.org/10.1161/CIRCRESAHA.115.306893.Full Text
-
Schwarcz, S., and J. Cox. “Foreword.” Law & Contemporary Problems 78, no. 3 (2015): i–v.Open Access Copy Link to Item
-
Hodgkinson, Conrad P., Jose A. Gomez, Alan J. Payne, Lunan Zhang, Xiaowen Wang, Sophie Dal-Pra, Richard E. Pratt, and Victor J. Dzau. “Abi3bp regulates cardiac progenitor cell proliferation and differentiation.” Circ Res 115, no. 12 (December 5, 2014): 1007–16. https://doi.org/10.1161/CIRCRESAHA.115.304216.Full Text Link to Item
-
Dzau, Victor J., and Philip A. Pizzo. “Relieving pain in America: insights from an Institute of Medicine committee.” Jama 312, no. 15 (October 15, 2014): 1507–8. https://doi.org/10.1001/jama.2014.12986.Full Text Link to Item
-
Dzau, Victor, and Roxanne Khamsi. “Straight talk with...Victor Dzau. Interview by Roxanne Khamsi.” Nat Med 20, no. 4 (April 2014): 325. https://doi.org/10.1038/nm0414-325.Full Text Link to Item
-
Huang, Jing, Jian Guo, Farideh Beigi, Conrad P. Hodgkinson, Heberty T. Facundo, Zhiping Zhang, Jorge Espinoza-Derout, et al. “HASF is a stem cell paracrine factor that activates PKC epsilon mediated cytoprotection.” J Mol Cell Cardiol 66 (January 2014): 157–64. https://doi.org/10.1016/j.yjmcc.2013.11.010.Full Text Link to Item
-
Jayawardena, Tilanthi, Maria Mirotsou, and Victor J. Dzau. “Direct reprogramming of cardiac fibroblasts to cardiomyocytes using microRNAs.” Methods Mol Biol 1150 (2014): 263–72. https://doi.org/10.1007/978-1-4939-0512-6_18.Full Text Link to Item
-
Dzau, Victor J., Ziggy Yoediono, William F. Ellaissi, and Alex H. Cho. “Fostering innovation in medicine and health care: what must academic health centers do?” Acad Med 88, no. 10 (October 2013): 1424–29. https://doi.org/10.1097/ACM.0b013e3182a32fc2.Full Text Link to Item
-
Dzau, Victor J., Alex Cho, William Ellaissi, Ziggy Yoediono, Devdutta Sangvai, Bimal Shah, David Zaas, and Krishna Udayakumar. “Transforming academic health centers for an uncertain future.” N Engl J Med 369, no. 11 (September 12, 2013): 991–93. https://doi.org/10.1056/NEJMp1302374.Full Text Link to Item
-
Beigi, Farideh, Jeffrey Schmeckpeper, Pete Pow-Anpongkul, James Alan Payne, Lunan Zhang, Zhiping Zhang, Jing Huang, Maria Mirotsou, and Victor J. Dzau. “C3orf58, a novel paracrine protein, stimulates cardiomyocyte cell-cycle progression through the PI3K-AKT-CDK7 pathway.” Circ Res 113, no. 4 (August 2, 2013): 372–80. https://doi.org/10.1161/CIRCRESAHA.113.301075.Full Text Link to Item
-
Hodgkinson, Conrad P., Vinogran Naidoo, Karl G. Patti, Jose A. Gomez, Jeffrey Schmeckpeper, Zhiping Zhang, Bryce Davis, Richard E. Pratt, Maria Mirotsou, and Victor J. Dzau. “Abi3bp is a multifunctional autocrine/paracrine factor that regulates mesenchymal stem cell biology.” Stem Cells 31, no. 8 (August 2013): 1669–82. https://doi.org/10.1002/stem.1416.Full Text Link to Item
-
Wang, Hao, Jose A. Gomez, Sabine Klein, Zhiping Zhang, Barbara Seidler, Yanqiang Yang, Jeffrey Schmeckpeper, et al. “Adult renal mesenchymal stem cell-like cells contribute to juxtaglomerular cell recruitment.” J Am Soc Nephrol 24, no. 8 (July 2013): 1263–73. https://doi.org/10.1681/ASN.2012060596.Full Text Link to Item
-
Andolsek, Kathryn M., Gwendolyn Murphy, Alisa Nagler, Peggy R. Moore, Joanne Schlueter, John L. Weinerth, Michael S. Cuffe, and Victor J. Dzau. “Fostering creativity: how the Duke Graduate Medical Education Quasi-Endowment encourages innovation in GME.” Acad Med 88, no. 2 (February 2013): 185–91. https://doi.org/10.1097/ACM.0b013e31827c2b65.Full Text Link to Item
-
Jayawardena, Tilanthi M., Bakytbek Egemnazarov, Elizabeth A. Finch, Lunan Zhang, J Alan Payne, Kumar Pandya, Zhiping Zhang, Paul Rosenberg, Maria Mirotsou, and Victor J. Dzau. “MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes.” Circ Res 110, no. 11 (May 25, 2012): 1465–73. https://doi.org/10.1161/CIRCRESAHA.112.269035.Full Text Link to Item
-
Clark, C. J., and J. R. Poulsen. “Introduction.” Tropical Forest Conservation and Industry Partnership: An Experience From the Congo Basin, March 16, 2012, 1–20. https://doi.org/10.1002/9781119968238.ch1.Full Text
-
Ackerly, D Clay, Krishna Udayakumar, Robert Taber, Michael H. Merson, and Victor J. Dzau. “Perspective: global medicine: opportunities and challenges for academic health science systems.” Acad Med 86, no. 9 (September 2011): 1093–99. https://doi.org/10.1097/ACM.0b013e318226b455.Full Text Link to Item
-
Ackerly, D Clay, Devdutta G. Sangvai, Krishna Udayakumar, Bimal R. Shah, Noah S. Kalman, Alex H. Cho, Kevin A. Schulman, William J. Fulkerson, and Victor J. Dzau. “Training the next generation of physician-executives: an innovative residency pathway in management and leadership.” Acad Med 86, no. 5 (May 2011): 575–79. https://doi.org/10.1097/ACM.0b013e318212e51b.Full Text Link to Item
-
Mirotsou, Maria, Tilanthi M. Jayawardena, Jeffrey Schmeckpeper, Massimiliano Gnecchi, and Victor J. Dzau. “Paracrine mechanisms of stem cell reparative and regenerative actions in the heart.” J Mol Cell Cardiol 50, no. 2 (February 2011): 280–89. https://doi.org/10.1016/j.yjmcc.2010.08.005.Full Text Link to Item
-
He, Wei, Lunan Zhang, Aiguo Ni, Zhiping Zhang, Maria Mirotsou, Lan Mao, Richard E. Pratt, and Victor J. Dzau. “Exogenously administered secreted frizzled related protein 2 (Sfrp2) reduces fibrosis and improves cardiac function in a rat model of myocardial infarction.” Proc Natl Acad Sci U S A 107, no. 49 (December 7, 2010): 21110–15. https://doi.org/10.1073/pnas.1004708107.Full Text Link to Item
-
Gnecchi, M., and V. J. Dzau. “Adult Stem Cell-Based Therapy for the Heart,” December 1, 2010, 899–935. https://doi.org/10.1016/B978-0-12-381332-9.00043-8.Full Text
-
O’Rourke, Michael F., Michel E. Safar, and Victor Dzau. “The Cardiovascular Continuum extended: aging effects on the aorta and microvasculature.” Vasc Med 15, no. 6 (December 2010): 461–68. https://doi.org/10.1177/1358863X10382946.Full Text Link to Item
-
Hodgkinson, Conrad P., José A. Gomez, Maria Mirotsou, and Victor J. Dzau. “Genetic engineering of mesenchymal stem cells and its application in human disease therapy.” Hum Gene Ther 21, no. 11 (November 2010): 1513–26. https://doi.org/10.1089/hum.2010.165.Full Text Open Access Copy Link to Item
-
Huang, Jing, Zhiping Zhang, Jian Guo, Aiguo Ni, Arjun Deb, Lunan Zhang, Maria Mirotsou, Richard E. Pratt, and Victor J. Dzau. “Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium.” Circ Res 106, no. 11 (June 11, 2010): 1753–62. https://doi.org/10.1161/CIRCRESAHA.109.196030.Full Text Link to Item
-
Zhang, Zhiping, and Victor J. Dzau. “Angiotensin II type 1 receptor-associated protein is an endogenous inhibitor of angiotensin II type 1 receptor action in cardiac hypertrophy: role in check and balance.” Hypertension 55, no. 5 (May 2010): 1086–87. https://doi.org/10.1161/HYPERTENSIONAHA.110.150458.Full Text Link to Item
-
Matsushita, Kenichi, Fulvio Morello, Yaojiong Wu, Lunan Zhang, Shiro Iwanaga, Richard E. Pratt, and Victor J. Dzau. “Mesenchymal stem cells differentiate into renin-producing juxtaglomerular (JG)-like cells under the control of liver X receptor-alpha.” J Biol Chem 285, no. 16 (April 16, 2010): 11974–82. https://doi.org/10.1074/jbc.M109.099671.Full Text Link to Item
-
Dzau, Victor J., D Clay Ackerly, Pamela Sutton-Wallace, Michael H. Merson, R Sanders Williams, K Ranga Krishnan, Robert C. Taber, and Robert M. Califf. “The role of academic health science systems in the transformation of medicine.” Lancet 375, no. 9718 (March 13, 2010): 949–53. https://doi.org/10.1016/S0140-6736(09)61082-5.Full Text Link to Item
-
Dunlap, C. “Foreword.” Air Force Law Review 65 (2010): v.Link to Item
-
Dzau, Victor J., and Jeffery D. Molkentin. “Helmut Drexler, MD, 1951-2009.” Circulation 120, no. 23 (December 8, 2009): 2402–3. https://doi.org/10.1161/circulationaha.109.917120.Full Text Link to Item
-
Frenkel, Dan, Alok S. Pachori, Lunan Zhang, Adi Dembinsky-Vaknin, Dorit Farfara, Sanja Petrovic-Stojkovic, Victor J. Dzau, and Howard L. Weiner. “Nasal vaccination with troponin reduces troponin specific T-cell responses and improves heart function in myocardial ischemia-reperfusion injury.” Int Immunol 21, no. 7 (July 2009): 817–29. https://doi.org/10.1093/intimm/dxp051.Full Text Link to Item
-
Gnecchi, Massimiliano, Huamei He, Luis G. Melo, Nicolas Noiseaux, Fulvio Morello, Rudolf A. de Boer, Lunan Zhang, Richard E. Pratt, Victor J. Dzau, and Joanne S. Ingwall. “Early beneficial effects of bone marrow-derived mesenchymal stem cells overexpressing Akt on cardiac metabolism after myocardial infarction.” Stem Cells 27, no. 4 (April 2009): 971–79. https://doi.org/10.1002/stem.12.Full Text Link to Item
-
Zhang, Zhongyan, Arjun Deb, Zhiping Zhang, Alok Pachori, Wei He, Jian Guo, Richard Pratt, and Victor J. Dzau. “Secreted frizzled related protein 2 protects cells from apoptosis by blocking the effect of canonical Wnt3a.” J Mol Cell Cardiol 46, no. 3 (March 2009): 370–77. https://doi.org/10.1016/j.yjmcc.2008.11.016.Full Text Link to Item
-
Gnecchi, Massimiliano, Zhiping Zhang, Aiguo Ni, and Victor J. Dzau. “Paracrine mechanisms in adult stem cell signaling and therapy.” Circ Res 103, no. 11 (November 21, 2008): 1204–19. https://doi.org/10.1161/CIRCRESAHA.108.176826.Full Text Link to Item
-
Liew, C. C., and V. J. Dzau. “Introduction.” Cardiovascular Genetics and Genomics for the Cardiologist, April 15, 2008. https://doi.org/10.1002/9780470691977.Full Text
-
Liew, C. C., and V. J. Dzau. “The Gene in the Twenty-First Century,” April 15, 2008, 1–15. https://doi.org/10.1002/9780470691977.ch1.Full Text
-
Michener, J Lloyd, Susan Yaggy, Michelle Lyn, Samuel Warburton, Mary Champagne, MaryAnn Black, Michael Cuffe, et al. “Improving the health of the community: Duke's experience with community engagement.” Acad Med 83, no. 4 (April 2008): 408–13. https://doi.org/10.1097/ACM.0b013e3181668450.Full Text Link to Item
-
Williams, R Sanders, Patrick J. Casey, Robert K. Kamei, Edward G. Buckley, Khee Chee Soo, Michael H. Merson, Ranga K. Krishnan, and Victor J. Dzau. “A global partnership in medical education between Duke University and the National University of Singapore.” Acad Med 83, no. 2 (February 2008): 122–27. https://doi.org/10.1097/ACM.0b013e318160b8bc.Full Text Link to Item
-
Deb, Arjun, Bryce H. Davis, Jian Guo, Aiguo Ni, Jing Huang, Zhiping Zhang, Hui Mu, and Victor J. Dzau. “SFRP2 regulates cardiomyogenic differentiation by inhibiting a positive transcriptional autofeedback loop of Wnt3a.” Stem Cells 26, no. 1 (January 2008): 35–44. https://doi.org/10.1634/stemcells.2007-0475.Full Text Link to Item
-
Melo, L. G., A. S. Pachori, D. Kong, M. Gnecchi, and V. J. Dzau. “Endothelium-targeted Gene and Cell-based Therapy for Cardiovascular Disease,” November 12, 2007, 365–99. https://doi.org/10.1002/9780470988473.ch26.Full Text
-
Pachori, Alok S., Anthony Smith, Patricia McDonald, Lunan Zhang, Victor J. Dzau, and Luis G. Melo. “Heme-oxygenase-1-induced protection against hypoxia/reoxygenation is dependent on biliverdin reductase and its interaction with PI3K/Akt pathway.” J Mol Cell Cardiol 43, no. 5 (November 2007): 580–92. https://doi.org/10.1016/j.yjmcc.2007.08.003.Full Text Link to Item
-
Ip, James E., Yaojiong Wu, Jing Huang, Lunan Zhang, Richard E. Pratt, and Victor J. Dzau. “Mesenchymal stem cells use integrin beta1 not CXC chemokine receptor 4 for myocardial migration and engraftment.” Mol Biol Cell 18, no. 8 (August 2007): 2873–82. https://doi.org/10.1091/mbc.e07-02-0166.Full Text Link to Item
-
Liu, Xiaoli, Jeremy A. Simpson, Keith R. Brunt, Christopher A. Ward, Sean R. R. Hall, Robert T. Kinobe, Valerie Barrette, et al. “Preemptive heme oxygenase-1 gene delivery reveals reduced mortality and preservation of left ventricular function 1 yr after acute myocardial infarction.” Am J Physiol Heart Circ Physiol 293, no. 1 (July 2007): H48–59. https://doi.org/10.1152/ajpheart.00741.2006.Full Text Link to Item
-
Mirotsou, Maria, Zhongyan Zhang, Arjun Deb, Lunan Zhang, Massimiliano Gnecchi, Nicolas Noiseux, Hui Mu, Alok Pachori, and Victor Dzau. “Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair.” Proc Natl Acad Sci U S A 104, no. 5 (January 30, 2007): 1643–48. https://doi.org/10.1073/pnas.0610024104.Full Text Link to Item
-
Matsushita, Kenichi, Zhiping Zhang, Richard E. Pratt, and Victor J. Dzau. “Molecular mechanism of juxtaglomerular cell hyperplasia: a unifying hypothesis.” J Am Soc Hypertens 1, no. 3 (2007): 164–68. https://doi.org/10.1016/j.jash.2007.02.004.Full Text Link to Item
-
Dzau, Victor J., Elliott M. Antman, Henry R. Black, David L. Hayes, JoAnn E. Manson, Jorge Plutzky, Jeffrey J. Popma, and William Stevenson. “The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease).” Circulation 114, no. 25 (December 19, 2006): 2850–70. https://doi.org/10.1161/CIRCULATIONAHA.106.655688.Full Text Link to Item
-
Dzau, Victor J., Elliott M. Antman, Henry R. Black, David L. Hayes, JoAnn E. Manson, Jorge Plutzky, Jeffrey J. Popma, and William Stevenson. “The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part II: Clinical trial evidence (acute coronary syndromes through renal disease) and future directions.” Circulation 114, no. 25 (December 19, 2006): 2871–91. https://doi.org/10.1161/CIRCULATIONAHA.106.655761.Full Text Link to Item
-
Matsushita, Kenichi, Yaojiong Wu, Yoshihisa Okamoto, Richard E. Pratt, and Victor J. Dzau. “Local renin angiotensin expression regulates human mesenchymal stem cell differentiation to adipocytes.” Hypertension 48, no. 6 (December 2006): 1095–1102. https://doi.org/10.1161/01.HYP.0000248211.82232.a7.Full Text Link to Item
-
Noiseux, Nicolas, Massimiliano Gnecchi, Marco Lopez-Ilasaca, Lunan Zhang, Scott D. Solomon, Arjun Deb, Victor J. Dzau, and Richard E. Pratt. “Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation.” Mol Ther 14, no. 6 (December 2006): 840–50. https://doi.org/10.1016/j.ymthe.2006.05.016.Full Text Link to Item
-
Creager, M. A., V. J. Dzau, and J. Loscalzo. “Vascular medicine.” Vascular Medicine, December 1, 2006.
-
Mirotsou, Maria, Victor J. Dzau, Richard E. Pratt, and Ellen O. Weinberg. “Physiological genomics of cardiac disease: quantitative relationships between gene expression and left ventricular hypertrophy.” Physiol Genomics 27, no. 1 (October 3, 2006): 86–94. https://doi.org/10.1152/physiolgenomics.00028.2006.Full Text Link to Item
-
Wu, Yaojiong, James E. Ip, Jing Huang, Lunan Zhang, Kenichi Matsushita, Choong-Chin Liew, Richard E. Pratt, and Victor J. Dzau. “Essential role of ICAM-1/CD18 in mediating EPC recruitment, angiogenesis, and repair to the infarcted myocardium.” Circ Res 99, no. 3 (August 4, 2006): 315–22. https://doi.org/10.1161/01.RES.0000235986.35957.a3.Full Text Link to Item
-
Goldschmidt-Clermont, P. J., G. K. W. Lam, V. J. Dzau, C. Dong, J. Kurtzberg, M. A. Creager, D. W. Losordo, and M. Wassef. “Response to letter regarding article "Atherosclerosis 2005: Recent discoveries and novel hypotheses" [2].” Circulation 113, no. 21 (May 1, 2006). https://doi.org/10.1161/CIRCULATIONAHA.106.617068.Full Text
-
Gnecchi, Massimiliano, Huamei He, Nicolas Noiseux, Olin D. Liang, Lunan Zhang, Fulvio Morello, Hui Mu, et al. “Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement.” Faseb J 20, no. 6 (April 2006): 661–69. https://doi.org/10.1096/fj.05-5211com.Full Text Link to Item
-
Creager, M. A., V. J. Dzau, and J. Loscalzo. “Preface.” Vascular Medicine: A Companion to Braunwald’S Heart Disease, March 24, 2006, xvii. https://doi.org/10.1016/B978-0-7216-0284-4.50005-1.Full Text
-
Pachori, Alok S., Luis G. Melo, Lunan Zhang, Scott D. Solomon, and Victor J. Dzau. “Chronic recurrent myocardial ischemic injury is significantly attenuated by pre-emptive adeno-associated virus heme oxygenase-1 gene delivery.” J Am Coll Cardiol 47, no. 3 (February 7, 2006): 635–43. https://doi.org/10.1016/j.jacc.2005.09.038.Full Text Link to Item
-
Liu, Xiaoli, Alok S. Pachori, Christopher A. Ward, J Paul Davis, Massimiliano Gnecchi, Deling Kong, Lunan Zhang, et al. “Heme oxygenase-1 (HO-1) inhibits postmyocardial infarct remodeling and restores ventricular function.” Faseb J 20, no. 2 (February 2006): 207–16. https://doi.org/10.1096/fj.05-4435com.Full Text Link to Item
-
Pachori, A. S., L. G. Melo, and V. J. Dzau. “Gene therapy: role in myocardial protection.” Handb Exp Pharmacol, no. 176 Pt 2 (2006): 335–50. https://doi.org/10.1007/3-540-36028-x_11.Full Text Link to Item
-
Sussman, A. J., J. R. Otten, R. C. Goldszer, M. Hanson, D. J. Trull, K. Paulus, M. Brown, V. Dzau, and T. A. Brennan. “Integration of an academic medical center and a community hospital: The Brigham and Women's/Faulkner Hospital experience.” Academic Medicine 81, no. 10 SUPPL. (January 1, 2006): 18–25. https://doi.org/10.1097/01.ACM.0000235874.96097.ae.Full Text
-
Goldschmidt-Clermont, Pascal J., Mark A. Creager, Douglas W. Losordo, Gregory K. W. Lam, Momtaz Wassef, and Victor J. Dzau. “Atherosclerosis 2005: recent discoveries and novel hypotheses.” Circulation 112, no. 21 (November 22, 2005): 3348–53. https://doi.org/10.1161/CIRCULATIONAHA.105.577460.Full Text Link to Item
-
Sales, Virna L., Galina K. Sukhova, Marco A. Lopez-Ilasaca, Peter Libby, Victor J. Dzau, and Richard E. Pratt. “Angiotensin type 2 receptor is expressed in murine atherosclerotic lesions and modulates lesion evolution.” Circulation 112, no. 21 (November 22, 2005): 3328–36. https://doi.org/10.1161/CIRCULATIONAHA.105.541714.Full Text Link to Item
-
Dzau, Victor J., Massimiliano Gnecchi, and Alok S. Pachori. “Enhancing stem cell therapy through genetic modification.” J Am Coll Cardiol 46, no. 7 (October 4, 2005): 1351–53. https://doi.org/10.1016/j.jacc.2005.07.023.Full Text Link to Item
-
Dzau, Victor J., and Marco Lopez-Ilasaca. “Searching for transcriptional regulators of Ang II-induced vascular pathology.” J Clin Invest 115, no. 9 (September 2005): 2319–22. https://doi.org/10.1172/JCI26384.Full Text Link to Item
-
Cunha-Neto, Edecio, Victor J. Dzau, Paul D. Allen, Dimitri Stamatiou, Luiz Benvenutti, M Lourdes Higuchi, Natalia S. Koyama, Joao S. Silva, Jorge Kalil, and Choong-Chin Liew. “Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy.” Am J Pathol 167, no. 2 (August 2005): 305–13. https://doi.org/10.1016/S0002-9440(10)62976-8.Full Text Link to Item
-
Dzau, Victor J., Massimiliano Gnecchi, Alok S. Pachori, Fulvio Morello, and Luis G. Melo. “Therapeutic potential of endothelial progenitor cells in cardiovascular diseases.” Hypertension 46, no. 1 (July 2005): 7–18. https://doi.org/10.1161/01.HYP.0000168923.92885.f7.Full Text Link to Item
-
Morello, Fulvio, Rudolf A. de Boer, Knut R. Steffensen, Massimiliano Gnecchi, Jeffrey W. Chisholm, Frans Boomsma, Leonard M. Anderson, et al. “Liver X receptors alpha and beta regulate renin expression in vivo.” J Clin Invest 115, no. 7 (July 2005): 1913–22. https://doi.org/10.1172/JCI24594.Full Text Link to Item
-
Melo, Luis G., Alok S. Pachori, Massimiliano Gnecchi, and Victor J. Dzau. “Genetic therapies for cardiovascular diseases.” Trends Mol Med 11, no. 5 (May 2005): 240–50. https://doi.org/10.1016/j.molmed.2005.03.008.Full Text Link to Item
-
Dzau, Victor. “The cardiovascular continuum and renin-angiotensin-aldosterone system blockade.” J Hypertens Suppl 23, no. 1 (April 2005): S9-17.Link to Item
-
Guo, Shaodong, Marco Lopez-Ilasaca, and Victor J. Dzau. “Identification of calcium-modulating cyclophilin ligand (CAML) as transducer of angiotensin II-mediated nuclear factor of activated T cells (NFAT) activation.” J Biol Chem 280, no. 13 (April 1, 2005): 12536–41. https://doi.org/10.1074/jbc.M500296200.Full Text Link to Item
-
Gnecchi, Massimiliano, Huamei He, Olin D. Liang, Luis G. Melo, Fulvio Morello, Hui Mu, Nicolas Noiseux, et al. “Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells.” Nat Med 11, no. 4 (April 2005): 367–68. https://doi.org/10.1038/nm0405-367.Full Text Link to Item
-
Sussman, Andrew J., Jeffrey R. Otten, Robert C. Goldszer, Margaret Hanson, David J. Trull, Kenneth Paulus, Monte Brown, Victor Dzau, and Troyen A. Brennan. “Integration of an academic medical center and a community hospital: the Brigham and Women's/Faulkner hospital experience.” Acad Med 80, no. 3 (March 2005): 253–60. https://doi.org/10.1097/00001888-200503000-00009.Full Text Link to Item
-
Lopez-Ilasaca, Marco A., Julio C. Bernabe-Ortiz, Soon-Young Na, Victor J. Dzau, and Ramnik J. Xavier. “Bioluminescence resonance energy transfer identify scaffold protein CNK1 interactions in intact cells.” Febs Lett 579, no. 3 (January 31, 2005): 648–54. https://doi.org/10.1016/j.febslet.2004.12.039.Full Text Link to Item
-
McMurray, John J. V., Marc A. Pfeffer, Karl Swedberg, and Victor J. Dzau. “Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?” Circulation 110, no. 20 (November 16, 2004): 3281–88. https://doi.org/10.1161/01.CIR.0000147274.83071.68.Full Text Link to Item
-
Liew, Choong-Chin, and Victor J. Dzau. “Molecular genetics and genomics of heart failure.” Nat Rev Genet 5, no. 11 (November 2004): 811–25. https://doi.org/10.1038/nrg1470.Full Text Link to Item
-
Morello, Fulvio, Tjerk W. A. de Bruin, Jerome I. Rotter, Richard E. Pratt, Carla J. H. van der Kallen, Gary A. Hladik, Victor J. Dzau, Choong-Chin Liew, and Yii-Der I. Chen. “Differential gene expression of blood-derived cell lines in familial combined hyperlipidemia.” Arterioscler Thromb Vasc Biol 24, no. 11 (November 2004): 2149–54. https://doi.org/10.1161/01.ATV.0000145978.70872.63.Full Text Link to Item
-
Kong, Deling, Luis G. Melo, Massimiliano Gnecchi, Lunan Zhang, Gustavo Mostoslavsky, Chong C. Liew, Richard E. Pratt, and Victor J. Dzau. “Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries.” Circulation 110, no. 14 (October 5, 2004): 2039–46. https://doi.org/10.1161/01.CIR.0000143161.01901.BD.Full Text Link to Item
-
Melo, Luis G., Massimiliano Gnecchi, Alok S. Pachori, Deling Kong, Kai Wang, Xiaoli Liu, Richard E. Pratt, and Victor J. Dzau. “Endothelium-targeted gene and cell-based therapies for cardiovascular disease.” Arterioscler Thromb Vasc Biol 24, no. 10 (October 2004): 1761–74. https://doi.org/10.1161/01.ATV.0000142363.15113.88.Full Text Link to Item
-
Tamura, Kouichi, Yuqing E. Chen, Yutaka Tanaka, Masashi Sakai, Yuko Tsurumi, Yuichi Koide, Minoru Kihara, et al. “Nuclear receptor LXRalpha is involved in cAMP-mediated human renin gene expression.” Mol Cell Endocrinol 224, no. 1–2 (September 30, 2004): 11–20. https://doi.org/10.1016/j.mce.2004.07.005.Full Text Link to Item
-
Levy, Bruce D., Joel T. Katz, Marshall A. Wolf, Jane S. Sillman, Robert I. Handin, and Victor J. Dzau. “An initiative in mentoring to promote residents' and faculty members' careers.” Acad Med 79, no. 9 (September 2004): 845–50. https://doi.org/10.1097/00001888-200409000-00006.Full Text Link to Item
-
Melo, L. G., M. Gnecchi, A. S. Pachori, K. Wang, and V. J. Dzau. “Gene- and cell-based therapies for cardiovascular diseases: Current status and future directions.” European Heart Journal, Supplement 6, no. E (September 1, 2004). https://doi.org/10.1016/j.ehjsup.2004.06.001.Full Text
-
Ylä-Herttuala, S., and V. J. Dzau. “European Heart Journal Supplements: Introduction.” European Heart Journal, Supplement 6, no. E (September 1, 2004). https://doi.org/10.1016/j.ehjsup.2004.06.003.Full Text
-
Pachori, Alok S., Luis G. Melo, Melanie L. Hart, Nicholas Noiseux, Lunan Zhang, Fulvio Morello, Scott D. Solomon, Gregory L. Stahl, Richard E. Pratt, and Victor J. Dzau. “Hypoxia-regulated therapeutic gene as a preemptive treatment strategy against ischemia/reperfusion tissue injury.” Proc Natl Acad Sci U S A 101, no. 33 (August 17, 2004): 12282–87. https://doi.org/10.1073/pnas.0404616101.Full Text Link to Item
-
Dzau, Victor J. “Markers of malign across the cardiovascular continuum: interpretation and application.” Circulation 109, no. 25 Suppl 1 (June 29, 2004): IV1–2. https://doi.org/10.1161/01.CIR.0000133445.78855.aa.Full Text Link to Item
-
Gibbons, Gary H., Choong Chin Liew, Mark O. Goodarzi, Jerome I. Rotter, Willa A. Hsueh, Helmy M. Siragy, Richard Pratt, and Victor J. Dzau. “Genetic markers: progress and potential for cardiovascular disease.” Circulation 109, no. 25 Suppl 1 (June 29, 2004): IV47–58. https://doi.org/10.1161/01.CIR.0000133440.86427.26.Full Text Link to Item
-
Stampfer, Meir J., Paul M. Ridker, and Victor J. Dzau. “Risk factor criteria.” Circulation 109, no. 25 Suppl 1 (June 29, 2004): IV3–5. https://doi.org/10.1161/01.CIR.0000133446.69171.7d.Full Text Link to Item
-
Agrawal, R. S., S. Muangman, M. D. Layne, L. Melo, M. A. Perrella, R. T. Lee, L. Zhang, M. Lopez-Ilasaca, and V. J. Dzau. “Pre-emptive gene therapy using recombinant adeno-associated virus delivery of extracellular superoxide dismutase protects heart against ischemic reperfusion injury, improves ventricular function and prolongs survival.” Gene Ther 11, no. 12 (June 2004): 962–69. https://doi.org/10.1038/sj.gt.3302250.Full Text Link to Item
-
Melo, Luis G., Alok S. Pachori, Deling Kong, Massimiliano Gnecchi, Kai Wang, Richard E. Pratt, and Victor J. Dzau. “Molecular and cell-based therapies for protection, rescue, and repair of ischemic myocardium: reasons for cautious optimism.” Circulation 109, no. 20 (May 25, 2004): 2386–93. https://doi.org/10.1161/01.CIR.0000128597.37025.00.Full Text Link to Item
-
Braun-Dullaeus, Ruediger C., Michael J. Mann, Daniel G. Sedding, Steven W. Sherwood, Heiko E. von der Leyen, and Victor J. Dzau. “Cell cycle-dependent regulation of smooth muscle cell activation.” Arterioscler Thromb Vasc Biol 24, no. 5 (May 2004): 845–50. https://doi.org/10.1161/01.ATV.0000125704.28058.a2.Full Text Link to Item
-
Tomita, Naruya, John Y. S. Kim, Gary H. Gibbons, Lunan Zhang, Yasufumi Kaneda, Rolf A. K. Stahl, Malcom Ogborn, et al. “Gene therapy with an E2F transcription factor decoy inhibits cell cycle progression in rat anti-Thy 1 glomerulonephritis.” Int J Mol Med 13, no. 5 (May 2004): 629–36.Link to Item
-
Kong, Deling, Luis G. Melo, Abeel A. Mangi, Lunan Zhang, Marco Lopez-Ilasaca, Mark A. Perrella, Chong C. Liew, Richard E. Pratt, and Victor J. Dzau. “Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells.” Circulation 109, no. 14 (April 13, 2004): 1769–75. https://doi.org/10.1161/01.CIR.0000121732.85572.6F.Full Text Link to Item
-
Melo, Luis G., Alok S. Pachori, Deling Kong, Massimiliano Gnecchi, Kai Wang, Richard E. Pratt, and Victor J. Dzau. “Gene and cell-based therapies for heart disease.” Faseb J 18, no. 6 (April 2004): 648–63. https://doi.org/10.1096/fj.03-1171rev.Full Text Link to Item
-
Liew, C. C., and V. J. Dzau. “Human Genome Project and Cardiovascular Disease Genes,” March 19, 2004, 16–38. https://doi.org/10.1016/B978-0-7216-9428-3.50007-X.Full Text
-
Pachori, Alok S., Luis G. Melo, Lunan Zhang, Massimo Loda, Richard E. Pratt, and Victor J. Dzau. “Potential for germ line transmission after intramyocardial gene delivery by adeno-associated virus.” Biochem Biophys Res Commun 313, no. 3 (January 16, 2004): 528–33. https://doi.org/10.1016/j.bbrc.2003.11.140.Full Text Link to Item
-
Dzau, V. J. “Markers of malign across the cardiovascular continuum: Interpretation and application.” Circulation 109, no. 25 (2004): IV-1-IV–2.
-
Gibbons, G. H., C. C. Liew, M. O. Goodarzi, J. I. Rotter, W. A. Hsueh, H. M. Siragy, R. Pratt, and V. J. Dzau. “Genetic markers: Progress and potential for cardiovascular disease.” Circulation 109, no. 25 (2004): IV-47-IV–58.
-
Stampfer, M. J., P. M. Ridker, and V. J. Dzau. “Risk factor criteria.” Circulation 109, no. 25 (2004): IV-3-IV–5.
-
Lopez-Ilasaca, Marco, Xiushi Liu, Koichi Tamura, and Victor J. Dzau. “The angiotensin II type I receptor-associated protein, ATRAP, is a transmembrane protein and a modulator of angiotensin II signaling.” Mol Biol Cell 14, no. 12 (December 2003): 5038–50. https://doi.org/10.1091/mbc.e03-06-0383.Full Text Link to Item
-
Griese, Daniel P., Afshin Ehsan, Luis G. Melo, Deling Kong, Lunan Zhang, Michael J. Mann, Richard E. Pratt, Richard C. Mulligan, and Victor J. Dzau. “Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy.” Circulation 108, no. 21 (November 25, 2003): 2710–15. https://doi.org/10.1161/01.CIR.0000096490.16596.A6.Full Text Link to Item
-
Dzau, V. J., and J. F. Kapp. “American Journal of Cardiology: Introduction.” American Journal of Cardiology 92, no. 9 SUPPL. 2 (November 7, 2003). https://doi.org/10.1016/S0002-9149(03)00961-5.Full Text
-
Dzau, Victor J. “Predicting the future of human gene therapy for cardiovascular diseases: what will the management of coronary artery disease be like in 2005 and 2010?” Am J Cardiol 92, no. 9B (November 7, 2003): 32N-35N. https://doi.org/10.1016/s0002-9149(03)00966-4.Full Text Link to Item
-
Dzau, Victor J., Kevin Beatt, Giulio Pompilio, and Karen Smith. “Current perceptions of cardiovascular gene therapy.” Am J Cardiol 92, no. 9B (November 7, 2003): 18N-23N. https://doi.org/10.1016/s0002-9149(03)00964-0.Full Text Link to Item
-
Kleiman, Neal S., Nirav C. Patel, Keith B. Allen, Michael Simons, Seppo Ylä-Herttuala, Elaine Griffin, and Victor J. Dzau. “Evolving revascularization approaches for myocardial ischemia.” Am J Cardiol 92, no. 9B (November 7, 2003): 9N-17N. https://doi.org/10.1016/s0002-9149(03)00963-9.Full Text Link to Item
-
Mirotsou, Maria, Coran M. H. Watanabe, Peter G. Schultz, Richard E. Pratt, and Victor J. Dzau. “Elucidating the molecular mechanism of cardiac remodeling using a comparative genomic approach.” Physiol Genomics 15, no. 2 (October 17, 2003): 115–26. https://doi.org/10.1152/physiolgenomics.00071.2003.Full Text Link to Item
-
Durier, Séverine, Céline Fassot, Stéphane Laurent, Pierre Boutouyrie, Jean-Paul Couetil, Erika Fine, Patrick Lacolley, Victor J. Dzau, and Richard E. Pratt. “Physiological genomics of human arteries: quantitative relationship between gene expression and arterial stiffness.” Circulation 108, no. 15 (October 14, 2003): 1845–51. https://doi.org/10.1161/01.CIR.0000091407.86925.7A.Full Text Link to Item
-
Huber, P. E., M. J. Mann, L. G. Melo, A. Ehsan, D. Kong, L. Zhang, M. Rezvani, et al. “Focused ultrasound (HIFU) induces localized enhancement of reporter gene expression in rabbit carotid artery.” Gene Ther 10, no. 18 (September 2003): 1600–1607. https://doi.org/10.1038/sj.gt.3302045.Full Text Link to Item
-
Mangi, Abeel A., Nicolas Noiseux, Deling Kong, Huamei He, Mojgan Rezvani, Joanne S. Ingwall, and Victor J. Dzau. “Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts.” Nat Med 9, no. 9 (September 2003): 1195–1201. https://doi.org/10.1038/nm912.Full Text Link to Item
-
Dzau, Victor J., and Susan B. Glueck. “The future of Physiological Genomics.” Physiol Genomics 14, no. 3 (August 15, 2003): 167–68. https://doi.org/10.1152/physiolgenomics.00114.2003.Full Text Link to Item
-
Dzau, V. “Risk assessment in cardiovascular disease: From traditional risk factors to genomics.” European Heart Journal, Supplement 5, no. F (August 1, 2003). https://doi.org/10.1016/S1520-765X(03)90016-2.Full Text
-
Barrans, J David, James Ip, Ching-Wan Lam, Irene L. Hwang, Victor J. Dzau, and Choong-Chin Liew. “Chromosomal distribution of the human cardiovascular transcriptome.” Genomics 81, no. 5 (May 2003): 519–24. https://doi.org/10.1016/s0888-7543(03)00008-9.Full Text Link to Item
-
Anderson, Leonard M., Sung E. Choe, Rustam Y. Yukhananov, Rob L. Hopfner, George M. Church, Richard E. Pratt, and Victor J. Dzau. “Identification of a novel set of genes regulated by a unique liver X receptor-alpha -mediated transcription mechanism.” J Biol Chem 278, no. 17 (April 25, 2003): 15252–60. https://doi.org/10.1074/jbc.M208644200.Full Text Link to Item
-
Ranade, Koustubh, David Hinds, Chao Agnes Hsiung, Lee-Ming Chuang, Mau-Song Chang, Ying-Tsung Chen, Robert Pesich, et al. “A genome scan for hypertension susceptibility loci in populations of Chinese and Japanese origins.” Am J Hypertens 16, no. 2 (February 2003): 158–62. https://doi.org/10.1016/s0895-7061(02)03245-4.Full Text Link to Item
-
Weinberg, Ellen O., Maria Mirotsou, Joseph Gannon, Victor J. Dzau, Richard T. Lee, and Richard E. Pratt. “Sex dependence and temporal dependence of the left ventricular genomic response to pressure overload.” Physiol Genomics 12, no. 2 (January 15, 2003): 113–27. https://doi.org/10.1152/physiolgenomics.00046.2002.Full Text Link to Item
-
Glueck, S. B., and V. J. Dzau. “Our new requirement for MIAME standards.” Physiological Genomics 13 (January 1, 2003): 1–2. https://doi.org/10.1152/physiolgenomics.00019.2003.Full Text
-
Dzau, Victor J., Ruediger C. Braun-Dullaeus, and Daniel G. Sedding. “Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies.” Nat Med 8, no. 11 (November 2002): 1249–56. https://doi.org/10.1038/nm1102-1249.Full Text Link to Item
-
Mann, Michael J., and Victor J. Dzau. “Molecular approaches for the treatment of atherosclerosis.” Cardiol Clin 20, no. 4 (November 2002): 633–43. https://doi.org/10.1016/s0733-8651(02)00069-3.Full Text Link to Item
-
Morishita, R., G. H. Gibbons, Y. Kaneda, L. Zhang, T. Ogihara, and V. J. Dzau. “Apolipoprotein E-deficient mice created by systemic administration of antisense oligodeoxynucleotides: a new model for lipoprotein metabolism studies.” J Endocrinol 175, no. 2 (November 2002): 475–85. https://doi.org/10.1677/joe.0.1750475.Full Text Link to Item
-
Dzau, V. J. “Angiotensin II is an active mediator of cardiovascular disease.” Cardiology Review 19, no. 12 SUPPL. (October 1, 2002): 1–3.
-
Ton, Christopher, Dimitri Stamatiou, Victor J. Dzau, and Choong-Chin Liew. “Construction of a zebrafish cDNA microarray: gene expression profiling of the zebrafish during development.” Biochem Biophys Res Commun 296, no. 5 (September 6, 2002): 1134–42. https://doi.org/10.1016/s0006-291x(02)02010-7.Full Text Link to Item
-
Aird, William C., Susan B. Glueck, Victor J. Dzau, and Richard E. Pratt. “Separating the wheat from the chaff: focus on "in silico data filtering to identify new angiogenesis targets from a large in vitro gene profile data set".” Physiol Genomics 10, no. 1 (July 12, 2002): 1–3. https://doi.org/10.1152/physiolgenomics.00071.2002.Full Text Link to Item
-
Hwang, Juey-Jen, Paul D. Allen, George C. Tseng, Ching-Wan Lam, Lameh Fananapazir, Victor J. Dzau, and Choong-Chin Liew. “Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure.” Physiol Genomics 10, no. 1 (July 12, 2002): 31–44. https://doi.org/10.1152/physiolgenomics.00122.2001.Full Text Link to Item
-
Wu, Kwan-Dun, Chin-Fu Hsiao, Low-Tone Ho, Wayne Huey-Herng Sheu, Dee Pei, Lee-Ming Chuang, David Curb, et al. “Clustering and heritability of insulin resistance in Chinese and Japanese hypertensive families: a Stanford-Asian Pacific Program in Hypertension and Insulin Resistance sibling study.” Hypertens Res 25, no. 4 (July 2002): 529–36. https://doi.org/10.1291/hypres.25.529.Full Text Link to Item
-
Dzau, Victor J. “Transcription factor decoy.” Circ Res 90, no. 12 (June 28, 2002): 1234–36. https://doi.org/10.1161/01.res.0000025209.24283.73.Full Text Link to Item
-
Barrans, J David, Paul D. Allen, Dimitrios Stamatiou, Victor J. Dzau, and Choong-Chin Liew. “Global gene expression profiling of end-stage dilated cardiomyopathy using a human cardiovascular-based cDNA microarray.” Am J Pathol 160, no. 6 (June 2002): 2035–43. https://doi.org/10.1016/S0002-9440(10)61153-4.Full Text Link to Item
-
Ehsan, Afshin, Michael J. Mann, Giorgio Dell’Acqua, Koichi Tamura, Ruediger Braun-Dullaeus, and Victor J. Dzau. “Endothelial healing in vein grafts: proliferative burst unimpaired by genetic therapy of neointimal disease.” Circulation 105, no. 14 (April 9, 2002): 1686–92. https://doi.org/10.1161/01.cir.0000013775.02396.93.Full Text Link to Item
-
Dzau, Victor J., Kenneth Bernstein, David Celermajer, Jerome Cohen, Björn Dahlöf, John Deanfield, Javier Diez, et al. “Pathophysiologic and therapeutic importance of tissue ACE: a consensus report.” Cardiovasc Drugs Ther 16, no. 2 (March 2002): 149–60. https://doi.org/10.1023/a:1015709617405.Full Text Link to Item
-
Melo, Luis G., Reitu Agrawal, Lunan Zhang, Mojgan Rezvani, Abeel A. Mangi, Afshin Ehsan, Daniel P. Griese, et al. “Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene.” Circulation 105, no. 5 (February 5, 2002): 602–7. https://doi.org/10.1161/hc0502.103363.Full Text Link to Item
-
Glueck, Susan B., and Victor J. Dzau. “Physiological genomics: implications in hypertension research.” Hypertension 39, no. 2 Pt 2 (February 2002): 310–15. https://doi.org/10.1161/hy0202.104086.Full Text Link to Item
-
Francis, S. C., M. K. Raizada, A. A. Mangi, L. G. Melo, V. J. Dzau, P. R. Vale, J. M. Isner, et al. “Genetic targeting for cardiovascular therapeutics: Are we near the summit or just beginning the climb?” Physiological Genomics 2002, no. 7 (January 1, 2002): 79–94.
-
Tomita, Naruya, Ryuichi Morishita, Kei Yamamoto, Jitsuo Higaki, Victor J. Dzau, Toshio Ogihara, and Yasufumi Kaneda. “Targeted gene therapy for rat glomerulonephritis using HVJ-immunoliposomes.” J Gene Med 4, no. 5 (2002): 527–35. https://doi.org/10.1002/jgm.300.Full Text Link to Item
-
Francis, S. C., M. K. Raizada, A. A. Mangi, L. G. Melo, V. J. Dzau, P. R. Vale, J. M. Isner, et al. “Genetic targeting for cardiovascular therapeutics: are we near the summit or just beginning the climb?” Physiol Genomics 7, no. 2 (December 21, 2001): 79–94. https://doi.org/10.1152/physiolgenomics.00073.2001.Full Text Link to Item
-
Butte, A. J., V. J. Dzau, and S. B. Glueck. “Further defining housekeeping, or "maintenance," genes Focus on "A compendium of gene expression in normal human tissues".” Physiol Genomics 7, no. 2 (December 21, 2001): 95–96. https://doi.org/10.1152/physiolgenomics.2001.7.2.95.Full Text Link to Item
-
Dzau, V. J., and S. Glueck. “Physiological Genomics: Who we are and where we're going.” Physiol Genomics 7, no. 2 (December 21, 2001): 65–67. https://doi.org/10.1152/physiolgenomics.2001.7.2.65.Full Text Link to Item
-
Dzau, V. J., K. Bernstein, D. Celermajer, J. Cohen, B. Dahlöf, J. Deanfield, J. Diez, et al. “The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data.” Am J Cardiol 88, no. 9A (November 8, 2001): 1L-20L. https://doi.org/10.1016/s0002-9149(01)01878-1.Full Text Link to Item
-
Ranade, K., K. D. Wu, N. Risch, M. Olivier, D. Pei, C. F. Hsiao, L. M. Chuang, et al. “Genetic variation in aldosterone synthase predicts plasma glucose levels.” Proc Natl Acad Sci U S A 98, no. 23 (November 6, 2001): 13219–24. https://doi.org/10.1073/pnas.221467098.Full Text Link to Item
-
Dempsey, A. A., V. J. Dzau, and C. C. Liew. “Cardiovascular genomics: estimating the total number of genes expressed in the human cardiovascular system.” J Mol Cell Cardiol 33, no. 10 (October 2001): 1879–86. https://doi.org/10.1006/jmcc.2001.1447.Full Text Link to Item
-
Yet, S. F., R. Tian, M. D. Layne, Z. Y. Wang, K. Maemura, M. Solovyeva, B. Ith, et al. “Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice.” Circ Res 89, no. 2 (July 20, 2001): 168–73. https://doi.org/10.1161/hh1401.093314.Full Text Link to Item
-
Ranade, K., M. S. Chang, C. T. Ting, D. Pei, C. F. Hsiao, M. Olivier, R. Pesich, et al. “High-throughput genotyping with single nucleotide polymorphisms.” Genome Res 11, no. 7 (July 2001): 1262–68. https://doi.org/10.1101/gr.157801.Full Text Link to Item
-
Braun-Dullaeus, R. C., M. J. Mann, U. Seay, L. Zhang, H. E. von Der Leyen, R. E. Morris, and V. J. Dzau. “Cell cycle protein expression in vascular smooth muscle cells in vitro and in vivo is regulated through phosphatidylinositol 3-kinase and mammalian target of rapamycin.” Arterioscler Thromb Vasc Biol 21, no. 7 (July 2001): 1152–58. https://doi.org/10.1161/hq0701.092104.Full Text Link to Item
-
Daviet, L., J. Y. Lehtonen, W. Hayashida, V. J. Dzau, and M. Horiuchi. “Intracellular third loops in AT1 and AT2 receptors determine subtype specificity.” Life Sci 69, no. 5 (June 22, 2001): 509–16. https://doi.org/10.1016/s0024-3205(01)01144-4.Full Text Link to Item
-
Glueck, S. B., V. J. Dzau, R. Lee, and R. E. Pratt. “Challenges of comparative expression profiling studies of complex diseases: mouse models of myocardial hypertrophy. Focus on "Divergent transcriptional responses to independent genetic causes of cardiac hypertrophy".” Physiol Genomics 6, no. 1 (June 6, 2001): 1–2. https://doi.org/10.1152/physiolgenomics.2001.6.1.1.Full Text Link to Item
-
Leyen, H. E. von der, and V. J. Dzau. “Therapeutic potential of nitric oxide synthase gene manipulation.” Circulation 103, no. 22 (June 5, 2001): 2760–65. https://doi.org/10.1161/01.cir.103.22.2760.Full Text Link to Item
-
Hwang, J. J., V. J. Dzau, and C. C. Liew. “Genomics and the pathophysiology of heart failure.” Curr Cardiol Rep 3, no. 3 (May 2001): 198–207. https://doi.org/10.1007/s11886-001-0023-z.Full Text Link to Item
-
Ehsan, A., M. J. Mann, G. Dell’Acqua, and V. J. Dzau. “Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy.” J Thorac Cardiovasc Surg 121, no. 4 (April 2001): 714–22. https://doi.org/10.1067/mtc.2001.111204.Full Text Link to Item
-
Mangi, A. A., and V. J. Dzau. “Gene therapy for human bypass grafts.” Ann Med 33, no. 3 (April 2001): 153–55. https://doi.org/10.3109/07853890109002071.Full Text Link to Item
-
Dzau, V. J. “Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis.” Hypertension 37, no. 4 (April 2001): 1047–52. https://doi.org/10.1161/01.hyp.37.4.1047.Full Text Link to Item
-
Dzau, V. J., M. J. Mann, A. Ehsan, and D. P. Griese. “Gene therapy and genomic strategies for cardiovascular surgery: The emerging field of surgiomics.” J Thorac Cardiovasc Surg 121, no. 2 (February 2001): 206–16. https://doi.org/10.1067/mtc.2001.111211.Full Text Link to Item
-
Skarlatos, S. I., and V. Dzau. “New Vistas in Therapeutics: From Drug Design to Gene Therapy: Introduction.” Annals of the New York Academy of Sciences 953 (January 1, 2001): 1–2. https://doi.org/10.1111/j.1749-6632.2001.tb11355.x.Full Text
-
Alexander, R. W., and V. J. Dzau. “Vascular biology: the past 50 years.” Circulation 102, no. 20 Suppl 4 (November 14, 2000): IV112–16. https://doi.org/10.1161/01.cir.102.suppl_4.iv-112.Full Text Link to Item
-
Tamura, K., Y. E. Chen, M. Lopez-Ilasaca, L. Daviet, N. Tamura, T. Ishigami, M. Akishita, et al. “Molecular mechanism of fibronectin gene activation by cyclic stretch in vascular smooth muscle cells.” J Biol Chem 275, no. 44 (November 3, 2000): 34619–27. https://doi.org/10.1074/jbc.M004421200.Full Text Link to Item
-
Mann, M. J., and V. J. Dzau. “Therapeutic applications of transcription factor decoy oligonucleotides.” J Clin Invest 106, no. 9 (November 2000): 1071–75. https://doi.org/10.1172/JCI11459.Full Text Link to Item
-
Akishita, M., M. Iwai, L. Wu, L. Zhang, Y. Ouchi, V. J. Dzau, and M. Horiuchi. “Inhibitory effect of angiotensin II type 2 receptor on coronary arterial remodeling after aortic banding in mice.” Circulation 102, no. 14 (October 3, 2000): 1684–89. https://doi.org/10.1161/01.cir.102.14.1684.Full Text Link to Item
-
Tamura, K., Y. E. Chen, Q. Chen, N. Nyui, M. Horiuchi, I. Takasaki, N. Tamura, R. E. Pratt, V. J. Dzau, and S. Umemura. “Expression of renin-angiotensin system and extracellular matrix genes in cardiovascular cells and its regulation through AT1 receptor.” Mol Cell Biochem 212, no. 1–2 (September 2000): 203–9.Link to Item
-
Tomita, N., R. Morishita, S. Tomita, G. H. Gibbons, L. Zhang, M. Horiuchi, Y. Kaneda, J. Higaki, T. Ogihara, and V. J. Dzau. “Transcription factor decoy for NFkappaB inhibits TNF-alpha-induced cytokine and adhesion molecule expression in vivo.” Gene Ther 7, no. 15 (August 2000): 1326–32. https://doi.org/10.1038/sj.gt.3301243.Full Text Link to Item
-
Tamura, K., Y. E. Chen, M. Horiuchi, Q. Chen, L. Daviet, Z. Yang, M. Lopez-Ilasaca, H. Mu, R. E. Pratt, and V. J. Dzau. “LXRalpha functions as a cAMP-responsive transcriptional regulator of gene expression.” Proc Natl Acad Sci U S A 97, no. 15 (July 18, 2000): 8513–18. https://doi.org/10.1073/pnas.100519097.Full Text Link to Item
-
Morishita, R., G. H. Gibbons, Y. Kaneda, T. Ogihara, and V. J. Dzau. “Systemic administration of HVJ viral coat-liposome complex containing human insulin vector decreases glucose level in diabetic mouse: A model of gene therapy.” Biochem Biophys Res Commun 273, no. 2 (July 5, 2000): 666–74. https://doi.org/10.1006/bbrc.2000.2936.Full Text Link to Item
-
Ranade, K., A. C. Hsuing, K. D. Wu, M. S. Chang, Y. T. Chen, J. Hebert, Y. I. Chen, et al. “Lack of evidence for an association between alpha-adducin and blood pressure regulation in Asian populations.” Am J Hypertens 13, no. 6 Pt 1 (June 2000): 704–9. https://doi.org/10.1016/s0895-7061(00)00238-7.Full Text Link to Item
-
Akishita, M., M. Horiuchi, H. Yamada, L. Zhang, G. Shirakami, K. Tamura, Y. Ouchi, and V. J. Dzau. “Inflammation influences vascular remodeling through AT 2 receptor expression and signaling.” Physiological Genomics 2000, no. 2 (May 1, 2000): 13–20.
-
Morishita, R., G. H. Gibbons, N. Tomita, L. Zhang, Y. Kaneda, T. Ogihara, and V. J. Dzau. “Antisense oligodeoxynucleotide inhibition of vascular angiotensin-converting enzyme expression attenuates neointimal formation: evidence for tissue angiotensin-converting enzyme function.” Arterioscler Thromb Vasc Biol 20, no. 4 (April 2000): 915–22. https://doi.org/10.1161/01.atv.20.4.915.Full Text Link to Item
-
Holmes, E. W., T. F. Burks, V. Dzau, M. A. Hindery, R. F. Jones, C. I. Kaye, D. Korn, et al. “Measuring contributions to the research mission of medical schools.” Acad Med 75, no. 3 (March 2000): 303–13. https://doi.org/10.1097/00001888-200003000-00027.Full Text Link to Item
-
Akishita, M., M. Horiuchi, H. Yamada, L. Zhang, G. Shirakami, K. Tamura, Y. Ouchi, and V. J. Dzau. “Inflammation influences vascular remodeling through AT2 receptor expression and signaling.” Physiol Genomics 2, no. 1 (January 24, 2000): 13–20. https://doi.org/10.1152/physiolgenomics.2000.2.1.13.Full Text Link to Item
-
Dzau, V. “Future opportunities for the treatment of cardiovascular disease.” British Journal of Cardiology 7, no. SUPPL. 2 (January 1, 2000).
-
Mann, M. J., A. Ehsan, and V. J. Dzau. “Vascular growth factors as an adjunct to surgical revascularization.” Acc Current Journal Review 9, no. 4 (January 1, 2000): 43–46. https://doi.org/10.1016/S1062-1458(00)00065-9.Full Text
-
Weir, M. R., and V. J. Dzau. “The renin-angiotensin-aldosterone system: a specific target for hypertension management.” Am J Hypertens 12, no. 12 Pt 3 (December 1999): 205S-213S. https://doi.org/10.1016/s0895-7061(99)00103-x.Full Text Link to Item
-
Dzau, V., M. Frank, M. Reich, M. J. Austin, R. Aebersold, A. Cowley, D. Housman, R. Mulligan, and R. Rosenberg. “Constants and scientific progress.” Physiol Genomics 1, no. 3 (November 11, 1999): 107. https://doi.org/10.1152/physiolgenomics.1999.1.3.107.Full Text Link to Item
-
Mann, M. J., A. D. Whittemore, M. C. Donaldson, M. Belkin, M. S. Conte, J. F. Polak, E. J. Orav, A. Ehsan, G. Dell’Acqua, and V. J. Dzau. “Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial.” Lancet 354, no. 9189 (October 30, 1999): 1493–98. https://doi.org/10.1016/S0140-6736(99)09405-2.Full Text Link to Item
-
Poston, R. S., M. J. Mann, E. G. Hoyt, M. Ennen, V. J. Dzau, and R. C. Robbins. “Antisense oligodeoxynucleotides prevent acute cardiac allograft rejection via a novel, nontoxic, highly efficient transfection method.” Transplantation 68, no. 6 (September 27, 1999): 825–32. https://doi.org/10.1097/00007890-199909270-00015.Full Text Link to Item
-
Leyen, H. E. von der, R. Braun-Dullaeus, M. J. Mann, L. Zhang, J. Niebauer, and V. J. Dzau. “A pressure-mediated nonviral method for efficient arterial gene and oligonucleotide transfer.” Hum Gene Ther 10, no. 14 (September 20, 1999): 2355–64. https://doi.org/10.1089/10430349950017004.Full Text Link to Item
-
Braun-Dullaeus, R. C., M. J. Mann, A. Ziegler, H. E. von der Leyen, and V. J. Dzau. “A novel role for the cyclin-dependent kinase inhibitor p27(Kip1) in angiotensin II-stimulated vascular smooth muscle cell hypertrophy.” J Clin Invest 104, no. 6 (September 1999): 815–23. https://doi.org/10.1172/JCI5339.Full Text Link to Item
-
Akishita, M., H. Yamada, V. J. Dzau, and M. Horiuchi. “Increased vasoconstrictor response of the mouse lacking angiotensin II type 2 receptor.” Biochem Biophys Res Commun 261, no. 2 (August 2, 1999): 345–49. https://doi.org/10.1006/bbrc.1999.1027.Full Text Link to Item
-
Dzau, V. J., M. J. Austin, P. Brown, A. Cowley, D. Housman, R. Mulligan, and R. Rosenberg. “Revolution and renaissance.” Physiol Genomics 1, no. 1 (July 15, 1999): 1–2. https://doi.org/10.1152/physiolgenomics.1999.1.1.1.Full Text Link to Item
-
Lehtonen, J. Y., L. Daviet, C. Nahmias, M. Horiuchi, and V. J. Dzau. “Analysis of functional domains of angiotensin II type 2 receptor involved in apoptosis.” Mol Endocrinol 13, no. 7 (July 1999): 1051–60. https://doi.org/10.1210/mend.13.7.0303.Full Text Link to Item
-
Daviet, L., J. Y. Lehtonen, K. Tamura, D. P. Griese, M. Horiuchi, and V. J. Dzau. “Cloning and characterization of ATRAP, a novel protein that interacts with the angiotensin II type 1 receptor.” J Biol Chem 274, no. 24 (June 11, 1999): 17058–62. https://doi.org/10.1074/jbc.274.24.17058.Full Text Link to Item
-
Lehtonen, J. Y., M. Horiuchi, L. Daviet, M. Akishita, and V. J. Dzau. “Activation of the de novo biosynthesis of sphingolipids mediates angiotensin II type 2 receptor-induced apoptosis.” J Biol Chem 274, no. 24 (June 11, 1999): 16901–6. https://doi.org/10.1074/jbc.274.24.16901.Full Text Link to Item
-
Yamada, H., M. Akishita, M. Ito, K. Tamura, L. Daviet, J. Y. Lehtonen, V. J. Dzau, and M. Horiuchi. “AT2 receptor and vascular smooth muscle cell differentiation in vascular development.” Hypertension 33, no. 6 (June 1999): 1414–19. https://doi.org/10.1161/01.hyp.33.6.1414.Full Text Link to Item
-
Mann, M. J., G. H. Gibbons, H. Hutchinson, R. S. Poston, E. G. Hoyt, R. C. Robbins, and V. J. Dzau. “Pressure-mediated oligonucleotide transfection of rat and human cardiovascular tissues.” Proc Natl Acad Sci U S A 96, no. 11 (May 25, 1999): 6411–16. https://doi.org/10.1073/pnas.96.11.6411.Full Text Link to Item
-
Tomita, S., N. Tomita, T. Yamada, L. Zhang, Y. Kaneda, R. Morishita, T. Ogihara, V. J. Dzau, and M. Horiuchi. “Transcription factor decoy to study the molecular mechanism of negative regulation of renin gene expression in the liver in vivo.” Circ Res 84, no. 9 (May 14, 1999): 1059–66. https://doi.org/10.1161/01.res.84.9.1059.Full Text Link to Item
-
Horiuchi, M., W. Hayashida, M. Akishita, K. Tamura, L. Daviet, J. Y. Lehtonen, and V. J. Dzau. “Stimulation of different subtypes of angiotensin II receptors, AT1 and AT2 receptors, regulates STAT activation by negative crosstalk.” Circ Res 84, no. 8 (April 30, 1999): 876–82. https://doi.org/10.1161/01.res.84.8.876.Full Text Link to Item
-
Horiuchi, M., M. Akishita, and V. J. Dzau. “Recent progress in angiotensin II type 2 receptor research in the cardiovascular system.” Hypertension 33, no. 2 (February 1999): 613–21. https://doi.org/10.1161/01.hyp.33.2.613.Full Text Link to Item
-
Brown, M. D., A. Halpert, S. McKean, A. Sussman, and V. J. Dzau. “Assessing the value of hospitalists to academic health centers: Brigham and Women's Hospital and Harvard Medical School.” Am J Med 106, no. 2 (February 1999): 134–37.Link to Item
-
Ing, D. J., J. Zang, V. J. Dzau, K. A. Webster, and N. H. Bishopric. “Modulation of cytokine-induced cardiac myocyte apoptosis by nitric oxide, Bak, and Bcl-x.” Circ Res 84, no. 1 (January 8, 1999): 21–33. https://doi.org/10.1161/01.res.84.1.21.Full Text Link to Item
-
Akishita, M., M. Ito, J. Y. Lehtonen, L. Daviet, V. J. Dzau, and M. Horiuchi. “Expression of the AT2 receptor developmentally programs extracellular signal-regulated kinase activity and influences fetal vascular growth.” J Clin Invest 103, no. 1 (January 1999): 63–71. https://doi.org/10.1172/JCI5182.Full Text Link to Item
-
Pratt, R. E., and V. J. Dzau. “Genomics and hypertension: concepts, potentials, and opportunities.” Hypertension 33, no. 1 Pt 2 (January 1999): 238–47. https://doi.org/10.1161/01.hyp.33.1.238.Full Text Link to Item
-
Yamada, H., M. Akishita, M. Ito, K. Tamura, L. Daviet, J. Y. A. Lehtonen, V. J. Dzau, and M. Horiuchi. “AT2 receptor and vascular smooth muscle cell differentiation in vascular development.” Hypertension 33, no. 6 (1999): 1414–19.
-
Horiuchi, M., H. Yamada, M. Akishita, M. Ito, K. Tamura, and V. J. Dzau. “Interferon regulatory factors regulate interleukin-1beta-converting enzyme expression and apoptosis in vascular smooth muscle cells.” Hypertension 33, no. 1 (January 1999): 162–66. https://doi.org/10.1161/01.hyp.33.1.162.Full Text Link to Item
-
Sayeed-Shah, U., M. J. Mann, J. Martin, S. Grachev, S. Reimold, R. Laurence, V. Dzau, and L. H. Cohn. “Complete reversal of ischemic wall motion abnormalities by combined use of gene therapy with transmyocardial laser revascularization.” J Thorac Cardiovasc Surg 116, no. 5 (November 1998): 763–69. https://doi.org/10.1016/S0022-5223(98)00440-1.Full Text Link to Item
-
Dzau, V. J. “Mechanism of protective effects of ACE inhibition on coronary artery disease.” Eur Heart J 19 Suppl J (September 1998): J2–6.Link to Item
-
Tomita, N., M. Horiuchi, S. Tomita, G. H. Gibbons, J. Y. Kim, D. Baran, and V. J. Dzau. “An oligonucleotide decoy for transcription factor E2F inhibits mesangial cell proliferation in vitro.” Am J Physiol 275, no. 2 (August 1998): F278–84. https://doi.org/10.1152/ajprenal.1998.275.2.F278.Full Text Link to Item
-
Braun-Dullaeus, R. C., M. J. Mann, and V. J. Dzau. “Cell cycle progression: new therapeutic target for vascular proliferative disease.” Circulation 98, no. 1 (July 7, 1998): 82–89. https://doi.org/10.1161/01.cir.98.1.82.Full Text Link to Item
-
Dzau, V. J., and M. Horiuchi. “Vascular remodeling--the emerging paradigm of programmed cell death (apoptosis): the Francis B. Parker lectureship.” Chest 114, no. 1 Suppl (July 1998): 91S-99S. https://doi.org/10.1378/chest.114.1_supplement.91s-a.Full Text Link to Item
-
Poston, R. S., K. P. Tran, M. J. Mann, E. G. Hoyt, V. J. Dzau, and R. C. Robbins. “Prevention of ischemically induced neointimal hyperplasia using ex vivo antisense oligodeoxynucleotides.” J Heart Lung Transplant 17, no. 4 (April 1998): 349–55.Link to Item
-
Morishita, R., G. H. Gibbons, M. Horiuchi, Y. Kaneda, T. Ogihara, and V. J. Dzau. “Role of AP-1 complex in angiotensin II-mediated transforming growth factor-beta expression and growth of smooth muscle cells: using decoy approach against AP-1 binding site.” Biochem Biophys Res Commun 243, no. 2 (February 13, 1998): 361–67. https://doi.org/10.1006/bbrc.1997.8012.Full Text Link to Item
-
Masaki, H., T. Kurihara, A. Yamaki, N. Inomata, Y. Nozawa, Y. Mori, S. Murasawa, et al. “Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects.” J Clin Invest 101, no. 3 (February 1, 1998): 527–35. https://doi.org/10.1172/JCI1885.Full Text Link to Item
-
Dzau, V. J. “How will molecular therapeutics impact cardiovascular diseases?” British Journal of Cardiology 5, no. SUPPL. 3 (January 1, 1998).
-
Horiuchi, M., and V. J. Dzau. “Angiotensin II-regulated apoptosis in the cardiovascular system.” Heart Failure Reviews 3, no. 1 (January 1, 1998): 27–34. https://doi.org/10.1023/A:1009750429578.Full Text
-
Yamada, T., M. Akishita, M. J. Pollman, G. H. Gibbons, V. J. Dzau, and M. Horiuchi. “Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis and antagonizes angiotensin II type 1 receptor action: an in vitro gene transfer study.” Life Sci 63, no. 19 (1998): PL289–95. https://doi.org/10.1016/s0024-3205(98)00448-2.Full Text Link to Item
-
Dzau, V. J. “Presentation of the 1998 Kober Medal to Eugene Braunwald.” Proc Assoc Am Physicians 110, no. 5 (1998): 445–50.Link to Item
-
Dzau, V. J., H. E. von der Leyen, and R. Morishita. “The concept and potentials of cardiovascular gene therapy.” Indian Heart J 50, no. 1 (1998): 23–33.Link to Item
-
Horiuchi, M., M. Akishita, and V. J. Dzau. “Molecular and cellular mechanism of angiotensin II-mediated apoptosis.” Endocr Res 24, no. 3–4 (1998): 307–14. https://doi.org/10.3109/07435809809032610.Full Text Link to Item
-
Braun-Dullaeus, R. C., H. E. Von Der Leyen, M. J. Mann, L. Zhang, R. E. Morris, and V. J. Dzau. “Loss of p27Kip1 and induction of Cdk1 in the rat carotid artery following ballon catheter injury. in vivo and in vitro influence of rapamycin.” Faseb Journal 11, no. 3 (December 1, 1997).
-
Dzau, V. J. “Concluding remarks.” Journal of Hypertension, Supplement 15, no. 6 (December 1, 1997): 37.
-
Koike, G., H. J. Jacob, A. W. Cowley, V. J. Dzau, D. Fanestil, M. R. Grigor, S. B. Harrap, et al. “The comprehensive total genome scan to map genes responsible for high blood pressure in the rat.” Faseb Journal 11, no. 3 (December 1, 1997).
-
Dzau, V. J., G. H. Gibbons, M. Mann, and R. Braun-Dullaeus. “Future horizons in cardiovascular molecular therapeutics.” Am J Cardiol 80, no. 9A (November 6, 1997): 33I-39I. https://doi.org/10.1016/s0002-9149(97)00790-x.Full Text Link to Item
-
Mann, M. J., and V. J. Dzau. “Genetic manipulation of vein grafts.” Curr Opin Cardiol 12, no. 6 (November 1997): 522–27. https://doi.org/10.1097/00001573-199711000-00004.Full Text Link to Item
-
Hein, L., L. Meinel, R. E. Pratt, V. J. Dzau, and B. K. Kobilka. “Intracellular trafficking of angiotensin II and its AT1 and AT2 receptors: evidence for selective sorting of receptor and ligand.” Mol Endocrinol 11, no. 9 (August 1997): 1266–77. https://doi.org/10.1210/mend.11.9.9975.Full Text Link to Item
-
Horiuchi, M., W. Hayashida, T. Kambe, T. Yamada, and V. J. Dzau. “Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phosphatase-1 and induces apoptosis.” J Biol Chem 272, no. 30 (July 25, 1997): 19022–26. https://doi.org/10.1074/jbc.272.30.19022.Full Text Link to Item
-
Cooke, J. P., and V. J. Dzau. “Derangements of the nitric oxide synthase pathway, L-arginine, and cardiovascular diseases.” Circulation 96, no. 2 (July 15, 1997): 379–82.Link to Item
-
Morishita, R., G. H. Gibbons, M. Horiuchi, M. Nakajima, K. E. Ellison, W. Lee, Y. Kaneda, T. Ogihara, and V. J. Dzau. “Molecular Delivery System for Antisense Oligonucleotides: Enhanced Effectiveness of Antisense Oligonucleotides by HVJ-liposome Mediated Transfer.” J Cardiovasc Pharmacol Ther 2, no. 3 (July 1997): 213–22. https://doi.org/10.1177/107424849700200308.Full Text Link to Item
-
Mann, M. J., R. Morishita, G. H. Gibbons, H. E. von der Leyen, and V. J. Dzau. “DNA transfer into vascular smooth muscle using fusigenic Sendai virus (HVJ)-liposomes.” Mol Cell Biochem 172, no. 1–2 (July 1997): 3–12.Link to Item
-
Hein, L., M. E. Stevens, G. S. Barsh, R. E. Pratt, B. K. Kobilka, and V. J. Dzau. “Overexpression of angiotensin AT1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block.” Proc Natl Acad Sci U S A 94, no. 12 (June 10, 1997): 6391–96. https://doi.org/10.1073/pnas.94.12.6391.Full Text Link to Item
-
Horiuchi, M., T. Yamada, W. Hayashida, and V. J. Dzau. “Interferon regulatory factor-1 up-regulates angiotensin II type 2 receptor and induces apoptosis.” J Biol Chem 272, no. 18 (May 2, 1997): 11952–58. https://doi.org/10.1074/jbc.272.18.11952.Full Text Link to Item
-
Kaneda, Y., R. Morishita, and V. J. Dzau. “Prevention of restenosis by gene therapy.” Ann N Y Acad Sci 811 (April 15, 1997): 299–308. https://doi.org/10.1111/j.1749-6632.1997.tb52010.x.Full Text Link to Item
-
Katsuya, T., M. Horiuchi, S. Minami, G. Koike, N. F. Santoro, A. J. Hsueh, and V. J. Dzau. “Genomic organization and polymorphism of human angiotensin II type 2 receptor: no evidence for its gene mutation in two families of human premature ovarian failure syndrome.” Mol Cell Endocrinol 127, no. 2 (March 28, 1997): 221–28. https://doi.org/10.1016/s0303-7207(97)04011-2.Full Text Link to Item
-
Mann, M. J., G. H. Gibbons, P. S. Tsao, H. E. von der Leyen, J. P. Cooke, R. Buitrago, R. Kernoff, and V. J. Dzau. “Cell cycle inhibition preserves endothelial function in genetically engineered rabbit vein grafts.” J Clin Invest 99, no. 6 (March 15, 1997): 1295–1301. https://doi.org/10.1172/JCI119288.Full Text Link to Item
-
Aoki, M., R. Morishita, A. Muraishi, A. Moriguchi, T. Sugimoto, K. Maeda, V. J. Dzau, Y. Kaneda, J. Higaki, and T. Ogihara. “Efficient in vivo gene transfer into the heart in the rat myocardial infarction model using the HVJ (Hemagglutinating Virus of Japan)--liposome method.” J Mol Cell Cardiol 29, no. 3 (March 1997): 949–59. https://doi.org/10.1006/jmcc.1996.0337.Full Text Link to Item
-
Dzau, V. J. “Introduction.” American Journal of Cardiology 80, no. 9 A (January 1, 1997). https://doi.org/10.1016/s0002-9149(97)00795-9.Full Text
-
Dzau, V. J. “New approaches to cardiovascular therapy: Panel discussion.” American Journal of Cardiology 80, no. 9 A (January 1, 1997). https://doi.org/10.1016/S0002-9149(97)00789-3.Full Text
-
Cooke, J. P., and V. J. Dzau. “Nitric oxide synthase: role in the genesis of vascular disease.” Annu Rev Med 48 (1997): 489–509. https://doi.org/10.1146/annurev.med.48.1.489.Full Text Link to Item
-
Diet, F., R. E. Pratt, G. J. Berry, N. Momose, G. H. Gibbons, and V. J. Dzau. “Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease.” Circulation 94, no. 11 (December 1, 1996): 2756–67. https://doi.org/10.1161/01.cir.94.11.2756.Full Text Link to Item
-
Dzau, V. J., and M. Horiuchi. “In vivo gene transfer and gene modulation in hypertension research.” Hypertension 28, no. 6 (December 1996): 1132–37. https://doi.org/10.1161/01.hyp.28.6.1132.Full Text Link to Item
-
Matsumoto, T., N. Sagawa, M. Mukoyama, I. Tanaka, H. Itoh, M. Goto, M. Horiuchi, V. J. Dzau, T. Mori, and K. Nakao. “Type 2 angiotensin II receptor is expressed in human myometrium and uterine leiomyoma and is down-regulated during pregnancy.” J Clin Endocrinol Metab 81, no. 12 (December 1996): 4366–72. https://doi.org/10.1210/jcem.81.12.8954043.Full Text Link to Item
-
Dzau, V. J., M. J. Mann, R. Morishita, and Y. Kaneda. “Fusigenic viral liposome for gene therapy in cardiovascular diseases.” Proc Natl Acad Sci U S A 93, no. 21 (October 15, 1996): 11421–25. https://doi.org/10.1073/pnas.93.21.11421.Full Text Link to Item
-
Hayashida, W., M. Horiuchi, and V. J. Dzau. “Intracellular third loop domain of angiotensin II type-2 receptor. Role in mediating signal transduction and cellular function.” J Biol Chem 271, no. 36 (September 6, 1996): 21985–92. https://doi.org/10.1074/jbc.271.36.21985.Full Text Link to Item
-
Leyen, H. E. von der, M. J. Mann, and V. J. Dzau. “Gene inhibition and gene augmentation for the treatment of vascular proliferative disorders.” Semin Interv Cardiol 1, no. 3 (September 1996): 209–14.Link to Item
-
Dzau, V. J., and M. Horiuchi. “Differential expression of angiotensin receptor subtypes in the myocardium: a hypothesis.” Eur Heart J 17, no. 7 (July 1996): 978–80. https://doi.org/10.1093/oxfordjournals.eurheartj.a015016.Full Text Link to Item
-
Ellison, K. E., N. H. Bishopric, K. A. Webster, R. Morishita, G. H. Gibbons, Y. Kaneda, B. Sato, and V. J. Dzau. “Fusigenic liposome-mediated DNA transfer into cardiac myocytes.” J Mol Cell Cardiol 28, no. 7 (July 1996): 1385–99. https://doi.org/10.1006/jmcc.1996.0130.Full Text Link to Item
-
Gibbons, G. H., and V. J. Dzau. “Molecular therapies for vascular diseases.” Science 272, no. 5262 (May 3, 1996): 689–93. https://doi.org/10.1126/science.272.5262.689.Full Text Link to Item
-
Wu, D. A., X. Bu, C. H. Warden, D. D. Shen, C. Y. Jeng, W. H. Sheu, M. M. Fuh, et al. “Quantitative trait locus mapping of human blood pressure to a genetic region at or near the lipoprotein lipase gene locus on chromosome 8p22.” J Clin Invest 97, no. 9 (May 1, 1996): 2111–18. https://doi.org/10.1172/JCI118648.Full Text Link to Item
-
Pratt, R. E., and V. J. Dzau. “Pharmacological strategies to prevent restenosis: lessons learned from blockade of the renin-angiotensin system.” Circulation 93, no. 5 (March 1, 1996): 848–52. https://doi.org/10.1161/01.cir.93.5.848.Full Text Link to Item
-
Yamada, T., M. Horiuchi, and V. J. Dzau. “Angiotensin II type 2 receptor mediates programmed cell death.” Proc Natl Acad Sci U S A 93, no. 1 (January 9, 1996): 156–60. https://doi.org/10.1073/pnas.93.1.156.Full Text Link to Item
-
Hein, L., G. S. Barsh, R. E. Pratt, V. J. Dzau, and B. K. Kobilka. “Correction: Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice (Nature (1995) 377 (744-747)).” Nature 380, no. 6572 (January 1, 1996): 366. https://doi.org/10.1038/380366a0.Full Text
-
Kloner, R. A., M. B. Fowler, and V. Dzau. “The guide to cardiology: Heart failure.” Prevention and Management of Congestive Heart Failure 2, no. 2 (January 1, 1996): 17–34.
-
Tomita, N., G. H. Gibbons, J. Kim, S. Tomita, L. Zhang, Y. Kaneda, D. Barant, and V. J. Dzau. “Potential gene therapy using e2f decoy approach with hvj-liposome method to glomerulonephritis in rats.” Journal of Investigative Medicine 44, no. 3 (January 1, 1996).
-
Tomita, N., R. Morishila, G. H. Gibbons, S. Tomita, M. Horiuchi, L. Zhang, Y. Kaneda, T. Ogihara, and V. J. Dzau. “Potential gene therapy for glomerulonephritis: Transfection of NFKB decoy inhibited TNF-A induced cytokine and adhesion molecules expression in vivo.” Journal of Investigative Medicine 44, no. 3 (January 1, 1996).
-
Koike, G., E. S. Winer, M. Horiuchi, D. M. Brown, C. Szpirer, V. J. Dzau, and H. J. Jacob. “Cloning, characterization, and genetic mapping of the rat type 2 angiotensin II receptor gene.” Hypertension 26, no. 6 Pt 1 (December 1995): 998–1002. https://doi.org/10.1161/01.hyp.26.6.998.Full Text Link to Item
-
Hein, L., V. J. Dzau, and G. S. Barsh. “Linkage mapping of the angiotensin AT2 receptor gene (Agtr2) to the mouse X chromosome.” Genomics 30, no. 2 (November 20, 1995): 369–71. https://doi.org/10.1006/geno.1995.0033.Full Text Link to Item
-
Nakajima, M., H. G. Hutchinson, M. Fujinaga, W. Hayashida, R. Morishita, L. Zhang, M. Horiuchi, R. E. Pratt, and V. J. Dzau. “The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer.” Proc Natl Acad Sci U S A 92, no. 23 (November 7, 1995): 10663–67. https://doi.org/10.1073/pnas.92.23.10663.Full Text Link to Item
-
Dubin, D., J. H. Peters, L. F. Brown, B. Logan, K. C. Kent, B. Berse, S. Berven, B. Cercek, B. G. Sharifi, and R. E. Pratt. “Balloon catheterization induced arterial expression of embryonic fibronectins.” Arterioscler Thromb Vasc Biol 15, no. 11 (November 1995): 1958–67. https://doi.org/10.1161/01.atv.15.11.1958.Full Text Link to Item
-
Hein, L., G. S. Barsh, R. E. Pratt, V. J. Dzau, and B. K. Kobilka. “Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice.” Nature 377, no. 6551 (October 26, 1995): 744–47. https://doi.org/10.1038/377744a0.Full Text Link to Item
-
Koike, G., H. J. Jacob, J. E. Krieger, C. Szpirer, M. R. Hoehe, M. Horiuchi, and V. J. Dzau. “Investigation of the phenylethanolamine N-methyltransferase gene as a candidate gene for hypertension.” Hypertension 26, no. 4 (October 1995): 595–601. https://doi.org/10.1161/01.hyp.26.4.595.Full Text Link to Item
-
Leyen, H. E. von der, and V. J. Dzau. “[Experimental approaches for gene therapy modification of vascular remodeling].” Z Kardiol 84, no. 10 (October 1995): 791–97.Link to Item
-
Schork, N. J., J. E. Krieger, M. R. Trolliet, K. G. Franchini, G. Koike, E. M. Krieger, E. S. Lander, V. J. Dzau, and H. J. Jacob. “A biometrical genome search in rats reveals the multigenic basis of blood pressure variation.” Genome Res 5, no. 2 (September 1995): 164–72. https://doi.org/10.1101/gr.5.2.164.Full Text Link to Item
-
Yamada, T., M. Horiuchi, R. Morishita, L. Zhang, R. E. Pratt, and V. J. Dzau. “In vivo identification of a negative regulatory element in the mouse renin gene using direct gene transfer.” J Clin Invest 96, no. 3 (September 1995): 1230–37. https://doi.org/10.1172/JCI118156.Full Text Link to Item
-
Malek, A. M., R. Ahlquist, G. H. Gibbons, V. J. Dzau, and S. Izumo. “A cone-plate apparatus for the in vitro biochemical and molecular analysis of the effect of shear stress on adherent cells.” Methods in Cell Science 17, no. 3 (September 1, 1995): 165–76. https://doi.org/10.1007/BF00996123.Full Text
-
Horiuchi, M., G. Koike, T. Yamada, M. Mukoyama, M. Nakajima, and V. J. Dzau. “The growth-dependent expression of angiotensin II type 2 receptor is regulated by transcription factors interferon regulatory factor-1 and -2.” J Biol Chem 270, no. 34 (August 25, 1995): 20225–30. https://doi.org/10.1074/jbc.270.34.20225.Full Text Link to Item
-
Dzau, V. J. “Molecular biology of angiotensin II biosynthesis and receptors.” Can J Cardiol 11 Suppl F (August 1995): 21F-26F.Link to Item
-
Morishita, R., G. H. Gibbons, and V. J. Dzau. “Potential for transcatheter application of antisense oligonucleotides for the treatment of vascular diseases.” J Interv Cardiol 8, no. 4 (August 1995): 377–81. https://doi.org/10.1111/j.1540-8183.1995.tb00562.x.Full Text Link to Item
-
Mukoyama, M., M. Horiuchi, M. Nakajima, R. E. Pratt, and V. J. Dzau. “Characterization of a rat type 2 angiotensin II receptor stably expressed in 293 cells.” Mol Cell Endocrinol 112, no. 1 (July 1995): 61–68. https://doi.org/10.1016/0303-7207(95)03586-v.Full Text Link to Item
-
Katsuya, T., G. Koike, T. W. Yee, N. Sharpe, R. Jackson, R. Norton, M. Horiuchi, R. E. Pratt, V. J. Dzau, and S. MacMahon. “Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease.” Lancet 345, no. 8965 (June 24, 1995): 1600–1603. https://doi.org/10.1016/s0140-6736(95)90115-9.Full Text Link to Item
-
Morishita, R., G. H. Gibbons, M. Horiuchi, K. E. Ellison, M. Nakama, L. Zhang, Y. Kaneda, T. Ogihara, and V. J. Dzau. “A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo.” Proc Natl Acad Sci U S A 92, no. 13 (June 20, 1995): 5855–59. https://doi.org/10.1073/pnas.92.13.5855.Full Text Link to Item
-
Katsuya, T., M. Horiuchi, Y. D. Chen, G. Koike, R. E. Pratt, V. J. Dzau, and G. M. Reaven. “Relations between deletion polymorphism of the angiotensin-converting enzyme gene and insulin resistance, glucose intolerance, hyperinsulinemia, and dyslipidemia.” Arterioscler Thromb Vasc Biol 15, no. 6 (June 1995): 779–82. https://doi.org/10.1161/01.atv.15.6.779.Full Text Link to Item
-
Mann, M. J., G. H. Gibbons, R. S. Kernoff, F. P. Diet, P. S. Tsao, J. P. Cooke, Y. Kaneda, and V. J. Dzau. “Genetic engineering of vein grafts resistant to atherosclerosis.” Proc Natl Acad Sci U S A 92, no. 10 (May 9, 1995): 4502–6. https://doi.org/10.1073/pnas.92.10.4502.Full Text Link to Item
-
Gregory, C. R., X. Huang, R. E. Pratt, V. J. Dzau, R. Shorthouse, M. E. Billingham, and R. E. Morris. “Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement.” Transplantation 59, no. 5 (March 15, 1995): 655–61. https://doi.org/10.1097/00007890-199503150-00002.Full Text Link to Item
-
Ohno, M., J. P. Cooke, V. J. Dzau, and G. H. Gibbons. “Fluid shear stress induces endothelial transforming growth factor beta-1 transcription and production. Modulation by potassium channel blockade.” J Clin Invest 95, no. 3 (March 1995): 1363–69. https://doi.org/10.1172/JCI117787.Full Text Link to Item
-
Leyen, H. E. von der, G. H. Gibbons, R. Morishita, N. P. Lewis, L. Zhang, M. Nakajima, Y. Kaneda, J. P. Cooke, and V. J. Dzau. “Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene.” Proc Natl Acad Sci U S A 92, no. 4 (February 14, 1995): 1137–41. https://doi.org/10.1073/pnas.92.4.1137.Full Text Link to Item
-
Dzau, V. J., G. H. Gibbons, B. K. Kobilka, R. M. Lawn, and R. E. Pratt. “Genetic models of human vascular disease.” Circulation 91, no. 2 (January 15, 1995): 521–31. https://doi.org/10.1161/01.cir.91.2.521.Full Text Link to Item
-
Dzau, V. J. “Angiotensin converting enzyme as a multimechanistic factor in CAD.” Journal of Myocardial Ischemia 7, no. SUPPL. 1 (January 1, 1995): 6–14.
-
Jacob, H. J., D. M. Brown, R. K. Bunker, M. J. Daly, V. J. Dzau, A. Goodman, G. Koike, V. Kren, T. Kurtz, and A. Lernmark. “A genetic linkage map of the laboratory rat, Rattus norvegicus.” Nat Genet 9, no. 1 (January 1995): 63–69. https://doi.org/10.1038/ng0195-63.Full Text Link to Item
-
Curnow, K. M. “Expression cloning of type 2 angiotension II receptor reveals a unique class of seven-transmembrane receptors.” J Endocrinol Invest 18, no. 7 (1995): 566–70. https://doi.org/10.1007/BF03349768.Full Text Link to Item
-
Sasamura, H., V. J. Dzau, and R. E. Pratt. “Desensitization of angiotensin receptor function.” Kidney Int 46, no. 6 (December 1994): 1499–1501. https://doi.org/10.1038/ki.1994.429.Full Text Link to Item
-
Dzau, V. J. “Pathobiology of atherosclerosis and plaque complications.” Am Heart J 128, no. 6 Pt 2 (December 1994): 1300–1304. https://doi.org/10.1016/0002-8703(94)90251-8.Full Text Link to Item
-
Morishita, R., G. H. Gibbons, Y. Kaneda, T. Ogihara, and V. J. Dzau. “Pharmacokinetics of antisense oligodeoxyribonucleotides (cyclin B1 and CDC 2 kinase) in the vessel wall in vivo: enhanced therapeutic utility for restenosis by HVJ-liposome delivery.” Gene 149, no. 1 (November 4, 1994): 13–19. https://doi.org/10.1016/0378-1119(94)90406-5.Full Text Link to Item
-
Koike, G., M. Horiuchi, T. Yamada, C. Szpirer, H. J. Jacob, and V. J. Dzau. “Human type 2 angiotensin II receptor gene: cloned, mapped to the X chromosome, and its mRNA is expressed in the human lung.” Biochem Biophys Res Commun 203, no. 3 (September 30, 1994): 1842–50. https://doi.org/10.1006/bbrc.1994.2402.Full Text Link to Item
-
Cooper, L. T., J. P. Cooke, and V. J. Dzau. “The vasculopathy of aging.” J Gerontol 49, no. 5 (September 1994): B191–96. https://doi.org/10.1093/geronj/49.5.b191.Full Text Link to Item
-
Morishita, R., G. H. Gibbons, K. E. Ellison, W. Lee, L. Zhang, H. Yu, Y. Kaneda, T. Ogihara, and V. J. Dzau. “Evidence for direct local effect of angiotensin in vascular hypertrophy. In vivo gene transfer of angiotensin converting enzyme.” J Clin Invest 94, no. 3 (September 1994): 978–84. https://doi.org/10.1172/JCI117464.Full Text Link to Item
-
Morishita, R., G. H. Gibbons, R. E. Pratt, N. Tomita, Y. Kaneda, T. Ogihara, and V. J. Dzau. “Autocrine and paracrine effects of atrial natriuretic peptide gene transfer on vascular smooth muscle and endothelial cellular growth.” J Clin Invest 94, no. 2 (August 1994): 824–29. https://doi.org/10.1172/JCI117402.Full Text Link to Item
-
Dzau, V. J. “Cell biology and genetics of angiotensin in cardiovascular disease.” J Hypertens Suppl 12, no. 4 (July 1994): S3-10.Link to Item
-
Dzau, V. J., M. Mukoyama, and R. E. Pratt. “Molecular biology of angiotensin receptors: target for drug research?” J Hypertens Suppl 12, no. 2 (July 1994): S1–5.Link to Item
-
Rakugi, H., D. S. Wang, V. J. Dzau, and R. E. Pratt. “Potential importance of tissue angiotensin-converting enzyme inhibition in preventing neointima formation.” Circulation 90, no. 1 (July 1994): 449–55. https://doi.org/10.1161/01.cir.90.1.449.Full Text Link to Item
-
Dzau, V. J., G. H. Gibbons, R. Morishita, and R. E. Pratt. “New perspectives in hypertension research. Potentials of vascular biology.” Hypertension 23, no. 6 Pt 2 (June 1994): 1132–40. https://doi.org/10.1161/01.hyp.23.6.1132.Full Text Link to Item
-
Gibbons, G. H., and V. J. Dzau. “The emerging concept of vascular remodeling.” N Engl J Med 330, no. 20 (May 19, 1994): 1431–38. https://doi.org/10.1056/NEJM199405193302008.Full Text Link to Item
-
Morishita, R., G. H. Gibbons, K. E. Ellison, M. Nakajima, H. von der Leyen, L. Zhang, Y. Kaneda, T. Ogihara, and V. J. Dzau. “Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides.” J Clin Invest 93, no. 4 (April 1994): 1458–64. https://doi.org/10.1172/JCI117123.Full Text Link to Item
-
Koike, G., J. E. Krieger, H. J. Jacob, M. Mukoyama, R. E. Pratt, and V. J. Dzau. “Angiotensin converting enzyme and genetic hypertension: cloning of rat cDNAs and characterization of the enzyme.” Biochem Biophys Res Commun 198, no. 1 (January 14, 1994): 380–86. https://doi.org/10.1006/bbrc.1994.1053.Full Text Link to Item
-
Dzau, V. J., J. G. F. Cleland, and J. Díez. “Overview.” Journal of Hypertension 12 (January 1, 1994): S1–2. https://doi.org/10.1097/00004872-199407030-00001.Full Text
-
Dzau, V. J., R. Pratt, and G. H. Gibbons. “Angiotensin as local modulating factor in ventricular dysfunction and failure due to coronary artery disease.” Drugs 47 Suppl 4 (1994): 1–13. https://doi.org/10.2165/00003495-199400474-00003.Full Text Link to Item
-
Dzau, V. J., and R. Re. “Tissue angiotensin system in cardiovascular medicine. A paradigm shift?” Circulation 89, no. 1 (January 1994): 493–98. https://doi.org/10.1161/01.cir.89.1.493.Full Text Link to Item
-
Kim, D. K., L. Zhang, V. J. Dzau, and R. E. Pratt. “H19, a developmentally regulated gene, is reexpressed in rat vascular smooth muscle cells after injury.” J Clin Invest 93, no. 1 (January 1994): 355–60. https://doi.org/10.1172/JCI116967.Full Text Link to Item
-
Rakugi, H., D. K. Kim, J. E. Krieger, D. S. Wang, V. J. Dzau, and R. E. Pratt. “Induction of angiotensin converting enzyme in the neointima after vascular injury. Possible role in restenosis.” J Clin Invest 93, no. 1 (January 1994): 339–46. https://doi.org/10.1172/JCI116965.Full Text Link to Item
-
Nakajima, M., M. Mukoyama, R. E. Pratt, M. Horiuchi, and V. J. Dzau. “Cloning of cDNA and analysis of the gene for mouse angiotensin II type 2 receptor.” Biochem Biophys Res Commun 197, no. 2 (December 15, 1993): 393–99. https://doi.org/10.1006/bbrc.1993.2492.Full Text Link to Item
-
Mukoyama, M., M. Nakajima, M. Horiuchi, H. Sasamura, R. E. Pratt, and V. J. Dzau. “Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors.” J Biol Chem 268, no. 33 (November 25, 1993): 24539–42.Link to Item
-
“Structure and function of academic divisions of cardiology. Task Force Reports from the Association of Professors of Cardiology.” Arch Intern Med 153, no. 20 (October 25, 1993): 2305–16. https://doi.org/10.1001/archinte.153.20.2305.Full Text Link to Item
-
Horiuchi, M., R. E. Pratt, N. Nakamura, and V. J. Dzau. “Distinct nuclear proteins competing for an overlapping sequence of cyclic adenosine monophosphate and negative regulatory elements regulate tissue-specific mouse renin gene expression.” J Clin Invest 92, no. 4 (October 1993): 1805–11. https://doi.org/10.1172/JCI116770.Full Text Link to Item
-
Malek, A. M., G. H. Gibbons, V. J. Dzau, and S. Izumo. “Fluid shear stress differentially modulates expression of genes encoding basic fibroblast growth factor and platelet-derived growth factor B chain in vascular endothelium.” J Clin Invest 92, no. 4 (October 1993): 2013–21. https://doi.org/10.1172/JCI116796.Full Text Link to Item
-
Morishita, R., G. H. Gibbons, K. E. Ellison, M. Nakajima, L. Zhang, Y. Kaneda, T. Ogihara, and V. J. Dzau. “Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia.” Proc Natl Acad Sci U S A 90, no. 18 (September 15, 1993): 8474–78. https://doi.org/10.1073/pnas.90.18.8474.Full Text Link to Item
-
Ohno, M., G. H. Gibbons, V. J. Dzau, and J. P. Cooke. “Shear stress elevates endothelial cGMP. Role of a potassium channel and G protein coupling.” Circulation 88, no. 1 (July 1993): 193–97. https://doi.org/10.1161/01.cir.88.1.193.Full Text Link to Item
-
Morishita, R., G. H. Gibbons, Y. Kaneda, T. Ogihara, and V. J. Dzau. “Novel and effective gene transfer technique for study of vascular renin angiotensin system.” J Clin Invest 91, no. 6 (June 1993): 2580–85. https://doi.org/10.1172/JCI116496.Full Text Link to Item
-
Morishita, R., G. H. Gibbons, Y. Kaneda, T. Ogihara, and V. J. Dzau. “Novel in vitro gene transfer method for study of local modulators in vascular smooth muscle cells.” Hypertension 21, no. 6 Pt 2 (June 1993): 894–99. https://doi.org/10.1161/01.hyp.21.6.894.Full Text Link to Item
-
Dzau, V. J. “Local contractile and growth modulators in the myocardium.” Clin Cardiol 16, no. 5 Suppl 2 (May 1993): II5–9. https://doi.org/10.1002/clc.4960161403.Full Text Link to Item
-
Dzau, V. J., R. Morishita, and G. H. Gibbons. “Gene therapy for cardiovascular disease.” Trends Biotechnol 11, no. 5 (May 1993): 205–10. https://doi.org/10.1016/0167-7799(93)90116-Q.Full Text Link to Item
-
Itoh, H., M. Mukoyama, R. E. Pratt, G. H. Gibbons, and V. J. Dzau. “Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II.” J Clin Invest 91, no. 5 (May 1993): 2268–74. https://doi.org/10.1172/JCI116454.Full Text Link to Item
-
Paul, M., J. Wagner, and V. J. Dzau. “Gene expression of the renin-angiotensin system in human tissues. Quantitative analysis by the polymerase chain reaction.” J Clin Invest 91, no. 5 (May 1993): 2058–64. https://doi.org/10.1172/JCI116428.Full Text Link to Item
-
Schunkert, H., S. S. Tang, S. E. Litwin, D. Diamant, G. Riegger, V. J. Dzau, and J. R. Ingelfinger. “Regulation of intrarenal and circulating renin-angiotensin systems in severe heart failure in the rat.” Cardiovasc Res 27, no. 5 (May 1993): 731–35. https://doi.org/10.1093/cvr/27.5.731.Full Text Link to Item
-
Dzau, V. J. “Tissue renin-angiotensin system in myocardial hypertrophy and failure.” Arch Intern Med 153, no. 8 (April 26, 1993): 937–42.Link to Item
-
Dzau, V. J., H. Sasamura, and L. Hein. “Heterogeneity of angiotensin synthetic pathways and receptor subtypes: physiological and pharmacological implications.” J Hypertens Suppl 11, no. 3 (April 1993): S13–18.Link to Item
-
Dzau, V. J., G. H. Gibbons, J. P. Cooke, and N. Omoigui. “Vascular biology and medicine in the 1990s: scope, concepts, potentials, and perspectives.” Circulation 87, no. 3 (March 1993): 705–19. https://doi.org/10.1161/01.cir.87.3.705.Full Text Link to Item
-
Lee, P. C., G. H. Gibbons, and V. J. Dzau. “Cellular and molecular mechanisms of coronary artery restenosis.” Coron Artery Dis 4, no. 3 (March 1993): 254–59. https://doi.org/10.1097/00019501-199303000-00005.Full Text Link to Item
-
Omoigui, N., and V. J. Dzau. “Differential effects of antihypertensive agents in experimental and human atherosclerosis.” Am J Hypertens 6, no. 3 Pt 2 (March 1993): 30S-39S. https://doi.org/10.1093/ajh/6.3.30s.Full Text Link to Item
-
Gregory, C. R., R. E. Pratt, P. Huie, R. Shorthouse, V. J. Dzau, M. E. Billingham, and R. E. Morris. “Effects of treatment with cyclosporine, FK 506, rapamycin, mycophenolic acid, or deoxyspergualin on vascular muscle proliferation in vitro and in vivo.” Transplant Proc 25, no. 1 Pt 1 (February 1993): 770–71.Link to Item
-
Schunkert, H., J. R. Ingelfinger, A. T. Hirsch, Y. Pinto, W. J. Remme, H. Jacob, and V. J. Dzau. “Feedback regulation of angiotensin converting enzyme activity and mRNA levels by angiotensin II.” Circ Res 72, no. 2 (February 1993): 312–18. https://doi.org/10.1161/01.res.72.2.312.Full Text Link to Item
-
Cooke, J. P., B. Y. Wang, N. Andon, J. Loscalzo, and V. J. Dzau. “S-nitrosocaptopril: A novel nitrovasodilator resistant to nitrate tolerance.” Journal of Vascular Medicine and Biology 4, no. 2–3 (January 1, 1993): 115–21.
-
Dzau, V. J. “Vascular renin-angiotensin system and vascular protection.” Journal of Cardiovascular Pharmacology 22, no. 6 (January 1, 1993): 907. https://doi.org/10.1097/00005344-199312000-00021.Full Text
-
Dzau, V. J. “Erratum: Vascular renin-angiotensin system and vascular protection (Journal of Cardiovascular Pharmacology (1993) 22:5 (S1-9)).” Journal of Cardiovascular Pharmacology 22, no. 6 (January 1, 1993): 907.
-
Dzau, V. J. “Vascular renin-angiotensin system and vascular protection.” J Cardiovasc Pharmacol 22 Suppl 5 (1993): S1–9. https://doi.org/10.1097/00005344-199322005-00002.Full Text Link to Item
-
Dzau, V. J. “The role of mechanical and humoral factors in growth regulation of vascular smooth muscle and cardiac myocytes.” Curr Opin Nephrol Hypertens 2, no. 1 (January 1993): 27–32. https://doi.org/10.1097/00041552-199301000-00004.Full Text Link to Item
-
Dzau, V. J. “Local expression and pathophysiological role of renin-angiotensin in the blood vessels and heart.” Basic Res Cardiol 88 Suppl 1 (1993): 1–14. https://doi.org/10.1007/978-3-642-72497-8_1.Full Text Link to Item
-
Dzau, V. J., T. F. Luscher, and G. M. Rubanyi. “The renin-Angiotensin system and vascular protection: Introduction.” Journal of Cardiovascular Pharmacology 22, no. SUPPL. 5 (January 1, 1993).
-
Katz, A. M. “Panel discussion: Question and answer session.” Clinical Cardiology 16, no. 2 S (January 1, 1993): 30–31. https://doi.org/10.1002/clc.4960161408.Full Text
-
Morishita, R., G. H. Gibbons, K. E. Ellison, M. Nakajima, H. von der Leyen, L. Zhang, Y. Kaneda, T. Ogihara, and V. J. Dzau. “Antisense oligonucleotides directed at cell cycle regulatory genes as strategy for restenosis therapy.” Trans Assoc Am Physicians 106 (1993): 54–61.Link to Item
-
Dzau, V. J., and G. H. Gibbons. “Vascular remodeling: mechanisms and implications.” J Cardiovasc Pharmacol 21 Suppl 1 (1993): S1–5.Link to Item
-
Itoh, H., M. Mukoyama, R. E. Pratt, and V. J. Dzau. “Specific blockade of basic fibroblast growth factor gene expression in endothelial cells by antisense oligonucleotide.” Biochem Biophys Res Commun 188, no. 3 (November 16, 1992): 1205–13. https://doi.org/10.1016/0006-291x(92)91359-x.Full Text Link to Item
-
Hirsch, A. T., C. E. Talsness, A. D. Smith, H. Schunkert, J. R. Ingelfinger, and V. J. Dzau. “Differential effects of captopril and enalapril on tissue renin-angiotensin systems in experimental heart failure.” Circulation 86, no. 5 (November 1992): 1566–74. https://doi.org/10.1161/01.cir.86.5.1566.Full Text Link to Item
-
Schunkert, H., J. R. Ingelfinger, H. Jacob, B. Jackson, B. Bouyounes, and V. J. Dzau. “Reciprocal feedback regulation of kidney angiotensinogen and renin mRNA expressions by angiotensin II.” Am J Physiol 263, no. 5 Pt 1 (November 1992): E863–69. https://doi.org/10.1152/ajpendo.1992.263.5.E863.Full Text Link to Item
-
Dzau, V. J. “Autocrine and paracrine mechanisms in the pathophysiology of heart failure.” Am J Cardiol 70, no. 10 (October 8, 1992): 4C-11C. https://doi.org/10.1016/0002-9149(92)91352-5.Full Text Link to Item
-
Creager, M. A., S. J. Gallagher, X. J. Girerd, S. M. Coleman, V. J. Dzau, and J. P. Cooke. “L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans.” J Clin Invest 90, no. 4 (October 1992): 1248–53. https://doi.org/10.1172/JCI115987.Full Text Link to Item
-
Frohlich, E. D., C. Apstein, A. V. Chobanian, R. B. Devereux, H. P. Dustan, V. Dzau, F. Fauad-Tarazi, M. J. Horan, M. Marcus, and B. Massie. “The heart in hypertension.” N Engl J Med 327, no. 14 (October 1, 1992): 998–1008. https://doi.org/10.1056/NEJM199210013271406.Full Text Link to Item
-
Schunkert, H., J. R. Ingelfinger, A. T. Hirsch, S. S. Tang, S. E. Litwin, C. E. Talsness, and V. J. Dzau. “Evidence for tissue-specific activation of renal angiotensinogen mRNA expression in chronic stable experimental heart failure.” J Clin Invest 90, no. 4 (October 1992): 1523–29. https://doi.org/10.1172/JCI116020.Full Text Link to Item
-
Gibbons, G. H., R. E. Pratt, and V. J. Dzau. “Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II.” J Clin Invest 90, no. 2 (August 1992): 456–61. https://doi.org/10.1172/JCI115881.Full Text Link to Item
-
Tang, S. S., H. Rogg, R. Schumacher, and V. J. Dzau. “Characterization of nuclear angiotensin-II-binding sites in rat liver and comparison with plasma membrane receptors.” Endocrinology 131, no. 1 (July 1992): 374–80. https://doi.org/10.1210/endo.131.1.1612017.Full Text Link to Item
-
Cowley, A. W., V. Dzau, P. Buttrick, J. Cooke, R. B. Devereux, C. L. Grines, G. C. Haidet, and M. D. Thames. “Working group on noncoronary cardiovascular disease and exercise in women.” Med Sci Sports Exerc 24, no. 6 Suppl (June 1992): S277–87.Link to Item
-
Dzau, V. J. “Angiotensin converting enzyme inhibitors and the cardiovascular system.” J Hypertens Suppl 10, no. 3 (June 1992): S3-10.Link to Item
-
Andrawis, N. S., V. J. Dzau, and R. E. Pratt. “Autocrine stimulation of mas oncogene leads to altered growth control.” Cell Biol Int Rep 16, no. 6 (June 1992): 547–56. https://doi.org/10.1016/s0309-1651(05)80053-0.Full Text Link to Item
-
Itoh, H., R. E. Pratt, M. Ohno, and V. J. Dzau. “Atrial natriuretic polypeptide as a novel antigrowth factor of endothelial cells.” Hypertension 19, no. 6 Pt 2 (June 1992): 758–61. https://doi.org/10.1161/01.hyp.19.6.758.Full Text Link to Item
-
Sasamura, H., L. Hein, J. E. Krieger, R. E. Pratt, B. K. Kobilka, and V. J. Dzau. “Cloning, characterization, and expression of two angiotensin receptor (AT-1) isoforms from the mouse genome.” Biochem Biophys Res Commun 185, no. 1 (May 29, 1992): 253–59. https://doi.org/10.1016/s0006-291x(05)80983-0.Full Text Link to Item
-
Paul, M., D. W. Burt, J. E. Krieger, N. Nakamura, and V. J. Dzau. “Tissue specificity of renin promoter activity and regulation in mice.” Am J Physiol 262, no. 5 Pt 1 (May 1992): E644–50. https://doi.org/10.1152/ajpendo.1992.262.5.E644.Full Text Link to Item
-
Dzau, V. J., H. J. Jacob, K. Lindpainter, D. Ganten, and E. S. Lander. “Genetic mapping in hypertension.” J Vasc Surg 15, no. 5 (May 1992): 930. https://doi.org/10.1016/0741-5214(92)90757-y.Full Text Link to Item
-
Dzau, V. J., and R. E. Pratt. “Antisense technology to block autocrine growth factors.” J Vasc Surg 15, no. 5 (May 1992): 934–35. https://doi.org/10.1016/0741-5214(92)90760-6.Full Text Link to Item
-
Swales, J. D., and V. J. Dzau. “Angiotensin-converting enzyme inhibition: research advances and clinical implications.” Am Heart J 123, no. 5 (May 1992): 1412–13. https://doi.org/10.1016/0002-8703(92)91062-6.Full Text Link to Item
-
Zuo, W. M., R. E. Pratt, C. H. Heusser, J. P. Bews, M. M. de Gasparo, and V. J. Dzau. “Characterization of a monoclonal antibody specific for human active renin.” Hypertension 19, no. 3 (March 1992): 249–54. https://doi.org/10.1161/01.hyp.19.3.249.Full Text Link to Item
-
Barrett, G., M. Horiuchi, M. Paul, R. E. Pratt, N. Nakamura, and V. J. Dzau. “Identification of a negative regulatory element involved in tissue-specific expression of mouse renin genes.” Proc Natl Acad Sci U S A 89, no. 3 (February 1, 1992): 885–89. https://doi.org/10.1073/pnas.89.3.885.Full Text Link to Item
-
Hirsch, A. T., V. J. Dzau, S. S. Cutler, D. J. Levenson, and M. A. Creager. “Effect of isradipine on cardiopulmonary baroreflex function, regional blood flow, and vascular responsiveness in hypertensive patients.” J Cardiovasc Pharmacol 19, no. 2 (February 1992): 272–81. https://doi.org/10.1097/00005344-199202000-00016.Full Text Link to Item
-
Paul, M., N. Nakamura, R. E. Pratt, D. W. Burt, and V. J. Dzau. “Cell-dependent posttranslational processing and secretion of recombinant mouse renin-2.” Am J Physiol 262, no. 2 Pt 1 (February 1992): E224–29. https://doi.org/10.1152/ajpendo.1992.262.2.E224.Full Text Link to Item
-
Dzau, V. J. “The inter-relationship of hypertension, dyslipidaemia and atherosclerosis: The important role of the endothelium.” Journal of Drug Development, Supplement 4, no. 4 (January 1, 1992): 3–7.
-
Jr, A. W. C., V. Dzau, P. Buttrick, J. Cooke, R. B. Devereux, C. L. Grines, G. C. Haidet, and M. D. Thames. “Working group on noncoronary cardiovascular disease and exercise in women.” Medicine and Science in Sports and Exercise 24, no. 6 SUPPL. (1992): S277–87.
-
Kloner, R. A., A. J. Naftalin, and V. J. Dzau. “The guide to cardiology: Evaluation and management of hypertension.” Cardiovascular Reviews and Reports 13, no. 1 (January 1, 1992).
-
Wilcox, C. S., and V. J. Dzau. “Effect of captopril on the release of the components of the renin-angiotensin system into plasma and lymph.” J Am Soc Nephrol 2, no. 7 (January 1992): 1241–50. https://doi.org/10.1681/ASN.V271241.Full Text Link to Item
-
Dzau, V. J. “Introduction: Atherosclerosis beyond cholesterol.” Journal of Vascular Medicine and Biology 3, no. 5 (December 1, 1991): 351.
-
Omoigui, N., and V. J. Dzau. “Differential effects of antihypertensive agents in experimental and human atherosclerosis.” Journal of Vascular Medicine and Biology 3, no. 5 (December 1, 1991): 382–91.
-
Andrawis, N. S., T. A. Brock, V. J. Dzau, and R. E. Pratt. “Mas oncogene receptor coupling and peptide specificity in Balb 3T3 and vascular smooth muscle cells.” Am J Med Sci 302, no. 6 (December 1991): 329–34. https://doi.org/10.1097/00000441-199112000-00001.Full Text Link to Item
-
Cooke, J. P., E. Rossitch, N. A. Andon, J. Loscalzo, and V. J. Dzau. “Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator.” J Clin Invest 88, no. 5 (November 1991): 1663–71. https://doi.org/10.1172/JCI115481.Full Text Link to Item
-
Dzau, V. J., and G. H. Gibbons. “Endothelium and growth factors in vascular remodeling of hypertension.” Hypertension 18, no. 5 Suppl (November 1991): III115–21. https://doi.org/10.1161/01.hyp.18.5_suppl.iii115.Full Text Link to Item
-
Jacob, H. J., K. Lindpaintner, S. E. Lincoln, K. Kusumi, R. K. Bunker, Y. P. Mao, D. Ganten, V. J. Dzau, and E. S. Lander. “Genetic mapping of a gene causing hypertension in the stroke-prone spontaneously hypertensive rat.” Cell 67, no. 1 (October 4, 1991): 213–24. https://doi.org/10.1016/0092-8674(91)90584-l.Full Text Link to Item
-
Dzau, V. J., G. H. Gibbons, and R. E. Pratt. “Molecular mechanisms of vascular renin-angiotensin system in myointimal hyperplasia.” Hypertension 18, no. 4 Suppl (October 1991): II100–105. https://doi.org/10.1161/01.hyp.18.4_suppl.ii100.Full Text Link to Item
-
Krieger, J. E., and V. J. Dzau. “Molecular biology of hypertension.” Hypertension 18, no. 3 Suppl (September 1991): I3-17. https://doi.org/10.1161/01.hyp.18.3_suppl.i3.Full Text Link to Item
-
Horiuchi, M., N. Nakamura, S. S. Tang, G. Barrett, and V. J. Dzau. “Molecular mechanism of tissue-specific regulation of mouse renin gene expression by cAMP. Identification of an inhibitory protein that binds nuclear transcriptional factor.” J Biol Chem 266, no. 24 (August 25, 1991): 16247–54.Link to Item
-
Hirsch, A. T., C. E. Talsness, H. Schunkert, M. Paul, and V. J. Dzau. “Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure.” Circ Res 69, no. 2 (August 1991): 475–82. https://doi.org/10.1161/01.res.69.2.475.Full Text Link to Item
-
Ingelfinger, J. R., and V. J. Dzau. “Molecular biology of renal injury: emphasis on the role of the renin-angiotensin system.” J Am Soc Nephrol 2, no. 2 Suppl 1 (August 1991): S9-20. https://doi.org/10.1681/ASN.V22s9.Full Text Link to Item
-
Creager, M. A., M. A. Roddy, K. M. Holland, A. T. Hirsch, and V. J. Dzau. “Sodium depresses arterial baroreceptor reflex function in normotensive humans.” Hypertension 17, no. 6 Pt 2 (June 1991): 989–96. https://doi.org/10.1161/01.hyp.17.6.989.Full Text Link to Item
-
Dubin, D., R. E. Pratt, K. Y. Hui, and V. J. Dzau. “Characterization of prorenin activation using a synthetic peptide substrate.” J Hypertens 9, no. 6 (June 1991): 483–86. https://doi.org/10.1097/00004872-199106000-00001.Full Text Link to Item
-
Jacob, H. J., C. D. Sigmund, T. R. Shockley, K. W. Gross, and V. J. Dzau. “Renin promoter SV40 T-antigen transgenic mouse. A model of primary renal vascular hyperplasia.” Hypertension 17, no. 6 Pt 2 (June 1991): 1167–1162. https://doi.org/10.1161/01.hyp.17.6.1167.Full Text Link to Item
-
Itoh, H., R. E. Pratt, and V. J. Dzau. “Interaction of atrial natriuretic polypeptide and angiotensin II on protooncogene expression and vascular cell growth.” Biochem Biophys Res Commun 176, no. 3 (May 15, 1991): 1601–9. https://doi.org/10.1016/0006-291x(91)90471-i.Full Text Link to Item
-
Dzau, V. J. “Renin and myocardial infarction in hypertension.” N Engl J Med 324, no. 16 (April 18, 1991): 1128–30. https://doi.org/10.1056/nejm199104183241610.Full Text Link to Item
-
Naftilan, A. J., W. M. Zuo, J. Inglefinger, T. J. Ryan, R. E. Pratt, and V. J. Dzau. “Localization and differential regulation of angiotensinogen mRNA expression in the vessel wall.” J Clin Invest 87, no. 4 (April 1991): 1300–1311. https://doi.org/10.1172/JCI115133.Full Text Link to Item
-
Dzau, V., and E. Braunwald. “Resolved and unresolved issues in the prevention and treatment of coronary artery disease: a workshop consensus statement.” Am Heart J 121, no. 4 Pt 1 (April 1991): 1244–63. https://doi.org/10.1016/0002-8703(91)90694-d.Full Text Link to Item
-
Mockrin, S. C., V. J. Dzau, K. W. Gross, and M. J. Horan. “Transgenic animals. New approaches to hypertension research.” Hypertension 17, no. 3 (March 1991): 394–99. https://doi.org/10.1161/01.hyp.17.3.394.Full Text Link to Item
-
Simonson, D. C., and V. J. Dzau. “Workshop IX--Lipids, insulin, diabetes.” Am J Med 90, no. 2A (February 21, 1991): 85S-86S. https://doi.org/10.1016/0002-9343(91)90046-z.Full Text Link to Item
-
Sigmund, C. D., C. A. Jones, H. J. Jacob, J. Ingelfinger, U. Kim, D. Gamble, V. J. Dzau, and K. W. Gross. “Pathophysiology of vascular smooth muscle in renin promoter-T-antigen transgenic mice.” Am J Physiol 260, no. 2 Pt 2 (February 1991): F249–57. https://doi.org/10.1152/ajprenal.1991.260.2.F249.Full Text Link to Item
-
Cooke, J. P., J. Dzau, and A. Creager. “Endothelial dysfunction in hypercholesterolemia is corrected by L-arginine.” Basic Res Cardiol 86 Suppl 2 (1991): 173–81. https://doi.org/10.1007/978-3-642-72461-9_17.Full Text Link to Item
-
Dzau, V. J. “Recent advances in the control of heart failure: Introduction.” American Heart Journal 121, no. 3 I (January 1, 1991): 950. https://doi.org/10.1016/0002-8703(91)90224-6.Full Text
-
Dzau, V. J., and G. Gibbons. “Does hypertension potentiate atherosclerosis via vascular hypertrophy?” J Cardiovasc Pharmacol 17 Suppl 2 (1991): S34. https://doi.org/10.1097/00005344-199117002-00008.Full Text Link to Item
-
Dzau, V. J., and G. H. Gibbons. “Endothelium and growth factors in vascular remodeling of hypertension.” Hypertension 18, no. 5 SUPPL. (1991): III115–21.
-
Kloner, R. A., and V. J. Dzau. “The guide to cardiology: Heart failure.” Cardiovascular Reviews and Reports 12, no. 7 (January 1, 1991): 19-20+23.
-
Krieger, J. E., and V. J. Dzau. “Molecular biology of hypertension.” Hypertension 18, no. 3 (January 1, 1991): I-3-I–17.
-
Pratt, R. E., H. Itoh, G. H. Gibbons, and V. J. Dzau. “Role of angiotensin in the control of vascular smooth muscle growth.” Journal of Vascular Medicine and Biology 3, no. 1 (January 1, 1991): 25–29.
-
Schunkert, H., J. R. Ingelfinger, and V. J. Dzau. “Evolving concepts of the intrarenal renin-angiotensin system in health and disease: contributions of molecular biology.” Ren Physiol Biochem 14, no. 4–5 (1991): 146–54. https://doi.org/10.1159/000173400.Full Text Link to Item
-
Girerd, X. J., A. T. Hirsch, J. P. Cooke, V. J. Dzau, and M. A. Creager. “L-arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits.” Circ Res 67, no. 6 (December 1990): 1301–8. https://doi.org/10.1161/01.res.67.6.1301.Full Text Link to Item
-
Schunkert, H., V. J. Dzau, S. S. Tang, A. T. Hirsch, C. S. Apstein, and B. H. Lorell. “Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation.” J Clin Invest 86, no. 6 (December 1990): 1913–20. https://doi.org/10.1172/JCI114924.Full Text Link to Item
-
Sigmund, C. D., K. Okuyama, J. Ingelfinger, C. A. Jones, J. J. Mullins, C. Kane, U. Kim, C. Z. Wu, L. Kenny, and Y. Rustum. “Isolation and characterization of renin-expressing cell lines from transgenic mice containing a renin-promoter viral oncogene fusion construct.” J Biol Chem 265, no. 32 (November 15, 1990): 19916–22.Link to Item
-
Takeuchi, K., N. Nakamura, N. S. Cook, R. E. Pratt, and V. J. Dzau. “Angiotensin II can regulate gene expression by the AP-1 binding sequence via a protein kinase C-dependent pathway.” Biochem Biophys Res Commun 172, no. 3 (November 15, 1990): 1189–94. https://doi.org/10.1016/0006-291x(90)91574-c.Full Text Link to Item
-
Itoh, H., R. E. Pratt, and V. J. Dzau. “Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells.” J Clin Invest 86, no. 5 (November 1990): 1690–97. https://doi.org/10.1172/JCI114893.Full Text Link to Item
-
Hirsch, A. T., Y. M. Pinto, H. Schunkert, and V. J. Dzau. “Potential role of the tissue renin-angiotensin system in the pathophysiology of congestive heart failure.” Am J Cardiol 66, no. 11 (October 2, 1990): 22D-30D. https://doi.org/10.1016/0002-9149(90)90473-e.Full Text Link to Item
-
Creager, M. A., J. P. Cooke, M. E. Mendelsohn, S. J. Gallagher, S. M. Coleman, J. Loscalzo, and V. J. Dzau. “Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans.” J Clin Invest 86, no. 1 (July 1990): 228–34. https://doi.org/10.1172/JCI114688.Full Text Link to Item
-
Ingelfinger, J. R., H. Schunkert, K. E. Ellison, M. Pivor, W. M. Zuo, R. Pratt, and V. J. Dzau. “Intrarenal angiotensinogen: localization and regulation.” Pediatr Nephrol 4, no. 4 (July 1990): 424–28. https://doi.org/10.1007/BF00862530.Full Text Link to Item
-
Creager, M. A., A. T. Hirsch, V. J. Dzau, E. G. Nabel, S. S. Cutler, and W. S. Colucci. “Baroreflex regulation of regional blood flow in congestive heart failure.” Am J Physiol 258, no. 5 Pt 2 (May 1990): H1409–14. https://doi.org/10.1152/ajpheart.1990.258.5.H1409.Full Text Link to Item
-
Dzau, V. J., and A. T. Hirsch. “Emerging role of the tissue renin-angiotensin systems in congestive heart failure.” Eur Heart J 11 Suppl B (April 1990): 65–71. https://doi.org/10.1093/eurheartj/11.suppl_b.65.Full Text Link to Item
-
Ingelfinger, J. R., W. M. Zuo, E. A. Fon, K. E. Ellison, and V. J. Dzau. “In situ hybridization evidence for angiotensinogen messenger RNA in the rat proximal tubule. An hypothesis for the intrarenal renin angiotensin system.” J Clin Invest 85, no. 2 (February 1990): 417–23. https://doi.org/10.1172/JCI114454.Full Text Link to Item
-
Gibbons, G. H., and V. J. Dzau. “Angiotensin converting enzyme inhibition and vascular hypertrophy in hypertension.” Cardiovasc Drugs Ther 4, no. 1 (February 1990): 237–42. https://doi.org/10.1007/BF01857638.Full Text Link to Item
-
Cooke, J. P., and V. J. Dzau. “The time has come for vascular medicine.” Ann Intern Med 112, no. 2 (January 15, 1990): 138–39. https://doi.org/10.7326/0003-4819-112-2-138.Full Text Link to Item
-
Dzau, V. J. “Summary.” Journal of Cardiovascular Pharmacology 15 (January 1, 1990): S62–63. https://doi.org/10.1097/00005344-199000152-00011.Full Text
-
Dzau, V. J. “Mechanism of action of angiotensin-converting enzyme (ACE) inhibitors in hypertension and heart failure. Role of plasma versus tissue ACE.” Drugs 39 Suppl 2 (1990): 11–16. https://doi.org/10.2165/00003495-199000392-00004.Full Text Link to Item
-
Dzau, V. J. “Atherosclerosis and hypertension: mechanisms and interrelationships.” J Cardiovasc Pharmacol 15 Suppl 5 (1990): S59–64.Link to Item
-
Dzau, V. J. “Worldwide clinical experience with ACE inhibitors. The role of quinapril: introduction.” Journal of Cardiovascular Pharmacology 15, no. SUPPL. 2 (January 1, 1990).
-
Dzau, V. J. “World wide clinical experience with ACE inhibitors. The role of quinapril: summary.” Journal of Cardiovascular Pharmacology 15, no. SUPPL. 2 (January 1, 1990).
-
Dzau, V. J. “Paracrine renin angiotensin system in the kidney: Molecular evidence and functional significance.” The Frontiers of Nephrology: Proceedings of the International Forum “The Frontiers of Nephrology” Honoring Fuminori Sakai. Ics877, January 1, 1990, 89–99.
-
Tang, S. S., L. Stevenson, and V. J. Dzau. “Endothelial renin-angiotensin pathway. Adrenergic regulation of angiotensin secretion.” Circ Res 66, no. 1 (January 1990): 103–8. https://doi.org/10.1161/01.res.66.1.103.Full Text Link to Item
-
Naftilan, A. J., R. Williams, D. Burt, M. Paul, R. E. Pratt, P. Hobart, J. Chirgwin, and V. J. Dzau. “A lack of genetic linkage of renin gene restriction fragment length polymorphisms with human hypertension.” Hypertension 14, no. 6 (December 1989): 614–18. https://doi.org/10.1161/01.hyp.14.6.614.Full Text Link to Item
-
Dzau, V. J. “Multiple pathways of angiotensin production in the blood vessel wall: evidence, possibilities and hypotheses.” J Hypertens 7, no. 12 (December 1989): 933–36. https://doi.org/10.1097/00004872-198912000-00001.Full Text Link to Item
-
Rudd, M. A., S. Plavin, A. T. Hirsch, J. R. Ingelfinger, and V. J. Dzau. “Atrial natriuretic factor-specific antibody as a tool for physiological studies. Evidence for role of atrial natriuretic factor in aldosterone and renal electrolyte regulation.” Circ Res 65, no. 5 (November 1989): 1324–29. https://doi.org/10.1161/01.res.65.5.1324.Full Text Link to Item
-
Dzau, V. J., and J. R. Ingelfinger. “Molecular biology and pathophysiology of the intrarenal renin-angiotensin system.” J Hypertens Suppl 7, no. 7 (September 1989): S3–8. https://doi.org/10.1097/00004872-198909007-00002.Full Text Link to Item
-
Hirsch, A. T., V. J. Dzau, J. A. Majzoub, and M. A. Creager. “Vasopressin-mediated forearm vasodilation in normal humans. Evidence for a vascular vasopressin V2 receptor.” J Clin Invest 84, no. 2 (August 1989): 418–26. https://doi.org/10.1172/JCI114182.Full Text Link to Item
-
Hirsch, A. T., D. J. Levenson, S. S. Cutler, V. J. Dzau, and M. A. Creager. “Regional vascular responses to prolonged lower body negative pressure in normal subjects.” Am J Physiol 257, no. 1 Pt 2 (July 1989): H219–25. https://doi.org/10.1152/ajpheart.1989.257.1.H219.Full Text Link to Item
-
Dzau, V. J., M. Paul, N. Nakamura, R. E. Pratt, and J. R. Ingelfinger. “Role of molecular biology in hypertension research. State of the Art lecture.” Hypertension 13, no. 6 Pt 2 (June 1989): 731–40. https://doi.org/10.1161/01.hyp.13.6.731.Full Text Link to Item
-
Ellison, K. E., J. R. Ingelfinger, M. Pivor, and V. J. Dzau. “Androgen regulation of rat renal angiotensinogen messenger RNA expression.” J Clin Invest 83, no. 6 (June 1989): 1941–45. https://doi.org/10.1172/JCI114102.Full Text Link to Item
-
Naftilan, A. J., R. E. Pratt, C. S. Eldridge, H. L. Lin, and V. J. Dzau. “Angiotensin II induces c-fos expression in smooth muscle via transcriptional control.” Hypertension 13, no. 6 Pt 2 (June 1989): 706–11. https://doi.org/10.1161/01.hyp.13.6.706.Full Text Link to Item
-
Burt, D. W., N. Nakamura, P. Kelley, and V. J. Dzau. “Identification of negative and positive regulatory elements in the human renin gene.” J Biol Chem 264, no. 13 (May 5, 1989): 7357–62.Link to Item
-
Dzau, V. I. “Quinapril--a new angiotensin-converting enzyme inhibitor: an overview.” Angiology 40, no. 4 Pt 2 (April 1989): 329–30. https://doi.org/10.1177/000331978904000401.Full Text Link to Item
-
Ingelfinger, J. R., R. E. Pratt, T. P. Roth, and V. J. Dzau. “Processing of one-chain to two-chain renin in the mouse submandibular gland is influenced by androgen.” Pediatr Res 25, no. 4 (April 1989): 332–35. https://doi.org/10.1203/00006450-198904000-00003.Full Text Link to Item
-
Naftilan, A. J., R. E. Pratt, and V. J. Dzau. “Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells.” J Clin Invest 83, no. 4 (April 1989): 1419–24. https://doi.org/10.1172/JCI114032.Full Text Link to Item
-
Dubin, D., K. Hui, R. E. Pratt, and V. J. Dzau. “Synthetic peptide inhibitors of prorenin activation.” J Hypertens Suppl 7, no. 2 (April 1989): S71–73. https://doi.org/10.1097/00004872-198904002-00015.Full Text Link to Item
-
Pratt, R. E., W. M. Zou, A. J. Naftilan, J. R. Ingelfinger, and V. J. Dzau. “Altered sodium regulation of renal angiotensinogen mRNA in the spontaneously hypertensive rat.” Am J Physiol 256, no. 3 Pt 2 (March 1989): F469–74. https://doi.org/10.1152/ajprenal.1989.256.3.F469.Full Text Link to Item
-
Dzau, V. J., and M. A. Creager. “Progress in angiotensin-converting enzyme inhibition in heart failure: rationale, mechanisms, and clinical responses.” Cardiol Clin 7, no. 1 (February 1989): 119–30.Link to Item
-
Dzau, V. J. “Treatment strategies: an evaluation of antihypertensive therapy.” Am J Med 86, no. 1B (January 23, 1989): 113–15. https://doi.org/10.1016/0002-9343(89)90145-9.Full Text Link to Item
-
Sacks, F. M., M. A. Creager, S. J. Gallagher, J. Loscalzo, and V. J. Dzau. “Effects of alpha- and beta-adrenergic antagonists on plasma apolipoproteins and forearm blood flow in patients with mild hypertension.” Am J Med 86, no. 1B (January 23, 1989): 8–13. https://doi.org/10.1016/0002-9343(89)90121-6.Full Text Link to Item
-
Hirsch, A. T., M. A. Creager, and V. J. Dzau. “Relation of atrial natriuretic factor to vasoconstrictor hormones and regional blood flow in congestive heart failure.” Am J Cardiol 63, no. 3 (January 15, 1989): 211–16. https://doi.org/10.1016/0002-9149(89)90287-7.Full Text Link to Item
-
Dzau, V. J. “Short- and long-term determinants of cardiovascular function and therapy: contributions of circulating and tissue renin-angiotensin systems.” J Cardiovasc Pharmacol 14 Suppl 4 (1989): S1–5.Link to Item
-
Dzau, V. J. “Factors influencing the lipid response to selective alpha 1-inhibition.” J Cardiovasc Pharmacol 13 Suppl 2 (1989): S50–52. https://doi.org/10.1097/00005344-198900132-00010.Full Text Link to Item
-
Dzau, V. J. “Cardiovascular hemostasis. Effects of circulating and local renin-angiotensin-system.” Munchener Medizinische Wochenschrift 131, no. 37 SPEC. ISS. (January 1, 1989).
-
Dzau, V. J. “ACE inhibitors in hypertension: a US perspective.” Cardiology 76 Suppl 2 (1989): 23–30. https://doi.org/10.1159/000174556.Full Text Link to Item
-
Nakamura, N., D. W. Burt, M. Paul, and V. J. Dzau. “Negative control elements and cAMP responsive sequences in the tissue-specific expression of mouse renin genes.” Proc Natl Acad Sci U S A 86, no. 1 (January 1989): 56–59. https://doi.org/10.1073/pnas.86.1.56.Full Text Link to Item
-
Dzau, V. J. “Clinical implications for therapy: possible cardioprotective effects of ACE inhibition.” Br J Clin Pharmacol 28 Suppl 2, no. Suppl 2 (1989): 183S-187S. https://doi.org/10.1111/j.1365-2125.1989.tb03594.x.Full Text Link to Item
-
Dzau, V. J. “Molecular and physiological aspects of tissue renin-angiotensin system: emphasis on cardiovascular control.” J Hypertens Suppl 6, no. 3 (December 1988): S7-12.Link to Item
-
Poole, S., R. E. Gaines Das, V. J. Dzau, A. M. Richards, and J. I. Robertson. “The international standard for atrial natriuretic factor. Calibration by an international collaborative study.” Hypertension 12, no. 6 (December 1988): 629–34. https://doi.org/10.1161/01.hyp.12.6.629.Full Text Link to Item
-
Burt, D. W., N. Nakamura, P. Kelley, and V. J. Dzau. “Functional human renin promoter in transfected cells: evidence for cell-specific expression.” J Hypertens Suppl 6, no. 4 (December 1988): S429–31. https://doi.org/10.1097/00004872-198812040-00135.Full Text Link to Item
-
Dzau, V. J. “Mechanism of the interaction of hypertension and hypercholesterolemia in atherogenesis: the effects of antihypertensive agents.” Am Heart J 116, no. 6 Pt 2 (December 1988): 1725–28. https://doi.org/10.1016/0002-8703(88)90221-9.Full Text Link to Item
-
Paul, M., N. Nakamura, R. E. Pratt, and V. J. Dzau. “Glycosylation influences intracellular transit time and secretion rate of human prorenin in transfected cells.” J Hypertens Suppl 6, no. 4 (December 1988): S487–89. https://doi.org/10.1097/00004872-198812040-00154.Full Text Link to Item
-
Dzau, V. J. “Recommendations of the Adult Treatment Panel of the National Cholesterol Education Program. Implications for the management of hypertension.” Hypertension 12, no. 5 (November 1988): 471–73. https://doi.org/10.1161/01.hyp.12.5.471.Full Text Link to Item
-
Dzau, V. J., R. E. Pratt, M. Paul, and N. Nakamura. “Molecular studies of human renin synthesis and gene expression.” Cardiovasc Drugs Ther 2, no. 4 (November 1988): 459–62. https://doi.org/10.1007/BF00051183.Full Text Link to Item
-
Dzau, V. J., and G. H. Gibbons. “Cell biology of vascular hypertrophy in systemic hypertension.” Am J Cardiol 62, no. 11 (October 5, 1988): 30G-35G. https://doi.org/10.1016/0002-9149(88)90029-x.Full Text Link to Item
-
Pratt, R. E., J. E. Carleton, T. P. Roth, and V. J. Dzau. “Evidence for two cellular pathways of renin secretion by the mouse submandibular gland.” Endocrinology 123, no. 4 (October 1988): 1721–27. https://doi.org/10.1210/endo-123-4-1721.Full Text Link to Item
-
Dzau, V. J. “Evolving concepts of the renin-angiotensin system. Focus on renal and vascular mechanisms.” Am J Hypertens 1, no. 4 Pt 2 (October 1988): 334S-337S. https://doi.org/10.1093/ajh/1.4.334s.Full Text Link to Item
-
Dzau, V. J., D. W. Burt, and R. E. Pratt. “Molecular biology of the renin-angiotensin system.” Am J Physiol 255, no. 4 Pt 2 (October 1988): F563–73. https://doi.org/10.1152/ajprenal.1988.255.4.F563.Full Text Link to Item
-
Dzau, V. J. “Contributions of neuroendocrine and local autocrine-paracrine mechanisms to the pathophysiology and pharmacology of congestive heart failure.” Am J Cardiol 62, no. 8 (September 9, 1988): 76E-81E. https://doi.org/10.1016/s0002-9149(88)80017-1.Full Text Link to Item
-
Creager, M. A., A. T. Hirsch, E. G. Nabel, S. S. Cutler, W. S. Colucci, and V. J. Dzau. “Responsiveness of atrial natriuretic factor to reduction in right atrial pressure in patients with chronic congestive heart failure.” J Am Coll Cardiol 11, no. 6 (June 1988): 1191–98. https://doi.org/10.1016/0735-1097(88)90281-1.Full Text Link to Item
-
Dzau, V. J. “Tissue renin-angiotensin system: physiologic and pharmacologic implications. Introduction.” Circulation 77, no. 6 Pt 2 (June 1988): I1–3.Link to Item
-
Dzau, V. J. “Circulating versus local renin-angiotensin system in cardiovascular homeostasis.” Circulation 77, no. 6 Pt 2 (June 1988): I4-13.Link to Item
-
Dzau, V. J. “Vascular and renal prostaglandins as counter-regulatory systems in heart failure.” Eur Heart J 9 Suppl H (June 1988): 15–19. https://doi.org/10.1093/eurheartj/9.suppl_h.15.Full Text Link to Item
-
Dzau, V. J., and M. E. Safar. “Large conduit arteries in hypertension: role of the vascular renin-angiotensin system.” Circulation 77, no. 5 (May 1988): 947–54. https://doi.org/10.1161/01.cir.77.5.947.Full Text Link to Item
-
Dzau, V. J. “Vascular renin-angiotensin system in hypertension. New insights into the mechanism of action of angiotensin converting enzyme inhibitors.” Am J Med 84, no. 4A (April 15, 1988): 4–8. https://doi.org/10.1016/0002-9343(88)90463-9.Full Text Link to Item
-
Dzau, V. J. “Cardiac renin-angiotensin system. Molecular and functional aspects.” Am J Med 84, no. 3A (March 11, 1988): 22–27. https://doi.org/10.1016/0002-9343(88)90201-x.Full Text Link to Item
-
Pratt, R. E., J. A. Flynn, P. M. Hobart, M. Paul, and V. J. Dzau. “Different secretory pathways of renin from mouse cells transfected with the human renin gene.” J Biol Chem 263, no. 7 (March 5, 1988): 3137–41.Link to Item
-
Ingelfinger, J. R., R. E. Pratt, and V. J. Dzau. “Regulation of extra-renal renin during ontogeny.” Endocrinology 122, no. 3 (March 1988): 782–86. https://doi.org/10.1210/endo-122-3-782.Full Text Link to Item
-
Paganelli, W. C., J. R. Cant, R. R. Pintal, I. Kifor, A. C. Barger, and V. J. Dzau. “Plasma atrial natriuretic factor during chronic thoracic inferior vena caval constriction.” Circ Res 62, no. 2 (February 1988): 279–85. https://doi.org/10.1161/01.res.62.2.279.Full Text Link to Item
-
Dzau, V. J. “Tissue renin-angiotensin system: Pharmacologic and pharmacologic implications. Introduction.” Circulation 77, no. 6 II SUPPL. (January 1, 1988).
-
Dzau, V. J. “Interactions of neurogenic, circulating and local humoral mechanisms in heart failure.” Tgo Tijdschrift Voor Therapie Geneesmiddel En Onderzoek 13, no. 5 SUPPL. (January 1, 1988): 9–13.
-
Dzau, V. J., and R. E. Pratt. “Renin gene expression, biosynthesis, and cellular pathways of secretion.” Clin Physiol Biochem 6, no. 3–4 (1988): 210–16.Link to Item
-
Hollenberg, N. K., V. J. Dzau, and C. S. Wilcox. “Roundtable discussion one.” American Journal of Hypertension 1, no. 4 (January 1, 1988): 350S-351S. https://doi.org/10.1093/ajh/1.4.350S.Full Text
-
Paul, M., D. W. Burt, N. Nakamura, R. E. Pratt, and V. J. Dzau. “Mapping of the human renin transcription start site: evidence for a single functional promoter.” Clin Exp Hypertens A 10, no. 6 (1988): 1313–16. https://doi.org/10.1080/07300077.1988.11878928.Full Text Link to Item
-
Pratt, R. E., D. W. Burt, N. Nakamura, M. Paul, and V. J. Dzau. “Identification of potential regulatory regions in the renin gene.” Clin Exp Hypertens A 10, no. 6 (1988): 1141–46. https://doi.org/10.1080/07300077.1988.11878806.Full Text Link to Item
-
Tang, S. S., and V. J. Dzau. “Partial purification of a prorenin activating enzyme in the aortic wall.” Clin Exp Hypertens A 10, no. 6 (1988): 1251–57. https://doi.org/10.1080/07300077.1988.11878915.Full Text Link to Item
-
Dzau, V. J., and G. H. Gibbons. “Autocrine-paracrine mechanisms of vascular myocytes in systemic hypertension.” Am J Cardiol 60, no. 17 (December 14, 1987): 99I-103I. https://doi.org/10.1016/0002-9149(87)90468-1.Full Text Link to Item
-
Chiu, P. J., S. Vemulapalli, M. Policelli, I. Kifor, E. J. Sybertz, and V. J. Dzau. “The responses of atrial natriuretic factor concentrations to acute volume changes in conscious rats.” Life Sci 41, no. 21 (November 23, 1987): 2339–47. https://doi.org/10.1016/0024-3205(87)90657-6.Full Text Link to Item
-
Farhi, E. R., J. R. Cant, W. C. Paganelli, V. J. Dzau, and A. C. Barger. “Stimulus-response curve of the renal baroreceptor: effect of converting enzyme inhibition and changes in salt intake.” Circ Res 61, no. 5 (November 1987): 670–77. https://doi.org/10.1161/01.res.61.5.670.Full Text Link to Item
-
Pratt, R. E., J. E. Carleton, J. P. Richie, C. Heusser, and V. J. Dzau. “Human renin biosynthesis and secretion in normal and ischemic kidneys.” Proc Natl Acad Sci U S A 84, no. 22 (November 1987): 7837–40. https://doi.org/10.1073/pnas.84.22.7837.Full Text Link to Item
-
Dzau, V. J., and S. L. Swartz. “Dissociation of the prostaglandin and renin angiotensin systems during captopril therapy for chronic congestive heart failure secondary to coronary artery disease.” Am J Cardiol 60, no. 13 (November 1, 1987): 1101–5. https://doi.org/10.1016/0002-9149(87)90361-4.Full Text Link to Item
-
Nabel, E. G., W. S. Colucci, L. S. Lilly, S. S. Cutler, J. A. Majzoub, M. G. St John Sutton, V. J. Dzau, and M. A. Creager. “Relationship of cardiac chamber volume to baroreflex activity in normal humans.” J Clin Endocrinol Metab 65, no. 3 (September 1987): 475–81. https://doi.org/10.1210/jcem-65-3-475.Full Text Link to Item
-
Dzau, V. J., J. A. Baxter, M. Cantin, A. de Bold, D. Ganten, K. Gross, A. Husain, T. Inagami, J. Menard, and S. Poole. “Report of the Joint Nomenclature and Standardization Committee of the International Society of Hypertension, American Heart Association and the World Health Organization.” J Hypertens 5, no. 4 (August 1987): 507–11. https://doi.org/10.1097/00004872-198708000-00018.Full Text Link to Item
-
Dzau, V. J. “Renal effects of angiotensin-converting enzyme inhibition in cardiac failure.” Am J Kidney Dis 10, no. 1 Suppl 1 (July 1987): 74–80.Link to Item
-
Dzau, V. J. “Possible prorenin activating mechanisms in the blood vessel wall.” J Hypertens Suppl 5, no. 2 (July 1987): S15–18. https://doi.org/10.1097/00004872-198707002-00004.Full Text Link to Item
-
Dzau, V. J., J. Rosenthal, and J. D. Swales. “Vascular renin--a consensus view.” J Hypertens Suppl 5, no. 2 (July 1987): S77–78. https://doi.org/10.1097/00004872-198707002-00014.Full Text Link to Item
-
Wood, J. M., H. P. Baum, J. Carleton, and V. J. Dzau. “Inhibition of renin-like activity in marmoset tissues by the renin inhibitor CGP 29 287.” J Hypertens Suppl 5, no. 2 (July 1987): S67–69. https://doi.org/10.1097/00004872-198707002-00012.Full Text Link to Item
-
Dzau, V. J. “Renal and circulatory mechanisms in congestive heart failure.” Kidney Int 31, no. 6 (June 1987): 1402–15. https://doi.org/10.1038/ki.1987.156.Full Text Link to Item
-
Dzau, V. J., K. E. Ellison, T. Brody, J. Ingelfinger, and R. E. Pratt. “A comparative study of the distributions of renin and angiotensinogen messenger ribonucleic acids in rat and mouse tissues.” Endocrinology 120, no. 6 (June 1987): 2334–38. https://doi.org/10.1210/endo-120-6-2334.Full Text Link to Item
-
Dzau, V. J., T. Brody, K. E. Ellison, R. E. Pratt, and J. R. Ingelfinger. “Tissue-specific regulation of renin expression in the mouse.” Hypertension 9, no. 6 Pt 2 (June 1987): III36–41. https://doi.org/10.1161/01.hyp.9.6_pt_2.iii36.Full Text Link to Item
-
Dzau, V. J., J. D. Baxter, M. Cantin, A. de Bold, D. Ganten, K. Gross, A. Husain, T. Inagami, J. Menard, and S. Poole. “Nomenclature for atrial peptides.” N Engl J Med 316, no. 20 (May 14, 1987): 1278–79. https://doi.org/10.1056/NEJM198705143162018.Full Text Link to Item
-
Dzau, V. J. “Renin-angiotensin system and renal circulation in clinical congestive heart failure.” Kidney Int Suppl 20 (May 1987): S203–9.Link to Item
-
Hirsch, A. T., V. J. Dzau, and M. A. Creager. “Baroreceptor function in congestive heart failure: effect on neurohumoral activation and regional vascular resistance.” Circulation 75, no. 5 Pt 2 (May 1987): IV36–48.Link to Item
-
Levenson, D. J., and V. J. Dzau. “Effects on angiotensin-converting enzyme inhibition on renal hemodynamics in renal artery stenosis.” Kidney Int Suppl 20 (May 1987): S173–79.Link to Item
-
Dzau, V. J., D. Gonzalez, C. Kaempfer, D. Dubin, and B. U. Wintroub. “Human neutrophils release serine proteases capable of activating prorenin.” Circ Res 60, no. 4 (April 1987): 595–601. https://doi.org/10.1161/01.res.60.4.595.Full Text Link to Item
-
Kifor, I., and V. J. Dzau. “Endothelial renin-angiotensin pathway: evidence for intracellular synthesis and secretion of angiotensins.” Circ Res 60, no. 3 (March 1987): 422–28. https://doi.org/10.1161/01.res.60.3.422.Full Text Link to Item
-
Dzau, V. J. “Implications of local angiotensin production in cardiovascular physiology and pharmacology.” Am J Cardiol 59, no. 2 (January 23, 1987): 59A-65A. https://doi.org/10.1016/0002-9149(87)90178-0.Full Text Link to Item
-
Dzau, V. J. “Evolution of the clinical management of hypertension. Emerging role of "specific" vasodilators as initial therapy.” Am J Med 82, no. 1A (January 5, 1987): 36–43. https://doi.org/10.1016/0002-9343(87)90142-2.Full Text Link to Item
-
Dzau, V. J. “Vascular angiotensin pathways: a new therapeutic target.” J Cardiovasc Pharmacol 10 Suppl 7 (1987): S9-16.Link to Item
-
Dzau, V. J. “Molecular studies of human renin structure and synthesis using monoclonal antibodies.” Clin Exp Hypertens A 9, no. 8–9 (1987): 1291–1304. https://doi.org/10.3109/10641968709158984.Full Text Link to Item
-
Dzau, V. J., D. Gonzalez, K. Ellison, S. Churchill, and N. Emmett. “Characterization of purified rabbit uterine renin: influence of pregnancy on uterine inactive renin.” Endocrinology 120, no. 1 (January 1987): 358–64. https://doi.org/10.1210/endo-120-1-358.Full Text Link to Item
-
Dzau, V. J., J. A. Baxter, M. Cantin, A. De Bold, D. Ganten, K. Gross, A. Husain, et al. “Report of the Joint Nomenclature and Standardization Committee of the International Society of Hypertension, the American Heart Association, and the World Health Organization.” Hypertension 10, no. 4 (January 1, 1987): 461–64.
-
Dzau, V. J., J. I. S. Robertson, A. M. Richards, R. E. Gaines Das, and S. Poole. “International collaborative study of the proposed international standard for atrial natriuretic factor: An initial analysis of radio-immunoassay results.” Journal of Hypertension 5, no. SUPPL. 5 (January 1, 1987).
-
Dzau, V. J., J. Rosenthal, and J. D. Swales. “Vascular renin - A consensus view: The following chairman's summary is based upon the papers and discussions held at the Ulm meeting.” Journal of Hypertension, Supplement 5 (January 1, 1987): S77–78.
-
Dzau, V. J., and F. M. Sacks. “Regulation of lipoprotein metabolism by adrenergic mechanisms.” J Cardiovasc Pharmacol 10 Suppl 9 (1987): S2–6.Link to Item
-
Dzau, V. J., and M. A. Creager. “Clinical response to angiotensin-converting enzyme inhibition in cardiac failure.” Clin Exp Hypertens A 9, no. 2–3 (1987): 521–29. https://doi.org/10.3109/10641968709164220.Full Text Link to Item
-
Dzau, V. J., and M. Creager. “Influence of angiotensin-converting-enzyme inhibitors on clinical outcome and survival in congestive heart failure.” Practical Cardiology 13, no. 12 (January 1, 1987): 40–49.
-
Dzau, V. J., and R. N. Re. “Evidence for the existence of renin in the heart.” Circulation 75, no. 1 Pt 2 (January 1987): I134–36.Link to Item
-
Ingelfinger, J. R., R. E. Pratt, K. Ellison, and V. J. Dzau. “Sodium regulation of angiotensinogen mRNA expression in rat kidney cortex and medulla.” J Clin Invest 78, no. 5 (November 1986): 1311–15. https://doi.org/10.1172/JCI112716.Full Text Link to Item
-
Rogart, R. B., A. deBruyn Kops, and V. J. Dzau. “Identification of two calcium channel receptor sites for [3H]nitrendipine in mammalian cardiac and smooth muscle membrane.” Proc Natl Acad Sci U S A 83, no. 19 (October 1986): 7452–56. https://doi.org/10.1073/pnas.83.19.7452.Full Text Link to Item
-
Dzau, V. J. “Significance of the vascular renin-angiotensin pathway.” Hypertension 8, no. 7 (July 1986): 553–59. https://doi.org/10.1161/01.hyp.8.7.553.Full Text Link to Item
-
Dzau, V. J., J. Ingelfinger, R. E. Pratt, and K. E. Ellison. “Identification of renin and angiotensinogen messenger RNA sequences in mouse and rat brains.” Hypertension 8, no. 6 (June 1986): 544–48. https://doi.org/10.1161/01.hyp.8.6.544.Full Text Link to Item
-
Fritz, L. C., A. E. Arfsten, V. J. Dzau, S. A. Atlas, J. D. Baxter, J. C. Fiddes, J. Shine, C. L. Cofer, P. Kushner, and P. A. Ponte. “Characterization of human prorenin expressed in mammalian cells from cloned cDNA.” Proc Natl Acad Sci U S A 83, no. 12 (June 1986): 4114–18. https://doi.org/10.1073/pnas.83.12.4114.Full Text Link to Item
-
Naftilan, A. J., V. J. Dzau, and J. Loscalzo. “Preliminary observations on abnormalities of membrane structure and function in essential hypertension.” Hypertension 8, no. 6 Pt 2 (June 1986): II174–79. https://doi.org/10.1161/01.hyp.8.6_pt_2.ii174.Full Text Link to Item
-
Day, R. P., K. Y. Hui, M. Gure, W. D. Carlson, V. J. Dzau, and E. Haber. “A monoclonal antibody specific for the amino terminal sequence of human prorenin identifies a common epitope on renal and amniotic fluid inactive renins.” J Hypertens 4, no. 3 (June 1986): 375–81. https://doi.org/10.1097/00004872-198606000-00020.Full Text Link to Item
-
Shemin, R. J., M. Phillippe, and V. Dzau. “Acute thrombosis of a composite ascending aortic conduit containing a Bjork-Shiley valve during pregnancy: successful emergency cesarean section and operative repair.” Clin Cardiol 9, no. 6 (June 1986): 299–301. https://doi.org/10.1002/clc.4960090614.Full Text Link to Item
-
Sacks, F. M., and V. J. Dzau. “Adrenergic effects on plasma lipoprotein metabolism. Speculation on mechanisms of action.” Am J Med 80, no. 2A (February 14, 1986): 71–81. https://doi.org/10.1016/0002-9343(86)90163-4.Full Text Link to Item
-
Dzau, V. J., M. Mudgett-Hunter, and E. Haber. “Monoclonal antibodies as molecular probes to study structural heterogeneity between human and animal renins and other aspartyl proteinases.” J Clin Endocrinol Metab 62, no. 2 (February 1986): 424–28. https://doi.org/10.1210/jcem-62-2-424.Full Text Link to Item
-
Dzau, V. J., C. S. Wilcox, K. Sands, and P. Dunckel. “Dog inactive renin: biochemical characterization and secretion into renal plasma and lymph.” Am J Physiol 250, no. 1 Pt 1 (January 1986): E55–61. https://doi.org/10.1152/ajpendo.1986.250.1.E55.Full Text Link to Item
-
Dzau, V. J., J. R. Ingelfinger, and R. E. Pratt. “Regulation of tissue renin and angiotensin gene expressions.” J Cardiovasc Pharmacol 8 Suppl 10 (1986): S11–16. https://doi.org/10.1097/00005344-198600101-00004.Full Text Link to Item
-
Dzau, V. J., and J. Kreisberg. “Cultured glomerular mesangial cells contain renin: influence of calcium and isoproterenol.” J Cardiovasc Pharmacol 8 Suppl 10 (1986): S6-10. https://doi.org/10.1097/00005344-198600101-00003.Full Text Link to Item
-
Ingelfinger, J. R., R. E. Pratt, K. E. Ellison, T. P. Roth, and V. J. Dzau. “Multiple sites of regulation of mouse renin expression in ontogeny.” Clin Exp Hypertens A 8, no. 4–5 (1986): 687–94. https://doi.org/10.3109/10641968609046586.Full Text Link to Item
-
Quay, S. C., A. Heropoulos, K. Commes, and V. J. Dzau. “Probing the renin active site by collisional quenching of endogenous fluorescence.” J Biol Chem 260, no. 28 (December 5, 1985): 15055–58.Link to Item
-
Chatterjee, K., W. W. Parmley, J. N. Cohn, T. B. Levine, N. A. Awan, D. T. Mason, D. P. Faxon, M. Creager, H. P. Gavras, and F. M. Fouad. “A cooperative multicenter study of captopril in congestive heart failure: hemodynamic effects and long-term response.” Am Heart J 110, no. 2 (August 1985): 439–47. https://doi.org/10.1016/0002-8703(85)90167-x.Full Text Link to Item
-
Lilly, L. S., R. E. Pratt, R. W. Alexander, D. M. Larson, K. E. Ellison, M. A. Gimbrone, and V. J. Dzau. “Renin expression by vascular endothelial cells in culture.” Circ Res 57, no. 2 (August 1985): 312–18. https://doi.org/10.1161/01.res.57.2.312.Full Text Link to Item
-
Nabel, E. G., G. H. Gibbons, and V. J. Dzau. “Pathophysiology of experimental renovascular hypertension.” Am J Kidney Dis 5, no. 4 (April 1985): A111–19. https://doi.org/10.1016/s0272-6386(85)80073-1.Full Text Link to Item
-
Given, B. D., T. H. Lee, P. H. Stone, and V. J. Dzau. “Nifedipine in severely hypertensive patients with congestive heart failure and preserved ventricular systolic function.” Arch Intern Med 145, no. 2 (February 1985): 281–85.Link to Item
-
Dzau, V. J. “In vivo inhibition of renin by antirenin antibodies: potential experimental and clinical applications.” J Cardiovasc Pharmacol 7 Suppl 4 (1985): S53–57. https://doi.org/10.1097/00005344-198507004-00011.Full Text Link to Item
-
Haber, E., and V. J. Dzau. “Molecular mechanisms that control renin secretion.” Hypertension 7, no. 6 Pt 1 (1985): 853–54. https://doi.org/10.1161/01.hyp.7.6.853.Full Text Link to Item
-
Kopelman, R. I., and V. J. Dzau. “Trends in the therapy for mild hypertension. A word of caution.” Arch Intern Med 145, no. 1 (January 1985): 47–49.Link to Item
-
Dzau, V. J., K. Ellison, D. McGowan, K. W. Gross, and A. Ouellette. “Hybridization studies with a renin cDNA probe: evidence for widespread expression of renin in the mouse.” J Hypertens Suppl 2, no. 3 (December 1984): S235–37.Link to Item
-
Lilly, L. S., V. J. Dzau, G. H. Williams, L. Rydstedt, and N. K. Hollenberg. “Hyponatremia in congestive heart failure: implications for neurohumoral activation and responses to orthostasis.” J Clin Endocrinol Metab 59, no. 5 (November 1984): 924–30. https://doi.org/10.1210/jcem-59-5-924.Full Text Link to Item
-
Dzau, V. J. “Vascular wall renin-angiotensin pathway in control of the circulation. A hypothesis.” Am J Med 77, no. 4A (October 5, 1984): 31–36. https://doi.org/10.1016/s0002-9343(84)80035-2.Full Text Link to Item
-
Dzau, V. J., and N. K. Hollenberg. “Renal response to captopril in severe heart failure: role of furosemide in natriuresis and reversal of hyponatremia.” Ann Intern Med 100, no. 6 (June 1984): 777–82. https://doi.org/10.7326/0003-4819-100-6-777.Full Text Link to Item
-
Husain, A., R. R. Smeby, D. Wilk, V. J. Dzau, and F. M. Bumpus. “Biochemical and immunological properties of dog brain isorenin.” Endocrinology 114, no. 6 (June 1984): 2210–15. https://doi.org/10.1210/endo-114-6-2210.Full Text Link to Item
-
Given, B. D., M. Phillippe, S. P. Sanders, and V. J. Dzau. “Procainamide cardioversion of fetal supraventricular tachyarrhythmia.” Am J Cardiol 53, no. 10 (May 15, 1984): 1460–61. https://doi.org/10.1016/s0002-9149(84)91257-8.Full Text Link to Item
-
Dzau, V. J., R. I. Kopelman, A. C. Barger, and E. Haber. “Comparison of renin-specific IgG and antibody fragments in studies of blood pressure regulation.” Am J Physiol 246, no. 3 Pt 2 (March 1984): H404–9. https://doi.org/10.1152/ajpheart.1984.246.3.H404.Full Text Link to Item
-
Dzau, V. J., M. Packer, L. S. Lilly, S. L. Swartz, N. K. Hollenberg, and G. H. Williams. “Prostaglandins in severe congestive heart failure. Relation to activation of the renin--angiotensin system and hyponatremia.” N Engl J Med 310, no. 6 (February 9, 1984): 347–52. https://doi.org/10.1056/NEJM198402093100603.Full Text Link to Item
-
Wintroub, B. U., L. B. Klickstein, V. J. Dzau, and K. W. Watt. “Granulocyte-angiotensin system. Identification of angiotensinogen as the plasma protein substrate of leukocyte cathepsin G.” Biochemistry 23, no. 2 (January 17, 1984): 227–32. https://doi.org/10.1021/bi00297a009.Full Text Link to Item
-
Dzau, V. J. “Vascular renin-angiotensin: a possible autocrine or paracrine system in control of vascular function.” J Cardiovasc Pharmacol 6 Suppl 2 (1984): S377–82.Link to Item
-
Dzau, V. J. “Vascular renin-angiotensin: A possible autocrine or paracrine system in control of vascular function.” Journal of Cardiovascular Pharmacology 6, no. SUPPL. 2 (January 1, 1984): 5377–82.
-
Dzau, V. J., D. Devine, M. Mudgett-Hunter, and E. Haber. “Monoclonal antibodies specific for human renin.” Trans Assoc Am Physicians 97 (1984): 146–50.Link to Item
-
Dzau, V. J., R. I. Kopelman, A. C. Barger, and R. Haber. “Comparison of renin-specific IgG and antibody fragments in studies of blood pressure regulation.” American Journal of Physiology Heart and Circulatory Physiology 15, no. 3 (January 1, 1984).
-
Gibbons, G. H., and V. J. Dzau. “The effect of calcium channel blockade on plasma renin activity (PRA) in the sodium-deprived conscious dog.” Federation Proceedings 43, no. 4 (January 1, 1984).
-
Haber, E., V. J. Dzau, R. M. Graham, and R. M. Zusman. “Hypertension: The evolution of a scientific journal.” Hypertension 6, no. 1 (January 1, 1984): 1.
-
Pratt, R. E., and V. J. Dzau. “Purification and characterization of one-chain and two-chain renins from mouse submandibular gland.” Hypertension 6, no. 2 II (1984): I-101-I–105.
-
Gibbons, G. H., V. J. Dzau, E. R. Farhi, and A. C. Barger. “Interaction of signals influencing renin release.” Annu Rev Physiol 46 (1984): 291–308. https://doi.org/10.1146/annurev.ph.46.030184.001451.Full Text Link to Item
-
Husain, A., D. Wilk, R. R. Smeby, V. J. Dzau, and F. M. Bumpus. “Isorenin in dog brain and other tissues.” Clin Exp Hypertens A 6, no. 10–11 (1984): 1795–99. https://doi.org/10.3109/10641968409046081.Full Text Link to Item
-
Pratt, R. E., V. J. Dzau, and A. J. Ouellette. “Influence of androgen on translatable renin mRNA in the mouse submandibular gland.” Hypertension 6, no. 5 (1984): 605–13. https://doi.org/10.1161/01.hyp.6.5.605.Full Text Link to Item
-
Pratt, R. E., and V. J. Dzau. “Purification and characterization of one-chain and two-chain renins from mouse submandibular gland.” Hypertension 6, no. 2 Pt 2 (1984): I101–5. https://doi.org/10.1161/01.hyp.6.2_pt_2.i101.Full Text Link to Item
-
Berliner, R., V. J. Dzau, N. K. Hollenberg, and P. J. Cannon. “Kidney and cardiovascular regulation. Introduction.” Fed Proc 42, no. 15 (December 1983): 3135.Link to Item
-
Dzau, V. J., N. K. Hollenberg, and G. H. Williams. “Neurohumoral mechanisms in heart failure: role in pathogenesis, therapy, and drug tolerance.” Fed Proc 42, no. 15 (December 1983): 3162–69.Link to Item
-
Ichikawa, I., R. A. Ferrone, K. L. Duchin, M. Manning, V. J. Dzau, and B. M. Brenner. “Relative contribution of vasopressin and angiotensin II to the altered renal microcirculatory dynamics in two-kidney Goldblatt hypertension.” Circ Res 53, no. 5 (November 1983): 592–602. https://doi.org/10.1161/01.res.53.5.592.Full Text Link to Item
-
Pratt, R. E., A. J. Ouellette, and V. J. Dzau. “Biosynthesis of renin: multiplicity of active and intermediate forms.” Proc Natl Acad Sci U S A 80, no. 22 (November 1983): 6809–13. https://doi.org/10.1073/pnas.80.22.6809.Full Text Link to Item
-
Given, B. D., T. Taylor, L. S. Lilly, and V. J. Dzau. “Symptomatic hypotension following the clonidine suppression test for pheochromocytoma.” Arch Intern Med 143, no. 11 (November 1983): 2195–96.Link to Item
-
“Captopril and renal insufficiency.” N Engl J Med 309, no. 11 (September 15, 1983): 665–67. https://doi.org/10.1056/nejm198309153091115.Full Text Link to Item
-
Ikemoto, F., V. J. Dzau, E. Haber, K. Takaori, and K. Yamamoto. “Immunoaffinity chromatography of canine high-molecular-weight renin: partial purification and characterization.” Clin Sci (Lond) 65, no. 2 (August 1983): 117–20. https://doi.org/10.1042/cs0650117.Full Text Link to Item
-
Herrmann, H. C., and V. J. Dzau. “The feedback regulation of angiotensinogen production by components of the renin-angiotensin system.” Circ Res 52, no. 3 (March 1983): 328–34. https://doi.org/10.1161/01.res.52.3.328.Full Text Link to Item
-
Hsueh, W. A., E. J. Carlson, and V. J. Dzau. “Characterization of inactive renin from human kidney and plasma. Evidence of a renal source of circulating inactive renin.” J Clin Invest 71, no. 3 (March 1983): 506–17. https://doi.org/10.1172/jci110795.Full Text Link to Item
-
Kopelman, R. I., V. J. Dzau, S. Shimabukuro, and A. C. Barger. “Compensatory response to hemorrhage in conscious dogs on normal and low salt intake.” Am J Physiol 244, no. 3 (March 1983): H351–56. https://doi.org/10.1152/ajpheart.1983.244.3.H351.Full Text Link to Item
-
Hricik, D. E., P. J. Browning, R. Kopelman, W. E. Goorno, N. E. Madias, and V. J. Dzau. “Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or renal-artery stenosis in a solitary kidney.” N Engl J Med 308, no. 7 (February 17, 1983): 373–76. https://doi.org/10.1056/NEJM198302173080706.Full Text Link to Item
-
Dzau, V. J., D. Devine, M. Mudgett-Hunter, R. I. Kopelman, A. C. Barger, and E. Haber. “Antibodies as specific renin inhibitors: studies with polyclonal and monoclonal antibodies and Fab fragments.” Clin Exp Hypertens A 5, no. 7–8 (1983): 1207–20. https://doi.org/10.3109/10641968309048852.Full Text Link to Item
-
Haber, E., R. Zusman, J. Burton, V. J. Dzau, and A. C. Barger. “Is renin a factor in the etiology of essential hypertension?” Hypertension 5, no. 6 III (1983): V-8-V–15.
-
Kopelman, R. I., V. J. Dzau, S. Shimabukuro, and A. C. Barger. “Compensatory response to hemorrhage in conscious dogs on normal and low salt intake.” American Journal of Physiology Heart and Circulatory Physiology 13, no. 3 (January 1, 1983).
-
Mizoguchi, H., V. J. Dzau, L. G. Siwek, and A. C. Barger. “Effect of intrarenal administration of dopamine on renin release in conscious dogs.” American Journal of Physiology Heart and Circulatory Physiology 13, no. 1 (January 1, 1983).
-
Dzau, V. J., G. H. Gibbons, and D. C. Levin. “Renovascular hypertension: an update on pathophysiology, diagnosis and treatment.” Am J Nephrol 3, no. 2–3 (1983): 172–84. https://doi.org/10.1159/000166707.Full Text Link to Item
-
Haber, E., R. Zusman, J. Burton, V. J. Dzau, and A. C. Barger. “Is renin a factor in the etiology of essential hypertension?” Hypertension 5, no. 6 Pt 3 (1983): V8-15. https://doi.org/10.1161/01.hyp.5.6_pt_3.v8.Full Text Link to Item
-
Mizoguchi, H., V. J. Dzau, L. G. Siwek, and A. C. Barger. “Effect of intrarenal administration of dopamine on renin release in conscious dogs.” Am J Physiol 244, no. 1 (January 1983): H39–45. https://doi.org/10.1152/ajpheart.1983.244.1.H39.Full Text Link to Item
-
Dzau, V. J., A. Brenner, and N. L. Emmett. “Evidence for renin in rat brain: differentiation from other reninlike enzymes.” Am J Physiol 242, no. 5 (May 1982): E292–97. https://doi.org/10.1152/ajpendo.1982.242.5.E292.Full Text Link to Item
-
Dzau, V. J., and H. C. Herrmann. “Hormonal control of angiotensinogen production.” Life Sci 30, no. 7–8 (February 15, 1982): 577–84. https://doi.org/10.1016/0024-3205(82)90272-7.Full Text Link to Item
-
Re, R., J. T. Fallon, V. Dzau, S. C. Quay, and E. Haber. “Renin synthesis by canine aortic smooth muscle cells in culture.” Life Sci 30, no. 1 (January 4, 1982): 99–106. https://doi.org/10.1016/0024-3205(82)90641-5.Full Text Link to Item
-
Dzau, V. J. “Isolation and regulation of brain renin.” Experimental Brain Research 45, no. Suppl. 4 (January 1, 1982): 92–108. https://doi.org/10.1007/978-3-642-46456-0_5.Full Text
-
Dzau, V. J., A. Brenner, and N. L. Emmett. “Evidence for renin in rat brain: Differentiation from other reninlike enzymes.” American Journal of Physiology Endocrinology and Metabolism 5, no. 5 (January 1, 1982).
-
Dzau, V. J., and K. E. Sands. “The regulation of angiotensinogen biosynthesis by the pituitary gland.” Federation Proceedings 41, no. 4 (January 1, 1982).
-
Dzau, V. J., and K. E. Sands. “Regulation of brain renin: Evidence for an independent brain renin.” Clinical Science 63, no. Suppl. 8 (January 1, 1982).
-
Mizoguchi, H., J. R. Cant, V. J. Dzau, and A. C. Barger. “A reduction in renal perfusion pressure sensitizes the kidney to dopamine-mediated renin release in conscious dogs.” Federation Proceedings 41, no. 4 (January 1, 1982).
-
Dzau, V. J., A. Brenner, S. Wolfsohn, and E. Haber. “Characterization of antibodies to canine renal renin. Studies of interspecies homology of renin using antibodies as probe.” Hypertension 4, no. 3 (1982): 341–47. https://doi.org/10.1161/01.hyp.4.3.341.Full Text Link to Item
-
Dzau, V. J., A. Tanaka, and R. E. Pratt. “The nature of renin precursor and inactive renin.” Clin Exp Hypertens A 4, no. 11–12 (1982): 1973–85. https://doi.org/10.3109/10641968209062363.Full Text Link to Item
-
Kaplan, M. M., P. R. Larsen, F. R. Crantz, V. J. Dzau, T. H. Rossing, and J. E. Haddow. “Prevalence of abnormal thyroid function test results in patients with acute medical illnesses.” Am J Med 72, no. 1 (January 1982): 9–16. https://doi.org/10.1016/0002-9343(82)90565-4.Full Text Link to Item
-
Dzau, V. J., A. Ouellette, and R. Pratt. “Studies of the biosynthesis of renin with a cell-free translation system.” Clin Sci (Lond) 61 Suppl 7 (December 1981): 241s-243s. https://doi.org/10.1042/cs061241s.Full Text Link to Item
-
Pratt, R. E., V. J. Dzau, and A. J. Ouellette. “Abundant androgen regulated mRNAs in mouse submandibular gland: cell-free translation of renin precursor mRNA.” Nucleic Acids Res 9, no. 14 (July 24, 1981): 3433–49. https://doi.org/10.1093/nar/9.14.3433.Full Text Link to Item
-
Dzau, V. J., W. S. Colucci, N. K. Hollenberg, and G. H. Williams. “Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure.” Circulation 63, no. 3 (March 1981): 645–51. https://doi.org/10.1161/01.cir.63.3.645.Full Text Link to Item
-
Dzau, V., M. Mudgett-Hunter, G. Kapler, and E. Haber. “Monoclonal antibodies binding renal renin.” Hypertension 3, no. 6 II (1981): II-4-II–8.
-
Mizoguchi, H., V. J. Dzau, L. Siwek, and A. C. Barger. “The possible role of dopamine in the regulation of renin release.” Physiologist 24, no. 4 (January 1, 1981).
-
Dzau, V. J., L. G. Siwek, S. Rosen, E. R. Farhi, H. Mizoguchi, and A. C. Barger. “Sequential renal hemodynamics in experimental benign and malignant hypertension.” Hypertension 3, no. 3 Pt 2 (1981): I63–68. https://doi.org/10.1161/01.hyp.3.3_pt_2.i63.Full Text Link to Item
-
Dzau, V., M. Mudgett-Hunter, G. Kapler, and E. Haber. “Monoclonal antibodies binding renal renin.” Hypertension 3, no. 6 Pt 2 (1981): II-4–8. https://doi.org/10.1161/01.hyp.3.6_pt_2.ii-4.Full Text Link to Item
-
Martin, A. R., M. A. Wolf, L. A. Thibodeau, V. Dzau, and E. Braunwald. “A trial of two strategies to modify the test-ordering behavior of medical residents.” N Engl J Med 303, no. 23 (December 4, 1980): 1330–36. https://doi.org/10.1056/NEJM198012043032304.Full Text Link to Item
-
Dzau, V. J., A. Brenner, N. Emmett, and E. Haber. “Identification of renin and renin-like enzymes in rat brain by a renin-specific antibody.” Clin Sci (Lond) 59 Suppl 6 (December 1980): 45s-47s. https://doi.org/10.1042/cs059045s.Full Text Link to Item
-
Sacks, H., S. Kupfer, and T. C. Chalmers. “Are uncontrolled clinical studies ever justified?” N Engl J Med 303, no. 18 (October 30, 1980): 1067. https://doi.org/10.1056/NEJM198010303031822.Full Text Link to Item
-
Dzau, V. J., W. S. Colucci, G. H. Williams, G. Curfman, L. Meggs, and N. K. Hollenberg. “Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure.” N Engl J Med 302, no. 25 (June 19, 1980): 1373–79. https://doi.org/10.1056/NEJM198006193022501.Full Text Link to Item
-
Dzau, V. J., R. I. Kopelman, A. C. Barger, and E. Haber. “Renin-specific antibody for study of cardiovascular homeostasis.” Science 207, no. 4435 (March 7, 1980): 1091–93. https://doi.org/10.1126/science.6986653.Full Text Link to Item
-
Dzau, V. J., L. Siwek, and A. C. Barger. “Sequential renal hemodynamic changes in experimental benign and malignant hypertension.” Circulation 62, no. 4 II (January 1, 1980).
-
Dzau, V. J., E. E. Slater, and E. Haber. “Complete purification of dog renal renin.” Biochemistry 18, no. 23 (November 13, 1979): 5224–28. https://doi.org/10.1021/bi00590a029.Full Text Link to Item
-
Slater, E. E., R. C. Cohn, V. J. Dzau, and E. Haber. “Purification of human renal renin.” Clin Sci Mol Med Suppl 4 (December 1978): 117s-119s. https://doi.org/10.1042/cs055117s.Full Text Link to Item
-
Dzau, V. J., E. E. Slater, and E. Haber. “Pure dog renal renin.” Circulation 58, no. 4 II (January 1, 1978).
-
Dzau, V. J., L. G. Siwek, and A. C. Barger. “Intrarenal dopaminergic receptors in control of renin release in the conscious dog.” Federation Proceedings 37, no. 3 (January 1, 1978).
-
Slater, E. E., R. C. Cohn, V. J. Dzau, and E. Haber. “Complete purification of human renin.” Circulation 58, no. 4 II (January 1, 1978).
-
Dzau, V. J., S. Szabo, and Y. C. Chang. “Aspiration of metallic mercury. A 22-year follow-up.” Jama 238, no. 14 (October 3, 1977): 1531–32.Link to Item
-
Szabo, S., E. S. Reynolds, L. M. Lictenberger, L. R. Haith, and V. J. Dzau. “Pathogenesis of duodenal ulcer. Gastric hyperacidity caused by propionitrile and cysteamine in rats.” Res Commun Chem Pathol Pharmacol 16, no. 2 (February 1977): 311–23.Link to Item
-
Dzau, V. J., A. A. Rossini, A. R. Christlieb, and G. H. Williams. “Aldosterone secretion during insulin therapy in uncomplicated diabetes mellitus.” Clinical Research 25, no. 3 (January 1, 1977).
-
Kovacs, K., E. Horvath, S. Szabo, V. J. Dzau, and E. S. Reynolds. “Effect of vinblastine on rat liver ultrastructure.” Arzneimittelforschung 27, no. 4 (1977): 825–28.Link to Item
-
Dzau, V. J., P. H. Schur, and L. Weinstein. “Vibrio fetus endocarditis in a patient with systemic lupus erythematosus.” Am J Med Sci 272, no. 3 (1976): 331–34. https://doi.org/10.1097/00000441-197611000-00010.Full Text Link to Item
-
Kovacs, K., E. Horvath, S. Szabo, V. J. Dzau, Y. C. Chang, D. Feldman, and E. S. Reynolds. “Effect of vinblastine on the fine structure of the rat adrenal cortex.” Horm Metab Res 7, no. 4 (July 1975): 356–356.Link to Item
-
Dzau, V. J., L. R. Haith, S. Szabo, and E. S. Reynolds. “Effect of metiamide on the development of duodenal ulcers produced by cysteamine or propionitrile in rats.” Clinical Research 23, no. 5 (January 1, 1975).
-
Dzau, V. J., F. Von Lichtenberg, E. S. Reynolds, D. Feen, and H. Goldman. “Letter: Hepatic bridging--a semantic collapse.” N Engl J Med 291, no. 4 (July 25, 1974): 212.Link to Item
-
Kovacs, K., E. Horvath, S. Szabo, V. J. Dzau, D. Feldman, Y. Chang, and E. S. Reynolds. “Effect of vinblastine on neurohypophysial and adenohypophysial microtubules.” Steroids Lipids Res 5, no. 3 (1974): 167–72.Link to Item
-
Szabo, S., V. J. Dzau, D. Feldman, and E. S. Reynolds. “Effect of propionitrile and cysteamine on gastric secretion in rats.” Clinical Research 22, no. 3 (January 1, 1974).
-
-
Book Sections
-
Pratt, R. E., and V. J. Dzau. “Molecular and cellular biology of angiotensin-mediated growth of the cardiovascular system.” In Cellular and Molecular Biology of the Renin-Angiotensin System, 471–83, 2018. https://doi.org/10.1201/9781351070492.Full Text
-
Dzau, V. J., W. F. ElLaissi, and K. Udayakumar. “Future Directions.” In The Transformation of Academic Health Centers: Meeting the Challenges of Healthcare’s Changing Landscape, 47–54, 2015. https://doi.org/10.1016/B978-0-12-800762-4.00006-2.Full Text
-
Hodgkinson, C. P., J. A. Gomez, A. Bareja, and V. J. Dzau. “Role of Paracrine Mechanisms.” In Stem Cell and Gene Therapy for Cardiovascular Disease, 39–48, 2015. https://doi.org/10.1016/B978-0-12-801888-0.00004-7.Full Text
-
Gnecchi, M., M. Mirotsou, and V. J. Dzau. “V. What is the paracrine effect of stem cells?: A. Stem cell therapy for heart repair: The paracrine paradigm.” In Heart Regeneration: Stem Cells and Beyond, 219–46, 2012. https://doi.org/10.1142/9789814299817_0005.Full Text
-
Feener, E. P., and V. J. Dzau. “Pathogenesis of cardiovascular disease in diabetes.” In Joslin’s Diabetes Mellitus: Fourteenth Edition, 867–84, 2011.
-
Gnecchi, M., and V. J. Dzau. “Adult Stem Cell-Based Therapy for the Heart.” In Heart Development and Regeneration: Volume I, 1:899–935, 2010. https://doi.org/10.1016/B978-0-12-381332-9.00043-8.Full Text
-
Creager, M. A., V. J. Dzau, and J. Loscalzo. “Connective Tissues of the Subendothelium.” In Vascular Medicine: A Companion to Braunwald’s Heart Disease, 31–60, 2006. https://doi.org/10.1016/B978-0-7216-0284-4.50009-9.Full Text
-
Keister, L. A. “Introduction,” Vol. 15, 2005. https://doi.org/10.1016/S0277-2833(05)15001-8.Full Text
-
Dzau, V. J. “Foreword,” Vol. 47, 1994.
-
Dzau, V. J. “Introduction,” 15:V–VI, 1990. https://doi.org/10.1097/00005344-199000152-00001.Full Text
-
Dzau, V. J. “Introduction,” 13:ix, 1989. https://doi.org/10.1097/00005344-198900132-00001.Full Text
-
-
Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.